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1 THE SOCIAL CONSTRUCTION OF AFRICA’S HIV EPIDEMIC 
 
 
1.1 The Social Construction of Disease Epidemics 
An epidemic is popularly understood to be an outbreak of an infectious 
disease affecting a wide swath of a population, more or less at the same time or 
perhaps in a long, contiguous stretch of time.  However, this simple definition of 
what constitutes an epidemic is not particularly useful in the formulation of 
public policies or in the design of health interventions by a variety of actors.  
These institutions that act in the domain of public health require an 
understanding not only of the biomedical and technical characteristics of a 
disease and its spread, but also of the social dynamics and characteristics that 
cause or condition the spread of a disease.  Often these social dynamics and 
characteristics, as one might imagine, can be quite difficult to perceive, identify 
and understand and are infinitely more difficult to act upon.  They may even be 
incorrectly perceived, identified, understood and acted upon, leading to a host of 
secondary problems which then become subsequently more difficult to address.  
However, the quest to mitigate or end an epidemic does require that the effort be 
made and this effort (conscious or otherwise) by individuals and institutions to 
perceive, identify and understand the social characteristics and dynamics of an 
epidemic is what I will refer to as the social construction of a disease epidemic. 
 
 Study of the social construction of disease traditionally falls into the 
confines of medical sociology and refers generally to the exploration of “the 
effects of class, race, gender, language, technology, culture, the political economy, 
and institutional and professional structures and norms in shaping the knowledge 
base which produces our assumptions about the prevalence, incidence, treatment, 
and meaning of disease”.1  As the social construction of disease clearly has public 
health policy implications, particularly in resource-poor settings where the effects 
of epidemic disease are often magnified, it can also be seen to fall within the area 
of development studies and development policy.  It is with this view towards 
understanding where and how development policies related to public health 
originate and the nature of their cumulative momentum—or path dependency if 
you like—that I shall explore the social construction of disease epidemics and of 
Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome 
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(HIV/AIDS) in particular.  I hope to show that, while social constructions are 
observable, and are indeed endemic to HIV policy and the avenues of HIV 
research which gain traction, they are rarely explicitly questioned or explored 
leading to a well-entrenched path of least resistance in research and policy.    
 
 This chapter shall explore social constructions of ‘sick’ individuals and how 
these constructions relate to perceptions of how and why a disease spreads.  We 
will look at how the social construction of sick individuals and beliefs about the 
transmissibility of their illness aggregate through mechanisms such as target 
grouping and become entrenched in policy, supporting many misconceptions and 
leading to path dependency in HIV policy that is difficult to contest, even with 
empirical evidence in support of alternative paths.  
 
 Section 1.2 then addresses the social dynamics behind the transformation 
of HIV/AIDS into a ‘sexually transmitted disease’ looking back into history and 
tracing some of the Colonial-era medical and health-related actions that have, 
arguably, carried over into the HIV discourse resulting in what I call 
‘institutionalized racism’ in HIV/AIDS policy within and towards African 
nations. While others have noted some similarities between for example, 
Colonial-era syphilis policies and HIV policies in Africa,2,3,4,5 I hope to build upon 
that work by connecting this long history of institutionalized racism with the 
more modern social constructions of the HIV epidemic which crowd out many 
avenues of debate about efficacious HIV policy in Africa. 
 
 Within each section, discussion of the policy implications of various 
aspects of social constructions has been integrated in order to demonstrate the 
relevance of these social constructions to modern public health policy in the area 
of HIV/AIDS in a pragmatic and, I hope, intuitive manner.  
 
 
1.1.1  Monsterization, Target Grouping and Risk Grouping 
Throughout human history, people suffering from different illnesses – 
infectious diseases in particular—have played many and varied roles.  The 
stereotypical images of the poverty-ridden and irresponsible consumptive 
(tuberculosis)6, the prostitute as an evil reservoir of ‘The Clap’ (gonorrhea) and 
the dirty, shunned sufferer of ‘The Pox’ (syphilis) still carry a certain weight in the 
minds of many people although few people in recent generations have actually 
had first-hand experience with many of these (in)famous diseases. These so-
called ‘metaphorical connotations’7 are common and continue to impact persons 
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living with a plethora of diseases.  In relation to HIV/AIDS, though the specific 
epidemics in developed countries (where HIV remains largely confined to men 
who have sex with men – MSM – and intravenous drug users) and the 
generalized epidemics found in many sub-Saharan African countries (where 
women are at least as effected as men) have little in common, the ‘iconography’ 
of HIV has made the voyage from the United States to sub-Saharan Africa 
virtually unaltered.  As AIDS was first identified exclusively in MSM in the 
United States – and was, indeed, named ‘Gay Immunodeficiency Virus’ until 
1982—it quickly became known as a sexually transmitted disease (and not, 
importantly, as a viral infection such as Hepatitis B) which affected gay men due 
to their ‘lifestyle’ choices and sexual ‘deviance’ which related not only to 
homosexual activity, but also reports by the early cohorts of AIDS patients in the 
USA of having had numerous sexual partners.8 This early and much-publicized 
classification of AIDS as a sexually-transmitted disease of promiscuity carried 
over to SSA regardless of the fact that historical epidemiological accounts are 
quite clear that AIDS in Africa most probably originated and was disseminated 
early on through blood exposures (and not sexual exposures).9  Though reported 
sexual behavior in SSA could not hope, in fact, to explain the magnitude of the 
HIV epidemics nor dramatic differences in prevalence between African countries 
(as discussed in detail later in this chapter), the imagery of the ‘sexual deviant’ as 
the reservoir of AIDS has been impossible to purge from both the popular and 
academic psyche, and has been extended from the homosexual population of the 
developed world to the heterosexual population of SSA.  
 
Figure 1 illustrates a simple scheme demonstrating how ‘sick’ individuals may 
be categorized, or in other words, what role they may be assigned in a society.  
While many other factors can and do contribute to the social construction of a 
‘sick’ person (i.e.: extant religious beliefs, socio-economic characteristics of the 
worst-affected population, availability of a cure or effective treatment, etc...), this 
figure simplifies matters somewhat by looking at the generic roles assigned to 
‘sick’ people based on just two factors: (1) Whether the person is perceived to 
have ‘caught’ the disease through his/her own irresponsible behavior or if it was 
presumably someone else’s fault and; (2) the perceived level of danger that the 
‘sick’ person poses to uninfected persons. 
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Figure 1. Categorization of Sick Individuals 
 
Source: Author’s own presentation 
 
 
In the social construction of HIV/AIDS, particularly in sub-Saharan Africa, 
the most commonly claimed modes of transmission are through sexual 
intercourse and mother-to-child transmission (MTCT) in the case of children.  
On an individual level, the sexual behavior that is perceived as necessary for one 
to become infected with HIV (ie: promiscuity, infidelity, multiple or concurrent 
partners, etc…) is considered ‘deviant’ as mentioned above in relation to the 
origins of AIDS iconography in the USA.  Those perceived as having become 
infected with HIV through sexual contact, however, may on the one hand be 
classified as simply ‘deviant’ if the perception of the probability of infecting other 
people remains low.  This was often the case during the earlier years of the 
epidemic in the USA as the majority of the American population did not feel 
threatened by a sexually transmitted disease believed to only be passed to and 
from gay men through homosexual intercourse.10 However, if the infected person 
is believed to not only have contracted HIV through their own irresponsible 
sexual behavior, but also to be in a position to infect others in the general 
population, then this person is perceived as a greater threat and could be 
categorized as a ‘monster’.  An example of this type of classification would be the 
iconography of prostitutes as reservoirs of sexually transmitted infections such as 
syphilis and gonorrhea and, from the mid-1980’s forward, also of HIV.11 
 
Both of these classificiations (‘deviant’ and ‘monster’) rely heavily on the 
assumption that the infected person is at fault for his/her infection.  If, on the 
other hand, one falls into a group that is seen as having been infected with HIV 
  How Person Became Infected  
    Own Fault 
(irresponsible behavior) 




































Coddled Victim  
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through no fault of one’s own (such as children or, at times, women), one may be 
classified as one of two types of ‘victim’: the shunned victim is the victim who is 
seen to have been infected through no fault of his/her own, but is considered a 
danger to others.  This group may include some women who could be seen to 
have been infected by philandering husbands—this is a topic oft-discussed in the 
academic literature on African women and HIV12,13—however, they may fall into 
the ‘shunned’ group when they bring children into the world as the risk of 
transmitting HIV from mother-to-child is generally perceived to be very high and 
HIV-infected mothers who choose to have children may be considered 
irresponsible.14 The coddled victim, conversely, is perceived as less of a potential 
danger to others (less infectious) and deserving of care and sympathy.  With the 
example of HIV given here, hemophiliacs are a perfect example of a victimized 
group (in the developed world) as they became infected through blood products 
received in a medical setting to treat a disease (hemophilia) which is acquired 
genetically.  The importance of this perceived threat to others, while not typically 
discussed in the HIV discourse, has been shown to be significant in the study of 
tuberculosis patients and their feelings of marginalization or ‘demonization’.15 
 
At the heart of this type of classification is the idea that “more than [being] 
mere sociological curiosities, these cultural meanings have an impact on the way 
the illness is experienced, how the illness is depicted, the social response to the 
illness, and what policies are created concerning the illness”16  In particular, the 
aggregation of these categories that is implicit in policy-making becomes of great 
concern in an area such as HIV/AIDS, with its vast outlays of resources, both 
human and financial, as well as the complex disease-specific infrastructure that 
exists in many nations.  This phenomenon of aggregation and the concrete policy 
consequences that follow will be discussed in the following sub-sections dealing 




Schneider and Ingram (1993) succinctly frame the issue of how the social 
construction of ‘target populations’ in policy-making shapes both the policy 
agenda as well as the policies themselves.  They point out how social 
constructions can portray groups of people either positively or negatively as 
discussed briefly above.  Consequently, political incentives are structured so that 
politicians generally “provide beneficial policy to powerful, positively constructed 
target populations and […] devise punitive, punishment-oriented policy for 
negatively constructed groups”.17  Political science perspectives on social 
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construction and policy range from the idea of ‘causal stories’18,19 to messages 
sent by policy which explicitly or implicitly communicate “what government is 
supposed to do, which citizens are deserving (and which not)”.20 They help to 
effectively identify who is to blame for a political problem and therefore, who is 
responsible for acting to resolve the problem.   
 
Forming a target group undeniably has political as well as economic 
justifications, and target populations “are measurable, empirical, phenomena” 
with policy being the specific tool which creates the empirical boundaries if they 
did not already exist.21  In the case of public health and infectious disease, the 
formation of a target group implicitly defines and sets apart the people whose 
behavior has been identified as propagating or advancing an epidemic (or, 
conversely, who are perceived victims of those who are seen as advancing an 
epidemic) and whose behavior must be changed through incentives, coercion or 
punishment in order to address the epidemic (or, conversely, who must be 
protected from those who are advancing the epidemic).  These target groups may 
or may not have had a distinct and well-defined social construction before a 
policy was introduced, but surely after the introduction of policy, their social 
construction is well under way.   
 
In the HIV/AIDS discourse, the social construction of target groups has 
evolved over time and often different contexts see the ‘same’ people put into 
different types of groups (i.e.: the political power of gay men as a group is quite 
different in the developed world vs. in most of sub-Saharan Africa). Though 
target groups are ubiquitous in HIV/AIDS policy-making, the exploration 
undertaken here to understand how they are formed and the assumptions 
(relating to the social construction of HIV-infected people) behind their 
formation have remained surprisingly free from examination and criticism up 
until now. Yet, there are some common themes which can be fit within 
Schneider and Ingrams’s (1993) framework of ‘types of target populations’ (Fig 2) 
and I shall use that framework to continue the discussion on the pertinence of 
target grouping in the HIV/AIDS discourse.  
 
The matrix uses two measures: (1) ‘power’ (weak or strong), generally 
understood as political power but which I will also extend to what has come to 
be called ‘interpersonal bargaining power’ and; (2) ‘constructions’ (positive or 
negative), which refer to the way that the group as a whole is socially perceived.  
The resulting matrix then identifies four types of target groups: ‘Advantaged’ 
(strong and positively constructed); ‘Contenders’ (strong but negatively 
constructed); ‘Dependents’’ (weak but positively constructed) and; ‘Deviants’ 
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(weak and negatively constructed).  You will note in Figure 2 that in the 
HIV/AIDS discourse, I have been unable to identify a target group which falls 
into the ‘Advantaged’ category; that is, I could not identify a politically powerful 
group of HIV-infected persons (or a group where HIV infection is particularly 
high) that is positively socially constructed or positively perceived by society.  It is 
also important in this matrix to understand that we are speaking of the 
beneficiaries of policies (i.e.: HIV-infected individuals that fall within a certain 
socio-political group) and not necessarily groups or organizations that lobby for 
HIV-infected persons.  A clear example of this distinction would be the well-
known Treatment Action Campaign (TAC) in South Africa. This group has great 
political power and has lobbied successfully for policies that have benefitted a 
vast array of HIV-infected target groups, however, they are not listed as a target 
group in and of themselves as they are generally understood to be a 3rd party 
political action (lobbying) group rather than a politically or socially-defined group 
of potential beneficiaries fighting for policies to benefit themselves, personally.  
 






















o ‘Elite’ citizens with HIV (i.e.: 
politicians, famous athletes, famous 
musicians, etc…) 










o Children with HIV 
o People who are believed to have 
contracted HIV nosocomially 
(medical setting) 
o Some women with HIV 
(particularly those who do not have 





o Intravenous (illicit) drug users with 
HIV 
o Poor men with HIV 
o Prisoners or ex-convicts with HIV 
o Prostitutes and people who are 
believed to engage in ‘transactional sex’ 
o Some women with HIV 
(particularly those who have passed it 
to their child and are then seen to be 
perpetrators) 
o Gay men in most of Sub Saharan 
Africa 
 
Adapted from Schneider and Ingram (1993) 
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This categorization of target groups is more than simply a convenient 
theoretical illustration.  The types of policies and the way that they are justified in 
the political sphere differ widely between the various groups with “rationales for 
providing beneficial policy to powerless groups [emphasizing] justice-oriented 
legitimations, rather than instrumental ones”22.  In the HIV/AIDS discourse, the 
prime example of justice-based legitimations can be found in the human rights 
discourse.  Instrumental legitimations would encompass arguments to address the 
epidemic based upon, for example, potentially broad economic benefits of 
mitigating the epidemic.  Interestingly, “the association of justice-oriented 
rationales to dependent populations seems to hold even when a case can be made 
linking the policy to national goals such as economic development”.23 
 
Justice-based or rights-based legitimations of policy allow for symbolic and 
rhetorical measures that ostensibly benefit target populations (i.e.: ‘universal 
access to HIV prevention’) and fall into an altruistic vision of government; while 
instrumentally-oriented rationales (i.e.: economic benefits for society as a whole) 
are neither symbolic nor altruistically framed and typically require larger resource 
investments in the target group.   
 
At this point, an important note should be made: Let us not be led astray by 
the modern fondness for the phrase ‘universal access’ in the HIV/AIDS 
discourse which would seem to imply that no target group exists.  The target 
group, of course, is the group that does not currently have access based on any 
number of characteristics such as income, gender, age, geography, etc... When 
attempting to identify the target group in statements about ‘universal access’, one 
must simply look at who already has access, and the remaining population then 
becomes the ‘target group’.   
 
By identifying ways that action towards target groups can instrumentally 
benefit society as a whole, governments would then be implicitly acknowledging 
that acting is no longer “altruistic”—in other words, their action would not be 
based only on helping the target groups themselves out of a sense of goodwill or 
an abstract notion of justice/rights, but rather on helping the society as a 
whole—and therefore, it would become more difficult for governments to justify 
inaction, symbolic action, rhetorical action or under-allocation of resources to the 
target group.   
 
This byplay can clearly be seen in the arguments surrounding HIV/AIDS 
policy.  All sorts of rhetoric and symbolic action can be seen in the international, 
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national and local commitments to ‘universal access to HIV prevention, 
treatment and care’.  It is difficult to imagine a more perfect example of rhetorical 
action than a commitment to universal access to HIV prevention.  This is because it is 
difficult to find any explicit explanation of what ‘universal access to HIV 
prevention’ may imply on a practical or logistical level. As HIV is a blood-borne 
pathogen, and this policy statement (this ‘commitment’ on the part of 
governments) is presumably directed towards governmental/institutional-
provided prevention, one could then interpret it to mean, in part, that stringent 
infection control measures will be adopted in all healthcare settings, with the 
concomitant investment of financial and human resources, to ensure that no one 
is a victim of completely preventable nosocomial transmission1 of HIV (or other 
infectious pathogens for that matter). Yet, this very resource-intensive 
interpretation of ‘universal access to HIV prevention’ is rarely acknowledged or 
adopted by governments in the highest-prevalence nations (nor by the 
international organizations working in these settings).  The ‘universal access to 
HIV prevention’ if it is examined or interpreted at all, is generally considered 
synonymous with access to condoms and, in some more affluent settings, with 
access to needle exchange programs for intravenous (illegal) drug users (IUDs).  
In other words, universal access to HIV prevention does not, in fact, refer to 
protection of the population from fairly universal, institutional-level threats of 
infection (i.e.: infection in formal and informal healthcare settings), but rather 
rhetorically guarantees access to information or interventions meant to bring 
about individual behavior change.  
 
By basing the universal access to HIV treatment, on the other hand, in a 
rhetorical and symbolic ‘statement’ of commitment, governments (and 
international organizations) simultaneously achieve two ends.  First, they ground 
the universal access to HIV treatment in a human rights discourse (the above-
mentioned justice-based rationale), rather than referring to any instrumental 
rationale (i.e.: immense public health expenditures saved by not having to treat 
opportunistic infections of AIDS patients, population-level preventative benefits 
of universal treatment, etc…).  This ensures the government’s role as the 
paternalistic and altruistic benefactor of passive HIV-infected persons.  Second, 
through the continued stress put on individual sexual behavior change as the 
exclusive legitimate prevention strategy, the target group for treatment (HIV-
infected persons), is effectively either ‘dependent’ (weak but positively-
                                                 
1 Nosocomial transmission is transmission of a pathogen in a healthcare setting and can 
include modes of transmission such as injections with re-used needles and/or syringes, 
blood transfusions with infected blood or non-sterile transfusion equipment, etc… 
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constructed) or ‘deviant’ (weak and negatively-constructed) which continues to 
absolve the government and international donors of political responsibility to 
invest the vast resources that would be needed to provide universal HIV 
treatment.  So, in the end, these ‘symbolic policies permit elected leaders to show 
great concern but relieve them of the need to allocate resources’.24   
 
An interesting and clear example of the importance of positive vs. negative 
social constructions in HIV treatment policy can be seen in the debates 
surrounding antiretroviral treatment (ART) for persons living with HIV (PLWH) 
and the use of antiretrovirals (ARVs) as pre-exposure prophylaxis (PrEP) for 
persons who are not infected with HIV.25,26,27,28  The financial, logistic, and human 
resource constraints to providing ART to all HIV-infected persons in need have 
been discussed extensively and simply broaching the subject of universal ART 
inspires immediate and interminable diatribes on the infeasibility of this strategy 
for treatment and prevention with the phrase, “we can’t treat our way out of the 
epidemic”, habitually thrown in for good measure.29 
 
Let us put this in the framework of social constructions of sick people and 
target groups.  Remember here that people living with HIV are almost invariably 
negatively-constructed.  PrEP, on the other hand, is targeted mainly towards 
adolescent girls and women (‘weak’ politically but positively perceived in society; 
in other words, they are generally seen as ‘victims’ of the HIV epidemic).  
However, we must, of course, note that the financial, logistic and human 
resource constraints that apply to ART provision for PLWH would necessarily 
intensify significantly for PrEP provision as ARVs in whatever form (oral, vaginal 
gel, etc…) would need to be produced and provided on-demand, for the vast 
non-HIV-infected population for generations to come.  Rather than providing 
ARVs to the 5-20% of the population infected with HIV, the financial, logistic 
and human resource constraints inherent in ARV provision would have to be 
overcome in order to provide PrEP to the 80-95% of the population that is not 
infected with HIV, presumably in perpetuity.  And yet, the same people 
(researchers, politicians, laypeople) who repeat the mantra “we cannot treat our 
way out of the epidemic” enthusiastically support the idea of PrEP.  The question 
is: why?  PrEP is astoundingly impractical and infeasible by any objective 
measure of feasibility (‘we cannot PrEP our way out of the epidemic’), yet its 
rhetorical political appeal is phenomenal.   
 
At the XVIII International AIDS Conference (AIDS2010) held in Vienna, a 
special panel session dealing with PrEP was held.30  The panel of experts 
(academic researchers, a high-ranking UNAIDS representative, the then-
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incoming President of the International AIDS Society, etc…) were asked to 
comment on the feasibility of PrEP in light of the above constraints to providing 
ARVs to a much smaller population (namely, as treatment for people living with 
HIV) and were also asked to comment on the diversion of ARV-related 
resources from people living with HIV to the uninfected population.  Dr. Patrick 
Ndase, whose presentation had specifically, though very briefly, mentioned 
concerns about diversion of resources from ART to PrEP, responded and 
correctly pointed out that ART coverage has increased and continues to increase 
dramatically in most of sub-Saharan Africa (SSA).  However, he did not address 
the question of feasibility of PrEP in light of the challenges inherent in ARV 
provision and, not unexpectedly, ended his response: “we cannot treat our way 
out of the epidemic”.  Prof. Helen Rees also added a note regarding the target 
population of PrEP in the context where she works (South Africa), noting that 
the adolescent girls whom she studies desperately need a way to avoid contracting 
HIV from their sexual partners without the knowledge of their partners (who 
presumably refuse to use condoms).  These adolescent girls were depicted as 
vulnerable and innocent, (positive social construction) victims of older, often 
HIV-infected male sexual partners who refuse to use condoms (the ‘monsters’ 
and ‘deviants’ from our earlier analyses).  These girls are voiceless (politically-
weak) and must be provided with a strategy to protect themselves from the 
above-mentioned men as their lack of interpersonal bargaining power (again, 
‘weak’) makes them the archetypal victims of the HIV epidemic.  We could not 
hope for a more perfect example of the social construction of infected people 
and its interplay with target grouping in HIV policy.   
 
Speaking of ART access in this discussion would have required a politically-
dangerous defense, as it were, of the HIV-infected men (‘monsters’ and 
‘deviants’) whereas, speaking of protecting the ‘dependent’ (politically-weak and 
positively-constructed) at-risk adolescent girls and young women is politically 
noble.  Here punitive policies towards the negatively-constructed HIV-infected 
men are not even necessary as the absence of treatment for them is akin to 
punishment.  The feasibility, epidemiological logic or relative efficacy from a 
population-level point of view of the one approach (ART for HIV-infected 
persons) vs. the other (PrEP for uninfected persons) is not up for policy 
discussion.  The policy agenda is unable to consider such dichotomies based 
strictly on science and evidence as policy is, as the name implies, political; which 
groups are targeted by policy is perhaps one of the most obvious and intuitive 
manifestations of the power of social constructions in the HIV/AIDS discourse.  
 
14 CHAPTER 1 
It is important to highlight here that where some might hope or believe that 
experts may bring a more ‘objective’ (i.e.: apolitical) point of view to the policy-
making table,  experts inevitably are also vulnerable to the strength and 
pervasiveness of social constructions and, in fact, often are the parties who  
define target groups through their research and discourse.  This only to say that it 
would be rather ingenuous to believe that the questions asked by expert 
researchers are not influenced by “which goals they think are important and 
which targets they believe are the most logically connected to the goals.  The 
tools that experts think will motivate the targets rest on assumptions about 





“…risk, as a form of expert knowledge […] requires individuals to practice forms of 
self-regulation”.32  
 
The idea of ‘risk’ in the health discourse and of ‘risk groups’ in the health 
policy discourse has become so ubiquitous as to virtually escape popular scrutiny.  
Skolbekken (1995), through a series of MEDLINE database searches for articles 
related to ‘risk’, describes what he terms the ‘risk epidemic’ in medical and, 
especially, epidemiological journals from 1967-1991.33  Skolbekken went so far as 
to perform methodical searches for synonyms of ‘risk’ such as “gamble, hazard, 
danger, probability, uncertainty and odds-ratio” to be sure he was not simply 
finding a recent change in terminology.34  With the exception of articles in The 
Lancet, he saw steep increases in ‘risk-articles’ with more than 50% of them 
published in the last  5 years of his study period (1985-1990).  He notes, 
significantly, that not only the absolute number of risk-articles increased, but that 
their share of the total number of articles published also rose precipitously, 
reaching an astounding 50% of articles published in epidemiological journals 
from 1985-1990.   
 
Though the word ‘risk’ is, technically, neutral (i.e.: the statistical probability or 
likelihood of an occurrence), in public health as in popular usage, it has become 
synonymous with ‘danger’, implying an increased likelihood of something 
‘negative’ happening.35  Rarely do we hear that someone is ‘at high risk’ of living a 
long and healthy life, for example, though this would be linguistically correct.   
 
In the public health discourse, there are two distinct types of risk.  The first 
deals with personal or, as they have come to be called, ‘lifestyle’ risks.  These risks 
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will be familiar to readers for lifestyle choices such as smoking tobacco which 
increases one’s likelihood (‘risk’) of developing some types of cancer and chronic 
obstructive pulmonary disease (COPD) or drinking excess quantities of alcohol, 
thereby increasing one’s risk of developing cirrhosis of the liver.  One common 
attribute of most ‘lifestyle’ risks was that they traditionally referred to ostensibly 
rewarding (i.e.: pleasurable), usually addictive and always optional behaviors.  In 
other words, ‘lifestyle’ risk used to be a euphemism for drug usage in all its many 
and varied forms; legal (i.e.: tobacco, alcohol) or illicit (i.e.: cocaine, heroin).  With 
the introduction of the concept of ‘lifestyle’ risks to the HIV discourse, however, 
we have found that sexual intercourse in all its many and varied forms is now 
considered a ‘lifestyle’ choice.  It began, of course, with the inclusion of sex 
between men in the United States when AIDS was believed to be a ‘gay’ disease 
(and homosexuality was believed to be a lifestyle choice) and quite rapidly spread 
to the entire heterosexual population of sub-Saharan Africa.  To have or not have 
heterosexual intercourse, previously not considered a ‘lifestyle’ choice, has now 
become the main focus of HIV prevention measures, ignoring the quite obvious 
fact that this ‘lifestyle’ choice is, in fact, a biological imperative which may not be 
ignored for the survival of the species.  Nor is desiring or enjoying sex an 
addiction to be overcome (excluding the extremely small percentage of cases of 
genuine pathological sex addiction).  Even the application of strategies that 
mimic the ‘harm reduction’ strategy for intravenous drug users (e.g.: needle 
exchange programs) has crept into the HIV discourse with messages implying 
that it is better not to have sex at all (‘Abstain’), but if you must, then limit 
yourself to one partner (‘Be faithful’) or to serial monogamy (i.e.: ‘lover’ exchange 
that parallels the needle exchange for IUDs) and use condoms (as realistic an 
expectation as expecting IUDs to always boil and chemically disinfect their 
syringes and needles): The infamous ‘ABC’ approach.  Risk groups drawn from 
this paradigm of ‘sexual harm reduction’ then become virtually meaningless as all 
adolescents and adults are then included in ‘high risk’ categories with shades of 
nuance based on things like levels of education, geography, etc… The question 
then is: ‘high risk’ relative to what or to whom? In other words, when an entire 
population is classified as being ‘high risk’ because of a purported ‘lifestyle’ 
choice (that is, in fact, a biological imperative), the reduction of that risky 
behavior is not policy sensitive.  People then become part of the ‘high risk’ group 
simply by being born in or living in certain geographical regions or socio-
economic strata. 
 
Interestingly, the second type of risk that exists in the general public health 
discourse is rarely discussed in relation to HIV/AIDS.  This second type of risk 
concerns health dangers to populations where “the health threat is regarded as a 
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hazard that is external, over which the individual has little control”.36  This type 
of risk will most probably be familiar to readers in the area of environmental 
hazards such as pollution or toxic waste and the respective risk groups would 
normally be defined geographically (i.e.: persons living within a certain radius 
from the source of an environmental risk).  Consider, however, that this type of 
external (or non-individual) risk also exists in HIV/AIDS and is, of course, 
related to the risk of nosocomial transmission (blood-borne transmission in a 
healthcare setting), a topic about which little is heard in the African HIV 
discourse. Were this risk discussed in the HIV discourse, then the resultant risk 
groups would be defined based upon, for example, likely users of medical 
facilities with unsafe practices (i.e.: lack of sterilization of equipment, reuse of 
needles and/or syringes, unsafe blood supply, etc…).  Many researchers do not 
consider this an innocent omission, but rather a coherent political strategy to 
avoid a popular political mutiny as it were;37 an evasion of the expected response 
of “anger at government authorities, feelings of powerlessness and anxiety, and 
concern over the seemingly deliberate and unregulated” dangers posed by 
institutional-level risks to a relatively powerless populace.38 To publicly 
acknowledge an institutional-level risk would, therefore, dramatically alter the 
causal story of the African AIDS epidemics and, consequently, the public 
perception of who is to ‘blame’ for the epidemics and hence, who is responsible 
for acting.  From this omission of ‘external’ risk in the HIV risk and risk-group 
discourse we can see the power of the political sphere in risk-grouping much as it 
exists in target-grouping.  
 
In terms of actual policy-making related to risk groups, this near-complete 
omission of institutional-level risk and almost-exclusive focus on individual-level 
risk in the political discourse manifests concretely in the lack of effort that is 
made to distinguish between potentially policy-sensitive risk reduction and what I 
will refer to as ‘quixotic risk reduction’.  Quixotic of course evokes the impossible 
and ill-fated attempts of Miguel de Cervantes’ 17th century character, Don 
Quixote de la Mancha, to revive the escapades of chivalry and knights of old, 
culminating in his now infamous adventures, including his attacks on a group of 
windmills which he imagines to be giants.  ‘Quixotic’, then, has come to mean 
‘irrational and doomed-to-failure’.  How does this apply to certain strategies of 
‘risk reduction’ in health? If public health policy makers were to declare that the 
best way to fight cholera is for people to stop drinking water, the quixotic (i.e.: 
irrational and doomed-to-fail) nature of this policy would no doubt be instantly 
recognized.  Cholera is most assuredly transmitted to humans through 
contaminated water; however, this would be a clear example of a ‘quixotic risk 
reduction’ strategy as it is aimed at eliminating a biologically-necessary and 
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natural individual behavior.  It is clearly neither reasonable nor rational to expect 
people to stop drinking water in order to avoid becoming infected with cholera, 
therefore making this hypothetical risk-reduction strategy quixotic.  As Eileen 
Stillwaggon (2006) so eloquently states: 
 
Drinking contaminated water is a behavior, but one can hardly 
say that people get sick with cholera because they have a drinking 
problem. Becoming sick with cholera should not be viewed as the 
result of drinking behavior but of the infectious dose in the water 
consumed and the immune strength of the person consuming the 
contaminated water.  Poor people have worse water, and they are 
less resistant.  They probably do not drink more water.39 
 
In just this way, the decades-old classification of risk groups in the 
HIV/AIDS discourse that hinges upon individual sexual behavior—stating that 
abstinence is always the best ‘choice’, followed by being faithful to one partner if 
one must have sex and finally, if one ‘chooses’ not to follow either of the 
previous mandates, then use condoms—effectively disconnects sexual 
intercourse from its biological and emotional purposes, attempting to represent it 
as a ‘lifestyle choice’ over which individuals have complete agency.  As engaging 
or not engaging in sexual intercourse is not, in itself, a lifestyle choice, the 
continuing and concerted efforts of governments and public health agencies 
around the world to intervene at the level of individual sexual behavior is 
quixotic. Though small changes in sexual behavior may be possible through 
public health education, the defined ‘risk behavior’ (sexual intercourse) can and 
will never be eliminated (just as drinking water as a behavior will never be 
eliminated) and as such, efforts to curb the spread of HIV that focus on the least 
policy-sensitive area of intervention, are doomed to fail.  
 
1.2 Yesterday’s Racial Science to Today’s ‘Racial Metaphors’: 
HIV/AIDS Policy in Africa 
 
As previously discussed, when examining public policy dealing with 
HIV/AIDS prevention, we see that policy interventions often remain narrowly 
focused on individual sexual behavior modification, effectively isolating 
individual behavior from its social, historical and economic contexts, not to 
mention marginalizing or disregarding biological and ecological drivers of the 
epidemic.40,41  Often, and unfortunately, when the extraordinarily high rates of 
HIV infection in several Sub-Saharan African nations are addressed, scholars and 
policymakers alike begin their work from the implicit or explicit assumption that 
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the high rates of infection are attributable to individual sexual behavior despite 
empirical evidence to the contrary,42,43,44  and a dearth of cross-country empirical 
evidence in support of the assumption.45,46,47,48 Although recent work abounds as 
to the social and economic drivers of the HIV/AIDS epidemic in Africa, one will 
find that the majority of this work consistently positions sexual behavior as a 
mediating factor.  Take, for example, studies of women’s economic 
empowerment that distill the connection between economic empowerment and 
HIV/AIDS down to the likelihood of a woman ‘falling into prostitution’ or using 
condoms.49,50,51 
 
Dozens of dedicated and discerning researchers from medical and social 
science backgrounds continue to question this paradigm that attributes 50- to 
100-fold differences in [HIV/AIDS] prevalence between North America/Europe 
and southern African nations52 to individual behavior differences.53,54,55,56  They 
have pointed out that the over-emphasis on sexual behavior, partially stemming 
from recent population-control programs and even much further back to 20th 
century “racial science”, has led to a dangerous neglect of institutional and 
biological co-factors (e.g.: malnutrition, parasitic infections, endemic diseases 
such as malaria, etc...) that arguably could account for a considerable portion of 
the difference in infection rates found between Sub-Saharan Africa and 
Europe/North America.57,58,59,60,61,62 
 
This section examines the persistent racial stereotypes of Africans that are a 
regrettable holdover from the Colonial period and color not only HIV/AIDS 
policy in many African nations, but also and importantly, the questions which 
continue to be asked by countless researchers from all disciplines.  Drawing from 
and expanding upon Packard and Epstein (1991)63, a brief review of colonial and 
post-colonial medical-racial history in Africa and its ideological contribution to 
the current dominant HIV/AIDS policy paradigm will be outlined. This will be 
followed by an exploration of the misperception of extraordinary African 
sexuality and how this continues to serve as a red herring in the HIV/AIDS 
policy debate. The section will then conclude with a review of some of the 
ecological factors that may contribute to high rates of HIV infection in various 
African nations which receive little attention from the mainstream development 
community due to the continued focus on what I argue are racially-biased and 
scientifically-weak arguments espousing extraordinary African sexuality as the 
primary driver of the devastating HIV epidemic in a number of African nations.  
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1.2.1 Institutionalized Racism 
This section seeks to raise awareness regarding institutionalized racism in 
HIV/AIDS policy in Africa.  It does not however, seek to label individual 
researchers or policymakers as racist.  Theories abound as to the nature and 
origins of institutions and here I will draw implicitly upon Hodgson’s idea that 
institutions “depend upon the thoughts and activities of individuals but are not 
reducible to them”.64 To say that racism has been institutionalized is not to say 
that the individuals whose actions are guided by these institutions are, inherently, 
in agreement with the institutions themselves and are, therefore, racist.  The 
challenge here, as it were, is to trace the origins and evolution of racist ideology 
in the formulation of contemporary HIV/AIDS policy in Africa in order to 
demonstrate two things: (1) that the sexual behavior change paradigm is 
dangerously detached from reality and, (2) that unless we understand from where 
this disconnect has arisen, we will not be able to change the general mindset that 
causes perfectly reasonable and educated people to go along with irrational and 
empirically weak assumptions. 
 
1.2.2 From Racial Science to “Racial Metaphors”65 
 
Racism, of  course, has a long and ignominious history in Africa, most notably 
though not exclusively in reference to colonial activities.  Without re-cataloguing 
the entire history of  racist intellectual thought and action as evidenced by 
European colonial powers in Africa, it is useful for our purposes to briefly review 
some aspects of  the explicit racism of  the colonial era in Africa and understand 
how they may create a bridge to implicit racist theories and practices in 
contemporary African health research and policy-making.                  
                     
Racial science, politics and medicine have been intertwined in much of  Sub-
Saharan Africa at least since the early 19th century.66  The Colonial establishment 
in Africa was famously fixated on the idea of  “difference” and “otherness”, 
exhibiting a high level of  “anxiety over sexuality, and the relationship which 
develops between sexuality, pathology and ‘difference’ in the form of  skin 
colour”.67  Even in areas of  disease not related to sexuality, this focus on 
“otherness” was demonstrated through ostensibly medical practices such as the 
use of  phrenology2 in the 19th century South African Cape community to 
“physically and morally differentiat[e] colonists from their 'savage' neighbour”.68  
                                                 
2 Phrenology is the divination of personal characteristics such as intelligence and 
propensity to criminal behavior from the physiology of the skull and brain. 
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These ideas which seem so crude and unscientific to contemporary scholars can 
nonetheless be seen as dangerous predecessors to newer and more subtle forms 
of  medical racism.  As Bank (1996) succinctly states: “phrenology anticipated the 
scientific racism of  the early twentieth century in its doctrines of  biological 
determinism, its interest in skulls and comparative anatomy, its reliance on 
systems of  classification based on broadly defined racial 'types' and, above all, in 
its obsessive preoccupation with the nature of  the 'native mind'”.69   
 
The 'native mind' – presumably as contrasted with the ‘European’ mind—
supposedly gave rise to a morality different from and inferior to the European 
morality, an idea which shows up strongly even in the contemporary literature 
dealing with HIV/AIDS in Africa.  When transcribed to the issue of  HIV/AIDS 
however, the concept is no longer referred to as the 'native mind', but rather as 
the ‘African system of  sexuality’.70  We are to understand that this ‘African system’ 
apparently comprises cultural characteristics that are said to be common to over 
700 million people from hundreds of  language and ethnic groups; “this 
supposedly homogeneous cultural zone is coincident in its boundaries with a 
region identified in the Western view with blackness”.71  The Caldwells (1987) 
and their numerous followers in this train of  thinking regarding the 'African 
system of  sexuality' have even gone so far as to invent a metaphor which 
classifies Africans as a separate species altogether: ‘Homo Ancestralis’.72  While 
some may argue that it is merely a harmless metaphor, the use of  a pseudo-
taxonomical (and therefore, pseudo-scientific) classification for Africans in a 
scientific article and specifically, the use of  the made-up word 'Ancestralis',  is not 
only inappropriate, but also naturally calls to mind heavy-browed, physically-
powerful but intellectually-weak, primate-like human ancestors.  The word 'Sapien' 
(obviously, the true classification for our species) in comparison, carries the 
weight of  knowledge and wisdom not only in the original Latin, but in derivative 
words in most Romance languages (e.g.: 'wise' being saggia in Italian, sage in 
French, sábio in Portuguese, sabio in Spanish, etc...).  The metaphor, as well as 
the invention of  the 'African system' also “assumes that culture is a concept set 
in stone – fixed, rigid and static”,73 implying that this backwards, ancestral human 
species living in Africa is a victim of  its own “self-destructive incompetence”,74 
unable to control its basest urges even when the survival of  the species is at risk.   
 
The scientific racism of  the early 20th century to which Bank refers above is 
still important exactly because it can be said to have “created scientific 
justifications for racist practice”.75  The recent pseudo-taxonomic label Home 
Ancestralis creates a scientific sounding name for a bogus, racist idea, again 
lending the weight of  science to racist ideals. 
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While different areas in Africa experienced very different kinds of  colonial 
rule and it would be impossible to present a homogenous picture, it may be 
enlightening to focus our attention briefly on the early 20th century British 
Colonial response to syphilis in East and Central Africa3.  While medical racism 
existed in areas not related to sexually transmitted disease (venereal disease), for 
our purposes, an examination of  Vaughan’s historical accounts of  anti-venereal 
policy may be most informative.76,77  Through this history we can witness one of  
the early phases of  the racialized discourse in African colonial medicine that may, 
arguably, still exert the most influence on modern thinking regarding the social 
epidemiology of  HIV in Africa.  
 
Anthropologists and medical missionaries have, for over 100 years, been 
incredibly focused on “[…] finding social and cultural ‘origins’ for disease 
patterns”.78  In this sense, venereal disease was particularly well-suited to the 
religious-moralistic-cultural argument, as control of  sexuality played such a 
crucial role in the Euro-Christian doctrine.  Early anthropologists found a 
veritable playground of  interesting material in Africa and their work “which 
documented the customs, beliefs and kinship systems of  African peoples, 
provided a vocabulary with which the African colonial subject would be defined 
and discussed”.79  The British Colonial and medical missionary response to 
venereal disease in the early 20th century revealed religious-moralistic-cultural 
undertones in two ways: saving the immortal souls of  Africans while 
simultaneously (and conditionally) freeing them from the ravages of  venereal 
disease which plagued them because of  “[…] the essential ‘sinfulness’ of  
traditional African society”.80  The push to tie together sin and disease could be 
seen not only in the medical-religious conceptualization of  disease, but also in 
the reticence towards using discrete biomedical treatments (injections in this case) 
to treat disease without simultaneously seeking to convert the afflicted.  “Healing, 
for medical missionaries, was part of  a programme of  social and moral 
engineering through which ‘Africa’ would be saved”.81         
 
Early, uninhibited treatment seeking behaviors of  Africans (for syphilis) were 
appreciated by some British Colonial medical officers who stressed quick and 
                                                 
3 Ironically, it was later acknowledged that much of what was thought to be Syphilis in 
Africa (Treponema pallidum) was actually Yaws (Treponema pallidum subsp. pertenue).  Both 
are members of the Phylum Spirochaetes and are virtually indistinguishable from one 
another under a microscope.  Yaws is passed from any skin-to-skin contact with lesions 
of an infected person making it a non-venereal subspecies of Syphilis (Dawson, 1987b; 
Vaughan, 1992) 
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effective treatment as the best and even only option to combat disease stating 
that “[..] the only propaganda that was worthwhile was quick and free treatment 
[and that] nothing could be done with the idea of  chastity: it must be treated as a 
public health problem and when enough of  the population has been treated, V.D. 
[venereal disease] would disappear”.82  These same treatment seeking behaviors 
were instead abhorred by the arguably more influential medical missionary 
establishment which lamented the lack of  shame among Africans and believed 
that “a sense of  shame attached to venereal disease was a necessary step on the 
way towards the enforcement of  a new moral code, and that this would ultimately 
be the only effective means of  control”.83  Again, inherent in the moralistic-
religious framing of  the syphilis problem is the idea that the uncontrolled, sinful 
sexuality of  Africans underlay the spread of  the disease and, crucially, that this 
sexuality was different than European sexuality.  Clearly this required a 
monumental willful ignorance on the part of  the medical missionary 
establishment as the “enlightened” and Christian populous of  Europe suffered 
severe epidemics of  syphilis for centuries until the introduction of  antibiotics in 
the 1940s and, in fact, public health departments in all affluent nations continue 
to battle this old enemy.  
 
 
1.2.3 African Promiscuity 
 
As we have seen with the example of  syphilis in the early 20th century, the 
preoccupation with ‘African sexuality’ (and its alleged difference from ‘European 
sexuality’) is not a modern phenomenon.  One of  the striking characteristics of  
contemporary scholarly works pertaining to HIV/AIDS continues to be the 
repeated and persistent characterization of  Africans as “promiscuous” and 
further, the use of  this catch-all explanation of  promiscuity as an explanation for 
an HIV/AIDS pandemic with infection rates orders of  magnitude greater than 
those that we find in industrialized nations.84  In the more recent literature, 
scholars have dutifully begun disguising the derogatory and value-laden word 
“promiscuous” with more innocuous-sounding words and phrases such as 
“people engaging in risky sexual behavior”85, “people with multiple sexual 
partners”86 or “people with concurrent sexual partners”.  However, what 
repeatedly escapes mention is the fact that sexual behavior which is common in 
affluent European nations and the United States, when it occurs in Africa, cannot 
possibly account for the vast differences in HIV infection rates between many 
African nations and Europe/North America.     
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With the example of  syphilis in British Colonial Africa above we’ve seen a 
brief  glimpse of  the medical and anthropological origins or early manifestations 
of  the misperception of  extraordinary African sexuality.  However, these 
inaccurate representations of  Africans continue to be recycled in 21st century 
arguments, most recently in relation to HIV/AIDS. 
 
Before diving into some data on sexual behavior, however, let us deliberate the 
arguments and concerns that, quite reasonably, circulate regarding 
methodological challenges in gathering and interpreting this kind of  data. When 
looking at the data on relatively modest levels of  sexual activity in many African 
nations (relative to the USA for example) the common reflexive response is to 
question the data based on supposed taboos and reticence regarding sex in 
African cultures.  These concerns only become peculiar in scientific inquiry when 
they are used to precipitously dismiss results which differ from the preconceived 
notions of  researchers.  The main issue with this strategy that paints African 
misreporting with a broad brush deals with magnitude and consistency as 




The magnitude of  the differences in reported sexual activity between many 
African nations and the United States, for example, is quite striking and would 
make this degree of  misreporting—and the assumption of  misreporting only in 
the African nations, not in the United States—highly unlikely (e.g. adolescent girls 
reporting sex with two or more partners per year in the USA is almost 9 times 
that in Swaziland as seen in Table 2, below, while Swaziland’s HIV prevalence 
among young people is more than 227 times that seen in the USA).  It is true that 
the demographic and health surveys (DHS) carried out in African nations are 
face-to-face interviews while the USA data is collected by self-completed, 
anonymous questionnaires.  We could then expect a marginally higher level of  
misreporting in the DHS relative to the United States due to social desirability 
bias.  The question then is: What would be considered a reasonable level of  
misreporting?  First, let us remind ourselves that HIV is not exclusively (nor 
efficiently) sexually transmitted but is rather a blood-borne pathogen with other 
modes of  transmission; meaning that we may not assume that all infected 
persons engage in any sexual activity, let alone ‘risky’ sexual activity, and have 
been infected sexually.  However, testing for sexually transmitted diseases (STDs, 
such as chlamydia or gonorrhea) together with administration of  survey 
questionnaires is a quite effective strategy for estimating levels of  misreporting 
of  sexual behavior, particularly as it concerns sexual debut.  
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Drawing on this theme, Eva Deuchert (2011) applies mathematical modeling 
to DHS data from Lesotho, Zimbabwe and Malawi where a significant 
proportion of  adolescent females with HIV (per the results of  concomitant 
serological testing) self-report as virgins.87  Deuchert sets out to calculate what 
proportion of  these reported virgins would have to be lying about their virginity 
(misreporting) in order for sexual transmission to account for the official 
UNAIDS claim of  95% of  HIV infections88 in the three nations.  Through a 
series of  adjustments to the model, Deuchert shows that between 40 and 90% of  
the self-reported virgins would have to be lying (depending on adjustment of  
other assumptions in the model about background HIV prevalence in virgins 
relative to the known sexually-active group) in order to reach a level of  sexual 
transmission of  HIV of  95%.  Deuchert acknowledges that we cannot know a 
priori what proportion of  reported virgins are lying, nor can we directly generalize 
data from other empirical studies, but as an exercise, she makes reference to the 
Multicentre Study of  Factors Determining the Different Prevalences of  HIV in 
Sub-Saharan Africa where STD testing was in fact included for young female (15-
24-year-old) respondents in order to more accurately measure misreporting of  
sexual status.89 Using the results of  the concomitant testing for STDs, that study’s 
authors then estimate the total percentage of  reported virgins misreporting their 
sexual status to be between 6 and 18%.  Introducing, then, a proportion of  20% 
of  reported virgins lying about their sexual status into her model as a high-end 
example, Deuchert finds that only 34 to 54% of  HIV transmission could then be 
attributed to sexual transmission in the respective DHS data (contrasted with the 
ever-present official estimates of  95% of  transmission being sexual in Africa).  
Obviously, there are a number of  caveats to this type of  research and there is 
great room and need for studies which incorporate ways to verify sexual status 
into surveys, yet in terms of  the data that are rejected by many HIV researchers a 
priori as unreliable, suffice it to say that making the assumption that 40 to 90% of  
survey respondents are lying when their reported behavior does not support the 
researcher’s preconceived hypothesis or expectations begs the question: then why 
conduct empirical research in the first place?  
 
The oft-repeated argument that social desirability bias leads to mammoth 
levels of  misreporting (particularly among girls) in Africa, when closely 
examined, turns out to be quite circular in nature.  Take for example a heavily 
cited study carried out in a rural area of  Tanzania several years ago.90 The main 
issue with this study in terms of  assumptions about misreporting arises when the 
authors state: “If  sexual partnerships were accurately reported, there should be a 
positive correlation between seropositivity (prevalence) and sero-conversion 
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(incidence) and partner numbers” (p 307).  The circular nature of  this argument 
is quite conspicuous.  In fact, the conclusion should read thus: “With reasonable 
levels of  misreporting, if  95% of  HIV transmission were indeed sexual, then 
there should be a positive correlation between seropositivity (prevalence) and 
sero-conversion (incidence) and partner numbers”.  However, as the authors did 
not, in fact, find a positive correlation between HIV incidence or prevalence and 
partner numbers, they immediately (and unjustifiably) assume that misreporting 
accounts for the lack of  a correlation where they had expected to find one.  This 
manipulation of  the explanatory story in order to retain an assumption (that HIV 
incidence and prevalence are affected only by sexual behavior) in the face of  
contradictory evidence is antithetical to scientific inquiry.  Reliable empirical 
studies  that provide reasonable estimates of  misreporting exist91 and there are 
strong arguments to carry out more studies of  this nature.  Unless and until 
reasonable levels of  misreporting are included in studies such as the one 
mentioned above in Tanzania, they remain relatively useless in the debate 
surrounding sexual behavior misreporting. Studies that pointedly exclude a 
methodical analysis of  misreporting allow researchers to claim any level of  
misreporting that would be needed in order for their assumptions about sexual 
behavior and HIV to remain in force.  Until the serious issue of  magnitude in 
misreporting (and, specifically, relative to levels of  HIV prevalence and incidence) 
is addressed openly and methodically, we must reject this circular argument that 
assumes astronomical levels of  misreporting (lying) on the part of  African 
respondents a priori when their reported sexual behavior cannot explain the 




 The second main issue with claims of  extremely high misreporting in African 
nations when sexual behavior does not correlate positively and significantly with 
HIV deals with consistency.  The idea behind social desirability bias deals with 
culture and taboos about sexual activity.  If  the argument is that sex is taboo in 
these African nations, then the idea that extraordinarily promiscuous sexual 
relations (as would be required to support serious generalized HIV epidemics 
driven by sexual behavior) are acceptable in these same nations is quite 
contradictory.  If  we look at the issue logically, we may either posit that sex is 
taboo in these nations or that sex is ubiquitous and extreme promiscuity socially 
acceptable.  We cannot argue contemporaneously for two seemingly mutually 
exclusive social systems in order to discount data that do not match our 
preconceived notions.  Tim Allen, discussing his first-hand experiences as a 
researcher living and working in Uganda, mentions how, in relation to sexual 
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behavior studies, researchers assume that subjects are taboo and “it is almost as if  
international researchers have not wanted to ask ‘indecent’ questions. 
Information about heterosexual vaginal intercourse […] seems to be mainly 
based on assumptions”.92 He points out as well that sexual topics (he uses the 
example of  ‘orgasm’) that are frequently and commonly spoken of  in popular 
Kampala newspapers are, incongruously, ‘taboo’ for academic researchers and so 
not to be found in the academic literature on Uganda.   
 
Moving on then to a relatively early and influential example of  the use of  the 
racial stereotype of  African promiscuity in the HIV discourse, let us look to DB 
Hrdy's oft-cited 1987 paper, Cultural Practices Contributing to the Transmission of  
Human Immunodeficiency Virus in Africa: 
 
Promiscuity, especially the total number of sexual partners, is correlated with 
AIDS in both the United States and Africa. Although generalizations are 
difficult, most traditional African societies are promiscuous by Western 
standards[...] For instance, in the Lese of Zaire, there is a period following 
puberty and before marriage when sexual relations between young men and a 
number of eligible women are virtually sanctioned by the society.93 
 
Hrdy begins with the unsupported and eminently arguable assertion that 
promiscuity is correlated with AIDS in the USA and Africa.  He then goes on to 
posit, with no supporting empirical evidence presented, that most African 
societies are generally promiscuous by Western standards.  Let us look briefly to 
available data and try to understand what “Western standards” might be and how 
several African nations might compare.  We will consider young women as, in 
high-incidence African nations, they are believed to be at particularly elevated risk 
of  infection, therefore frequently becoming the target group for sexual behavior 
prevention programs.   
 
We see that in 2006-2008, 38.1% of  female 15-19-year-olds in the USA 
reported engaging in pre-marital sexual intercourse in the 12 months leading up 
to the survey.94 This same figure for Kenya in 2008 was 15.5%, for Zimbabwe in 
2005, 8% and Tanzania in 2007-2008, 16.9% as shown in Table 1.95 
 
If, however, instead of  simply looking at young people engaging in sex, we 
look to the statistics regarding young people engaging in sex with multiple 
partners (i.e.: “promiscuity”), we find that, among sexually-active females aged 
15-19 in the USA, 36.2% reported having multiple sexual partners in the year 
leading up to the survey.96  In Kenya, that same figure is 6.5% (2008); in 
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Zimbabwe 6.8% (2005);  and in Tanzania (2007-2008), 11.2% as shown in Table 
2.97 
 
Table 1. Pre-marital sex, 15-19-year-olds 
 Percentage of  females aged 
15-19 engaging in pre-marital sex 
in the previous 12 months 
United States of  America (2006-2008) 38.1% 
Kenya (2008) 15.5% 
Lesotho (2009) 26% 
Tanzania (2007-2008) 16.9% 
Mozambique (2009) 52.3% 
Namibia (2006-2007) 32.8% 
Swaziland (2006-2007) 30.5% 
Uganda (2006) 18.2% 
Zambia (2007) 26.9% 
Zimbabwe (2005-2006)  8% 
Sources: Abma et al, 2010 for USA data; Demographic and Health Surveys, respective 
years for all other nations 
 
 
Table 2. Sex with two or more partners & HIV prevalence. 
 Percentage of  sexually 
active* females aged 15-19 
engaging in sex with 2 or more 




people of  both sexes 
(15-24 year-olds) 
United States of  America 
(2002) 
36.2% <.1% 
Kenya (2003) 6.5% 5.9% 
Lesotho (2009) 7.5% 15.4% (2004) 
Tanzania (2007-2008) 11.2% 3.6% 
Mozambique (2009) 19.7% 11.1% 
Namibia (2006) 3.1% -- 
Swaziland (2006-2007) 4.2% 22.7% 
Uganda (2006) 5.5% -- 
Zambia (2007) 9.7% 8.5% 
Zimbabwe (2005-2006) 6.8% 11% 
*Sexually active is defined as having reported intercourse in the 12 months preceding 
the survey. 
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Sources: Abma et al, 2010 for USA data; Demographic and Health Surveys, respective 
years for all other nations 
 
These data simply and clearly show that, not only do young Americans 
(females in this example though the relations between the USA and African 
nations hold for young males as well) have more pre-marital sex on average, but 
they are also considerably more “promiscuous” than girls in many high-
prevalence African nations.  A significant minority of  young, sexually-active 
Americans have had multiple sexual partners while having multiple sexual 
partners among young, sexually-active Africans in various nations, as in this 
example, is rarer.  We must also remember that, even in a nation (such as 
Mozambique in this example) where one measure of  sexual activity (sexually 
active adolescent girls, Table 1) is higher than in the United States, the magnitude 
of  the difference cannot be ignored.  HIV prevalence among 15-24-year-olds in 
Mozambique is over 100 times greater than in the same age group in the USA 
(11.1% vs. <0.1%).  The proportion of  sexually active adolescent girls in 
Mozambique, however, is only 1.4 times higher than in the USA.  1.4 times more 
sexually active girls cannot explain a prevalence of  HIV that is 100 times higher.  
It is notable as well that the measure of  ‘multiple partners’ (promiscuity) is far 
higher in the USA than in all of  the African nations.  If, indeed, as Hrdy states, 
promiscuity and HIV infection were directly correlated, then the young 
heterosexual American population would have been horribly decimated by AIDS 
in the previous two decades while many African nations would have relatively low 
prevalence.  Instead, the general population of  the USA exhibits an HIV 
infection rate of  less than 1% and HIV remains concentrated mainly among men 
who have sex with men (MSM) and intravenous drug users, exactly as in other 
industrialized nations.98   
 
Continuing to dissect Hrdy's supposition quoted above, we may move on to 
his tone of  righteous indignation that in Zaire (now the Democratic Republic of  
Congo), the society reportedly sanctions sexual relations between young men 
(post-puberty, but not yet married) and eligible (i.e.: unmarried) women.  It seems 
strange indeed that we in Western society would consider pre-marriage dating 
and sexual activity as acceptable, and even encourage the practice, otherwise 
known as “playing the field”, in our own nations.  Apparently, however, when it 
occurs in Africa, it is shocking and —far more disturbing— it is used as an 
explanatory factor for the extraordinarily high rates of  HIV/AIDS infection in 
some African nations.   
 
It would seem then that, rather than relying on empirical evidence, perhaps 
many policymakers and researchers rely on mathematical, epidemiological 
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modeling for information on the HIV epidemic, necessitating a critical look at 
the accuracy of  these models.  Deuchert and Brody in a 2007 paper question the 
validity of  several extant mathematical models used to simulate the HIV/AIDS 
epidemic.99  These models, rather than using empirical data on sexual behavior, 
begin with set parameters for the HIV prevalence in a country and the efficiency 
of  heterosexual HIV transmission (probability of  transmission per sexual 
encounter).  They then alter the number and distribution of  sexual partnerships 
to arrive at the pre-determined prevalence rate.  Deuchert and Brody find that 
when HIV sexual transmission efficiency is entered correctly, the existing 
mathematical models significantly overestimate the number of  sexual partners as 
well as misrepresenting the distribution of  partnerships needed to reach the HIV 
prevalence rates that exist in several high-prevalence nations.  They find popular 
models for example, which necessitate 47 sexual contacts per day with an infected 
partner and others requiring 286 contacts per year with ‘casual’ infected partners.  
While these sexual behavior parameters may be mathematically possible, they are 
exceedingly disconnected from empirical evidence demonstrating that in Sub-
Saharan Africa the average number of  annual sexual partners in the sexually 
active population is 1.5.100  
 
The paradox facing African policymakers is a tricky one: they are seemingly 
encouraged to base their policy decisions on sound scientific data, yet the 
international institutional framework within which they find themselves forces 
them to blindly accept or attempt to manage the deeply ingrained and almost 
universally accepted pseudo-scientific racial stereotypes of  “African sexuality” 
and accept the myth of  extraordinary African sexual activity as driving the 
HIV/AIDS epidemic.  As long as scholars and policymakers (international and 
domestic) feel free to make ostensibly scientific, yet unsupported comments such 
as this:  “the AIDS crisis in Africa could be brought under control only if  
Africans restrained their sexual cravings ... it follows that Africans should change 
their sexual behaviour”,101 without facing probing questions as to the scientific 
basis of  the assertion, the individual sexual behavior paradigm will remain 
dominant in HIV/AIDS policy discourse.  Efforts to change this norm and to 
bring accountability for those who assert such equivocations have been stymied 
by “[...] the fact that Western research on Africa, especially with respect to 
sexuality and other aspects of  cultural and social life, is not required to conform 
to conventional standards for evidence in scholarly work. It seems that assertions 
that would require documentation in scholarly work about people in other parts 
of  the world can be published without support when made about Africans. Racial 
bias in standards of  evidence is a problem of  long standing that has lethal 
consequences in AIDS discourse”.102   
30 CHAPTER 1 
 
1.2.4 Briefly Identifying Alternatives 
 
In discussing the scientific racism which has helped to spawn and continues to 
support the behavioral change paradigm in African HIV/AIDS policy, it is 
important to acknowledge that many who work in the field either designing or 
implementing these programs, most likely have the best of  intentions and would 
be aghast at being labeled “racist”.  This is not at all my intention.  It was my goal 
here to show how decades (and, in some cases, centuries) of  increasingly subtle 
institutionalized racism have conditioned many to blindly accept the tenets of  the 
behavioral change paradigm: namely, that all Africans, indeed, share a common 
culture that is highly sexualized in relation to “Western” culture and that their 
heightened collective sexuality has led to raging heterosexual HIV/AIDS 
epidemics which can only be stopped by changing said deviant sexual behavior.  
“The grip of  racist intellectual history affects the direction of  social science 
research and the range of  policy alternatives that can be considered. The weight 
of  past theories in the popular mind and in the imagery of  science is insidious 
and difficult to counter because so much of  racial stereotyping is in the ‘unstated 
assumptions and unthinking responses’, rather than in explicit postulates”.103    
 
If  we are to then move away from the injudicious and ineffectual sexual 
behavioral change approach, the next logical question to be asked by well-
meaning researchers and policymakers would be: So where do we go from here?  
Thankfully, while the sexual behavioral paradigm has been dominant in public 
policy for decades, researchers in fields ranging from epidemiology to medical 
anthropology to economics have continued working diligently to identify 
effective alternative strategies to combat HIV/AIDS.  Some of  these alternative 




It is useful at this point to borrow Susan Pedersen’s concept of  being 
“attentive to [the] silences as well as [the] explicit concerns” expressed in policies 
aiming to regulate public health issues.104   One might wonder why, for example, a 
rash of  HIV cases in children with HIV-negative mothers in Romania in 1989 
prompted immediate and concerted efforts to trace a nosocomial (medical) 
transmission route which, eventually, was identified and steps taken to avoid 
future medical transmission;105 However, the silence in the African HIV discourse 
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about the possibility of  significant levels of  nosocomial transmission is quite 
ominous.   
 
During the previously mentioned XVIII International AIDS Conference, Dr. 
Jimmy Kolker (then Chief  of  HIV/AIDS with the United Nations Children’s 
Fund- UNICEF) was interviewed about nosocomial transmission and responded 
to an inquiry about present efforts to trace modes of  transmission in HIV-
positive children whose mothers are uninfected (the least problematic population 
in which to ‘prove’ nosocomial transmission).  Dr. Kolker responded that “[…] 
we’re paying attention to Eastern Europe and Central Asia at this conference, 
that this nosocomial transmission—transmission in hospital settings— is a 
special problem in that region because of  various pediatric practices and so on 
and that, tracing the mode of  transmission, which is your question, is 
problematic because there is every incentive by the health care system to deny 
that this is taking place[…]”.   When asked about any movement towards 
acknowledging nosocomial transmission in Africa, Dr. Kolker did acknowledge 
that “[t]here are obviously examples of  contaminated blood [and] contaminated 
needles”, however, he recognized that, in fact, there has not been much 
movement towards investigating nosocomial transmission in Africa apart from a 
handful of  investigations in the early- to mid-2000s exploring the potential link 
between routine vaccinations and HIV in children, which were inconclusive.  He 
stated that the difficulty in finding a clear pattern of  nosocomial infection in 
Africa (as a continent) has hindered the effort and expressed openness to future 
studies to identify clear medical routes of  transmission.106 
 
However, it must be noted that enough evidence certainly exists to justify the 
launch of  outbreak investigations in high-prevalence African nations, particularly 
where babies and children whose mothers do not have HIV are found to be 
infected and transmission is most likely due to medical exposure.  Gisselquist et 
al., in a 2004 review article, cite 9 studies where “the proportion of  paediatric 
patients with HIV infections ranged from one to three times the proportion of  
HIV-infected women in antenatal settings within the same communities” in 
several African nations.107  They point out that the pediatric incidence was also 
quite a bit higher than the estimated one-sixth of  HIV incidence in children that 
would be expected from vertical (mother-to-child) transmission even had all the 
mothers been HIV-positive.  From Mozambique’s 2009 nationally representative 
seroprevalence and behavioral survey (INSIDA, part of  their Demographic and 
Health Survey), babies and children aged 0 to 11 were tested for HIV as well as 
their mothers.  It was found that approximately 31% of  the babies and children 
who had HIV were born to mothers who did not have HIV.108  A 1985 study in 
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Kinshasa found that 39% of  HIV-positive inpatient and outpatient children 1-24 
months old had HIV-negative mothers.109  A similar study in Burkina Faso in 
1989-90 found that 23% of  HIV-positive children in the study had HIV-negative 
mothers.  Van de Perre et al. (1987) reported from Rwanda that “[in a] survey 
among 150 health workers, prevalence for those with STDs and injections for 
STDs (47%) was almost double prevalence for those with STDs only (24%)”, 
throwing into doubt the common assumption that HIV-positive persons treated 
for STDs had unquestionably contracted HIV sexually.110   
 
Contrary to responses seen on other continents, findings such as these have 
not inspired a concerted effort to rule out nosocomial transmission in African 
nations and a nominal ‘consensus’ somehow emerged in the late 1980’s that the 
African HIV epidemic was primarily driven by extraordinary heterosexual 
activity; consequently, research about nosocomial transmission has become 
extremely rare and only three nations to date conduct serological testing of  
babies and children (and their mothers) as part of  their DHS survey, and this 
only in the latest editions.4  At the time of  writing, no published results of  
outbreak investigations (genetic sequencing of  viral RNA5 from different 
infected persons to trace the source or sources of  an outbreak) in high 
prevalence African nations could be found by this author.  Instead, the most 
common response to calls for outbreak investigations seems to be publications 
that dedicate ample time and resources to insisting that investigations need not be 
carried out.  
 
An illuminating and textbook example is Schmid et al., 2004 which attempts 
to refute claims that unsafe injections (one source of  nosocomial transmission) 
could be a significant source of  HIV infection in sub-Saharan Africa.  
Unfortunately, the authors continue to recycle the aforementioned circular 
arguments regarding sexual behavior and sexual transmission, for example stating 
that “HIV-1 is effectively transmitted by sex, as shown by high rates of  infection 
among couples”.111  Without further investigation to genetically link viral RNA 
from both members of  the couple, simply the fact of  both members of  the 
couple being infected is not evidence of  sexual transmission, effective or 
otherwise.  A long-term, rigorous study in Rakai which has become the gold 
standard for determining transmission efficiency, followed discordant couples, 
testing viral loads of  the infected partner—who was not aware of  her/his 
                                                 
4 Uganda, Swaziland and Mozambique 
5 Ribonucleic acid serves as the genetic building block for the functioning and replication 
of HIV 
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serostatus as demanded by the Ugandan government—as well as continually 
testing for seroconversion in the uninfected partner.112  No antiretroviral 
treatment was available to the infected persons and an average transmission 
efficiency of  .001 (1 in 1000) was calculated.  This would not be considered 
‘effective transmission by sex’ by any stretch of  the imagination. So when circular 
logic is discarded, we are forced to consider alternative modes of  transmission.  
  
Schmid et al., also fall into the trap that many others had fallen into before 
them, of  diminishing the importance of  a significant minority.  What is meant by 
this is the habit of  many researchers to speak of  an issue as unimportant—in this 
case, non-sexual transmission of  HIV—when it may not be responsible for the 
majority of  new cases.  The authors, while discussing pediatric HIV and the 
prevalence and incidence among infants and children, cite two small studies in 
Masaka, Uganda and Cote d’Ivoire which show, respectively, that 60% and 80% 
of  the HIV-infected children had infected mothers and assuming they had 
contracted HIV vertically through mother-to-child transmission (MTCT).  It is 
intriguing that the authors fail to mention or take into account that the study also 
shows, conversely, that 40% and 20% of  the children had uninfected mothers.  The 
authors cite these examples in support of  their claim of  low levels of  nosocomial 
transmission, yet one must wonder how these percentages of  likely nosocomial 
transmission could possibly be considered low.  Pointedly excluded from their 
discussion as well is the fact that, even in the complete absence of  antiretroviral 
treatment, MTCT of  HIV is 25-35% in the developing world.113  The idea of  
such nonchalance to 20%-40%+ of  infected babies and children in western 
nations having contracted HIV through healthcare is unimaginable and, again, 
highlights the disparity, not just in standards of  evidence, but also in what are 
considered acceptable levels of  institutional risk between the West and sub-
Saharan Africa in both scholarly work as well as global health policy.  
 
 Obviously, HIV can be and is transmitted sexually; however, it is a blood-
borne pathogen with a relatively low transmission efficiency through heterosexual 
intercourse, making the lack of  debate about nosocomial transmission in Africa 
inauspicious.  One wonders why medical and social science professionals are 
willing and even eager to look for and stamp out nosocomial transmission routes 
in Europe, parts of  Asia and the Americas, yet continue to insist (with no reliable 
empirical data this author has seen) that nosocomial transmission is not a 
problem in Africa, purportedly making up less than 2% of  all HIV cases. 114 
 
34 CHAPTER 1 
Co-factor Infections 
“Between otherwise healthy adults in developed nations, HIV has very low rates of 
heterosexual transmission”.115   
 
 It is no secret that the efficiency of  HIV transmission through heterosexual 
vaginal intercourse is quite low with a probability of  infection of  approximately 1 
in 1,000 between otherwise healthy adults as previously mentioned.116  However, 
numerous clinical studies have shown that the presence of  co-factor infections 
increases mean plasma viral load6 (and therefore, the infectiousness) of  persons 
infected with HIV.117  These concomitant infections also and unfortunately have 
been shown to increase the susceptibility of  non-infected persons to contracting 
HIV if  and when they are exposed.118 
 
Co-factor infections can be sexually-transmitted bacterial infections “both 
ulcerative and non-ulcerative, [that] increase the likelihood of  HIV 
transmission”.119  These STDs, which are highly common in the West as well as in 
Africa, such as gonorrhea, chlamydia, bacterial vaginitis and trichomoniasis, are 
easily treated with antibiotics in affluent nations where access to medical care is 
virtually guaranteed, but often remain untreated in poor settings, increasing 
susceptibility to HIV.120,121,122   
 
Co-factor infections may also be viral, bacterial or parasitic infections (not 
sexually transmitted), often endemic to certain regions (based on climate, 
geography, local flora and fauna as well as public sanitary conditions), which 
increase susceptibility to HIV infection and/or increase the infectiousness of  
HIV infected persons via increased HIV viral loads.123,124  These can include 
infections such as lymphatic filariasis, urinary schistosomiasis, helminthes 
(intestinal worms) and malaria.125,126,127,128,129,130,131,132,133 Again, these infections are 
curable and, ultimately, public health interventions that lower both infectiousness 
as well as susceptibility to HIV are a policy-sensitive area which requires further 
resources and acknowledgement of  the various positive synergies possible 
through addressing ‘health’ in a more holistic fashion.  
 
There is an established literature in public health and long-standing clinical 
practice demonstrating that persons with nutritional deficiencies, with parasitic 
diseases, whose general health is poor, who have little access to health services, or 
                                                 
6 Plasma viral load is the amount of HIV RNA in blood plasma measured by number of 
copies per mL of blood plasma.  Viral load may also be measured in semen and vaginal 
excretions.   
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who are otherwise economically disadvantaged have greater susceptibility to 
infectious diseases, whether they are transmitted sexually, by food, water, air, or 
other means. Louis Pasteur characterized the conditions necessary for the 
transmission of  infectious disease with the comment: ‘The microbe is nothing, 
the terrain everything'.134   
 
Sawers and Stillwaggon (2010) set out to explicitly identify, not only the 
drivers of  the African HIV epidemic but, uniquely, the driver(s) of  the vast 
difference in HIV prevalence between high-incidence Southern African nations 
and other sub-Saharan African nations (with low HIV prevalence) as well as 
other low to middle-income nations outside of  Africa.135  They performed 
multivariate, cross-country regression beginning with a ‘basic model’ which used 
fairly standard socio-economic control variables such as the Gini coefficient, per 
capita income, urbanization, a measure of  migration, age of  the epidemic, 
literacy, etc.  To this basic model they added a measure of  nosocomial 
transmission based on Deuchert and Brody’s 2007 study showing a positive and 
significant correlation between HIV prevalence and unsafe injection practices (it 
must be remembered that injections represent only one part of  nosocomial 
transmission risk).136  They then created a dummy variable which took a one value 
for the nine high-incidence nations in southern Africa and zero for all other 
nations.  The coefficient for this southern African dummy variable was positive 
and significant (2.79), but as they point out, simply living in southern Africa as a 
risk factor for HIV is not a policy-sensitive area; their goal was to test their 
theory that co-factor infections are “hidden” within that southern African 
dummy variable. To do this, they add measures of  prevalence of  five co-factor 
infections to the model (malaria, schistosomiasis, chlamydia, syphilis and 
gonorrhea). Using the basic model without the co-factor infections included, they 
find that HIV prevalence in southern Africa not explained by the model is close 
to 16 times the level found in the other low- and middle-income nations included 
in the model.  After adding the five co-factor infections to the basic model, they 
find the coefficients of  the co-factor infection variables to be positive and 
significant at the 99.9 percent level.  The R2 of  their enhanced model rose from 
66.8% to 80.1%.  The model went from explaining only about 10% of  the 16-
fold difference in HIV prevalence between the southern African nations and the 
other low- and middle-income nations, to explaining around 70% of  the 
difference.  Incidentally, they also find that the coefficient for per capita income 
in the basic model (without co-factor infections) is negative and significant (-
0.486) while after adding the co-factor infection variables, the coefficient for per 
capita income becomes positive and statistically insignificant.  This suggests that 
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inside the generic ‘black box’ of  poverty as a driver of  the HIV/AIDS epidemic 
in Africa, the high disease burden of  the poor is cached.137  
 
However, though co-factor infections are a sometimes acknowledged issue in 
the control and mitigation of  HIV, policies which target this area must, 
necessarily, deal with Health Systems Strengthening, arguably one of  the most 
costly and complex types of  policy interventions.  Apart from the absolute 
financial costs of  these types of  interventions though, one must also consider 
that these interventions that improve general health and/or nutrition, are 
unattractive to donor and governmental organizations working with HIV-specific 
funding as attribution of  results (i.e.: number of  new cases of  HIV averted) is 
virtually impossible, as Hunsmann (2012) describes in detail with a case study in 
Tanzania.138 
 
Antiretroviral Therapy (ART) As Prevention  
 
In September 2009 the American Centers for Disease Control (CDC) 
published a potentially game-changing review entitled Effect of  Antiretroviral 
Therapy on Risk of  Sexual Transmission of  HIV Infection and Superinfection.  The 
CDC’s report marks one of  the first fairly comprehensive summary reviews of  
clinical trials (including several in Africa) conducted specifically to study this 
phenomenon.  As discussed briefly above, the viral load of  an HIV-infected 
person greatly affects the probability of  transmission of  HIV to a non-infected 
person.  Antiretroviral medications effectively suppress viral loads, potentially 
transforming HIV into a chronic rather than terminal illness offering long-term 
health benefits to infected individuals as well as reducing their probability of  
infecting others.139  The public health benefit of  ART is directly related to this 
viral load suppression and for example, the city of  San Francisco’s recent change 
in recommendations for ART provision is a ringing endorsement of  the possible 
public health benefits.  Rather than waiting for CD4 cell counts7 to drop to 
critically low levels (e.g.: updated WHO guidelines to begin treatment once CD4 
cell counts drop below 350 cells per mm3), San Francisco’s Department of  Public 
Health is now recommending that medical practitioners begin HIV-infected 
                                                 
7 CD4 is short for ‘Cluster of Differentiation 4’ and is represented by the number of 
these cells per microliter (cells/μL) of blood.  CD4 cells are glycoproteins found on the 
surface of the human immune system’s helper T-cells and serve as a receptor site for 
HIV. Low CD4 levels are a sign of a weakened immune system and HIV progression.  
Normal CD4 levels in an HIV-uninfected adult are between approximately 500-1600. 
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persons on ART as soon as they are diagnosed with HIV.140  In part the decision 
came about to improve long-term outcomes of  HIV-infected patients, however, 
Dr. Mitchell H. Katz, director of  public health for the city has stated: “I do 
anticipate it will drive down the rates of  new infections […] It’s a nice, secondary 
benefit of  this new policy”.141   
 
Indeed, a robust combination of  clinical studies and mathematical modeling 
has demonstrated that the early phase of  HIV infection, roughly from 0-24 
months from seroconversion, is when viral loads are the highest  (several times 
higher even than after the actual onset of  AIDS years later and approximately 26 
times higher than during the long intermediary, asymptomatic phase); meaning 
that people are the most infectious to others precisely when they are not eligible 
for ART in most places.142,143,144,145  Of  course, any discussion of  the use of  ART 
as prevention must necessarily be accompanied by a caveat as concerns abound 
surrounding the question of  moral hazard.  Simply put, many are concerned that 
providing a highly effective treatment such as ART will lead to the belief  among 
HIV-infected persons and the general population that HIV is curable and that we 
will see consequent increases in unprotected sex which will offset the 
preventative benefits of  ART.  As people on ART will presumably live longer, 
they will have the potential to engage in more sexual encounters with a greater 
potential number of  partners.  The questions then are: 1) Will patients on ART 
have more unprotected sex and, 2) will the decreased infectiousness of  those on 
ART compensate for any possible increase in unprotected sexual activity?   
 
The first question has been addressed quite succinctly by Crepaz, Hart and 
Marks (2004) with a trio of  meta-analyses.  Using twenty-five English language 
studies of  ART clinical experiments (none, unfortunately, in Africa), they seek to 
determine whether “(1) being treated with HAART [Highly Active Antiretroviral 
Therapy], (2) having an undetectable viral load, or (3) holding specific beliefs 
about HAART and viral load are associated with increased likelihood of  engaging 
in unprotected sex”.146  They conclude that being treated with HAART and 
having an undetectable viral load does not increase the likelihood of  engaging in 
unprotected sex.  However, they did find that “[t]he likelihood of  unprotected 
sexual behavior was significantly higher in people who believed that HAART 
reduces HIV transmission or who were less concerned about engaging in unsafe 
sex given the availability of  HAART”.147  This is not an unimportant result; it 
does highlight the importance of  further studies to answer the question of  
whether the decreased infectiousness of  those on ART will, in fact, compensate 
for this potential increase in unprotected sexual activity.  This is an area where 
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further study is clearly needed and this issue will be addressed in the case study 
of  this thesis.   
 
The history and logic behind ART as prevention as well as the potential 
preventative externalities of  ART on a grand scale are discussed in more detail in 
the following chapter of  this thesis and the case study (Chapter 4) will focus 
specifically on the effects of  the social construction of  HIV and specifically of  
sexual behavior and vertical (mother-to-child)-based prevention messages (in 
Maputo, Mozambique) on things like patient/provider relationships, enrollment 
in and adherence to ART; an area that has yet to be studied in Africa and which, 




It is my hope that, in this introductory chapter, I have been able to guide 
readers through some of  the pertinent literature dealing with the social 
constructions of  an epidemic, as well as the political usage of  those 
constructions which often goes unquestioned in both the popular and academic 
literature.  In addition to the general literature review in these areas, one hopes 
that my own systemization of  the social construction of  sick people (Figure 1) as 
well as my application of  the classification schemes from part 1.1 to HIV policy 
(including the introduction of  the concept of  ‘quixotic risk reduction’) has given 
readers an intuitive yet clear understanding of  the powerful socio-political forces 
behind HIV policy and, indeed popular thinking, by both experts and lay people 
in terms of  HIV in sub-Saharan Africa.   
 
While HIV is undoubtedly transmitted through sex the world over, it is my 
hope that readers will begin to question the sexual behavioral change paradigm 
which attributes the extremely high levels of  HIV in several African nations 
exclusively to ‘extraordinary’ sexual activity.  The brief  exploration of  colonial 
and post-colonial medical racism in Africa is meant to shed a bit of  light on a 
largely shadowed area of  public policy: the institutionalization of  racism.  This 
institutionalized racism, apart from being ethically abhorrent, has life and death 
consequences in the HIV/AIDS policy debate.  As researchers and policy 
makers, we must be attentive to the silences in our avenues of  exploration and 
policy.  In the African HIV policy sphere, these silences are particularly profound 
in the areas of  the social construction of  HIV-infected (or ‘high risk’) persons, 
the logic behind the ‘standard’ HIV target groups, nosocomial transmission of  
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HIV, the role of  the burden of  disease in many high-incidence nations (co-factor 
infections) and the efficacy and feasibility of  ART for prevention.   
 
The following chapter will concentrate on one of  these neglected areas of  
HIV prevention (ART as prevention), outlining the clinical and epidemiological 
evidence of  its effectiveness as well as financial considerations important to the 
utilization of  this strategy.  The role of  the social construction of  HIV in Africa 
permeates policy priorities and will be an implicit theme of  Chapter 2 during 
discussions of  the dominance of  external (international) health financing which 
brings with it the policy-embedded racial stereotypes of  Africans discussed in this 
chapter. 
 
Chapter 3 will then explore the human resources for health (HRH) situation in 
Mozambique.  These issues will be reviewed in relation to their interplay with 
efforts to expand ART in Mozambique through the ongoing decentralization of  
HIV services.  
 
Chapter 4 will then focus on the case study carried out in Maputo, 
Mozambique from April through September 2011.  In 2001 with the introduction 
of  the public provision of  ART, the Mozambican Ministry of  Health clearly 
stated its commitment to utilizing ART as prevention.148  With that in mind, and 
considering the recent dramatic expansion of  ART provision since 
decentralization of  services in 2005 (with actual implementation in Maputo 
beginning in 2008), the case study will focus on the effect of  the social 
construction of  HIV in Mozambique (via HIV prevention messages) on patients’ 
experiences with ART in Maputo City.   
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2 THE ILLUSORY TRADE-OFF BETWEEN HIV PREVENTION AND TREATMENT 
 
 
2.1 Antiretroviral Treatment as HIV Prevention 
 
As discussed in Chapter 1, there is great need and potential for 
implementation of scientifically-sound, alternative HIV prevention paradigms in 
high prevalence nations. This chapter will focus on the possibilities offered by 
antiretroviral treatment (ART) as population-level prevention.  As Maputo, 
Mozambique will be the focus of the case study portion of this dissertation 
(Chapter 4), practical matters and examples will mainly refer to Mozambique 
from here forward.   
 
Until 2011, the idea of ART to prevent sexual transmission of HIV was 
mainly confined to epidemiological models and observational studies.1,2,3,4  
Though some city and regional health departments in developed nations (ex: San 
Francisco, British Columbia and New York) had adopted early or immediate 
treatment guidelines to explicitly take advantage of the purported benefits of 
ART as prevention5,6,7, still there was a lack of what many would consider 
concrete clinical evidence of the efficacy of this strategy.  This all changed in 
2011 with the early conclusion of the ‘HIV Prevention Trials Network 052’ 
(HPTN 052) study.  HPTN 052 is a multi-site, randomized clinical trial with the 
primary objective of comparing HIV infection rates between two groups of 
serodiscordant couples8, enrolling a total of 1,763 couples.  All HIV-infected 
participants had baseline CD4 levels of between 350 to 550 cells/μL (for 
comparison, 2009 WHO recommendations state that patients should begin ART 
for individual therapeutic purposes at CD4 levels ≤3508).  The HIV-infected 
partner from one group began taking antiretrovirals (ARVs) as soon as the study 
began (886 couples) while the HIV-infected partner from the second group 
began taking ARVs only after either developing an AIDS-defining illness or 
having two consecutive CD4 measurements of 200-250 or below (877 couples) 
per WHO 2006 recommendations9.  278 couples were from study sites in the 
Americas, 954 from African study sites and 531 from Asian study sites.  On April 
28, 2011, five years into the study, the Data and Safety Monitoring Board 
                                                 
8 Couples where one person is uninfected with HIV and the other is HIV-positive. 
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(DSMB) that periodically reviews unblinded data for National Institutes of 
Health (NIH) clinical studies, performed an interim review and called for an end 
to the trial, recommending that the results of the trial be announced as soon as 
possible and that all participants be offered immediate ART.10 The efficacy of 
ART to prevent transmission was shown to be so dramatic that it would have 
been unethical to continue the trial. 
 
The entire trial (both groups) saw a total of 28 linked infections (where the 
previously uninfected partner’s HIV RNA was genetically linked to the infected 
partner’s).  27 of these infections were found in the delayed ART group and only 
1 in the immediate ART group (p<.001).  The linked incidence (new HIV 
infections) per 100 person-years was found to be 0.1 [95% CI: 0.0-0.4] for the 
immediate ART group and 1.7 [95% CI: 1.1-2.5] for the delayed ART group.  
The conclusion of the study group’s analyses is that “early ART that suppresses 
viral replication led to 96% reduction of sexual transmission of HIV-1 in 
serodiscordant couples”.11   
2.2 The Prevention Cascade 
 
All large-scale prevention policies in high prevalence and high incidence 
settings historically and currently focus on the seronegative population through 
sexual behavior change campaigns.12 In generalized epidemics, the definition of 
‘at-risk’ or ‘high risk’ groups has become virtually meaningless as HIV prevalence 
grows in ever-increasing sectors of the population.  This means that prevention 
campaigns that continue to focus on ‘at-risk’ uninfected persons have an 
extraordinarily large target population in generalized epidemics and high coverage 
targets would be exceedingly difficult if not impossible to reach.  Kurth, Celum 
and Baeten et al. 2010 point out that after 30 years of behavior-based prevention 
strategies, only two nations (Uganda and Thailand) have shown progress in 
reversing HIV epidemics by targeting uninfected persons (and, in fact, the 
correlates of Uganda’s alleged gains remain controversial13).   
 
The issue of target population and subsequent coverage is more than 
academic. Though much clinical research continues to strive for PrEP 
interventions (antiretroviral-based vaginal gels, oral ARVs for uninfected persons, 
etc…) and other preventative measures that are close to 100% effective, public 
health practitioners are quite aware that when speaking of the population level, 
coverage is more important than efficacy.  In order to illustrate this point, let us 
look to the prevention cascades in Figures 3, 4 and 5.  These show a simple 
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comparison of ART, condoms or abstinence for prevention of sexual 
transmission of HIV.  
 
Condom coverage and usage is based on Mozambique’s 2009 Demographic 
and Health Surveys (DHS) where 38% of young adults (aged 15-24) report that 
they are able to obtain condoms and 22.6% of respondents in this same age 
group who had sex in the 12 months preceding the survey report having used a 
condom at their last intercourse14.  This age group reports the highest usage of 
condoms in Mozambique and so presents an upper-bound limit for condom 
usage in the nation.  Condoms for prevention of sexual HIV transmission are 
approximately 80-90% effective15,16 (we will use the upper-bound limit of 90% for 
this exercise).   
 
Abstinence coverage is based on Mozambique’s 2009 DHS data where 6.8% 
of adult respondents reported not having had sexual intercourse in the 12 
months preceding the survey. Abstinence for prevention of sexual HIV 
transmission is 100% effective.  
 
In regards to ART coverage, by the end of 2009, approximately 42% of adults 
(aged 15-49) in Mozambique meeting the WHO 2006 clinical standard to begin 
therapeutic treatment were receiving treatment.17 Mozambique has a national 
adherence level of 75%.18  As mentioned previously, ART as prevention of sexual 
transmission of HIV is 96% effective.   
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Figure 3. Prevention Cascade, ART. 
   
 
 
“Prevention Cascade” adapted from Patrick Ndase, 2010 (Presentation at the XVIII 
International AIDS Conference, 19 July 2010) 
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Figure 4. Prevention Cascade, Condoms. 
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Though these prevention cascades do not consider the nuances of consistent 
(or inconsistent) condom usage or length of abstinence nor differences in HIV 
transmission efficiency over time (e.g. HIV-infected persons have the highest 
viral loads and are consequently the most infectious during the first phase of 
infection lasting approximately 9-18 months when they are not yet eligible for 
ART), they still provide a useful illustration of the relative importance of 
coverage of prevention interventions in relation to efficacy.  For example, if 
condoms (with 90% efficacy) saw an increase to 31.5% usage (the same 
percentage of the Mozambican infected population that has access to and 
adheres to ART) the condom cascade would show 71.7 new infections versus 
69.8 in the ART group. So this 6% difference in efficacy (between condoms and 
ART) with equal coverage/usage of 31.5% results in a decrease of only 2 
infections (per 100,000 exposures). Whereas, conversely, a 6% increase in 
coverage/usage of condoms (from 23% usage to 29%) would witness 73.9 new 
infections, a decrease of 5.4 infections (per 100,000 exposures).  
 
Table 3 provides a visual representation of this. We can see that the decrease in 
new cases of HIV is much more pronounced along the rows (coverage/usage) 
than it is down the columns (efficacy).  Figure 6 represents this graphically, again 
highlighting the importance of coverage/usage over efficacy and showing the 
number of new infections at current coverage and usage levels of the three 
interventions (ART, condoms and abstinence).  
Table 3. Coverage versus Efficacy of Prevention Interventions, Number of New Cases of HIV per 
100,000 sexual exposures 
 








90% efficacy 77.5 68.5 55 37 
96% efficacy 76.5 66.4 52 32.8 
100% efficacy 75 65 50 30 
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If then we are to discuss coverage and usage of interventions, we must 
necessarily return to the idea of target population.  As mentioned, the target 
population of sexual behavior prevention (condoms and abstinence) in 
generalized epidemics is virtually all adults and, indeed, Mozambique is no 
exception. Mozambique’s 15-49-year-old population is roughly 10,760,000 (out of 
a total population of approximately 23,400,000)19.  The target population for 
ART according to WHO 2009 standards for therapeutic treatment is estimated at 
570,000 (or 380,000 according to WHO 2006 standards, but we will use the 2009 
standard as the importance of early ART for optimal population-level prevention 
cannot be overstated).20  This means that the target population of sexual behavior 
prevention strategies is almost 18 times the target population for ART 
interventions.9  Even were we to consider the entire population of Mozambique 
that is estimated to be infected with HIV (1,400,00021), as the target population 
for ART interventions, the target population for behavioral prevention strategies 
is still close to 8 times that of ART.   
 
 
                                                 
9 The same calculus would apply to other interventions aimed at uninfected persons such 
as PrEP. 
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2.3 Focus on the Positives 
Condoms 
Condom coverage and usage has, indeed, increased over the preceding 
decade-and-a-half. In  Mozambique’s 1997 DHS, young adults aged 15-24 who 
had had intercourse in the 12 months preceding the survey reported just 6.8% 
usage (at last sex with anyone), in 2003 that proportion increased to 19.4% and in 
2009 to 23%.10  Policymakers and donors in Mozambique are optimistic that the 
proportion of the sexually-active population using condoms will increase rapidly 
over the next half-decade. Explicit national condom targets refer to condom 
usage at last sex by 15-49-year-olds who have had sex with more than one partner 
in the preceding 12 month period, beginning from a reported baseline level of 
31% in 2003 and aiming to rise to 60% in 2011, 70% in 2013 and 80% in 2015.22 
Actual 2009 DHS figures put the percentage at 22.8%, calling into question the 
2003 31% estimate used as a baseline in the national targets, but also the reason 
for such extreme optimism that endeavors to achieve a stunning 37 percentage 
point increase from 2009-2011 and subsequent 10 percentage point increases 
every two years thereafter until 2015.  
 
These targets and their related public health strategies conspicuously ignore 
the reasons that Mozambicans report for using (or not using) condoms.  Looking 
at Table 4 below, we can see that the top reported reasons in Mozambique for 
using condoms are to prevent sexually-transmitted infections (STIs) and to 
prevent pregnancy. Strangely, the DHS questionnaire includes ‘worry about HIV 
infection’ as a reason for using condoms (question number 106, response ‘A’), 
however, this response is not found in the dataset, causing ambiguity as to 
whether the responses to the separate motivations to use condoms (‘to prevent 
sexually transmitted infections (STIs)’ or due to ‘worry abut HIV’) were 
ultimately combined by DHS staff and included under ‘to prevent STIs’ in the 
final dataset.  Apart from this ambiguity, however, what we can easily notice is 
that a very small percentage of respondents across all age groups report using 
condoms due to public messages advising them to do so. As multiple responses 
were possible for each participant, the percentages in Table 4 will not equal 100% 
and are tabulated as the number of respondents answering ‘yes’ to each particular 
reason for using condoms over the number of respondents in each age group 
who have ever had sexual intercourse and report having used a condom at their 
                                                 
10 Mozambique’s civil war officially ended in 1992 and though HIV was already a 
significant issue, the first condom social marketing programs only began in 1994 and had 
national coverage only in 1996. 
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last sexual intercourse. Complete figures are available in Appendix 1. The most 
common overlap of responses in all age groups occurred with ‘prevent STI’ and 
‘prevent pregnancy’ (ranging from 37 to 59% in the four age groups- shown in 
Appendix 1). The overlap between the motivations for using condoms of 
‘prevent STI’ and ‘due to public messages advising use’ is negligable (ranging 
from 0 to 1.3% in the four age groups- shown in Appendix 1).  
 
Table 4.  Reasons for Using Condoms by Age Group, Mozambique 2009 
 
Reasons for Using Condom at Last 
Intercourse* 
5-Year Age Groups 
15-19 20-24 25-29 30-34 
Public Messages Advising Use 2.0% 3.4% 2.7% 0.7% 
Prevent Sexually-Transmitted Infections 87.7% 75.2% 70.4% 68.7% 
Prevent Pregnancy 66.4% 67.1% 58.4% 57.5% 
Do not trust partner 4.8% 6.0% 7.1% 10.4% 
‘Other’ (unidentified) reason 2.5% 3.7% 8.8% 6.0% 
Source: Demographic and Health Surveys, Mozambique, 2009 
*Individual responses to a series of closed (yes/no) questions; multiple responses 
possible from individual respondents so that response percentages will not equal 100%. 
Denominator is the number of respondents in each age group who have ever had sexual 
intercourse and report having used a condom at last intercourse with anyone. 
 
 
In terms of why respondents report not using condoms, the calculations were 
performed exactly as with the previous table (reasons for usage) with only the 
denominator changing to reflect the number of respondents in each group who 
have ever had sexual intercourse and report not having used a condom at last 
intercourse with anyone.  A full breakdown is available in Appendix 1.  We can 
see in Table 5 below that “I trust my partner’ and ‘I’m married’ are the statements 
with which the most respondents agreed (in terms of their motivation for not 
using a condom) and that positive responses to both, as we might expect, 
increase with age. This may indicate that the relatively higher usage of condoms 
in the 15-19-year-old age group (which steadily decreases with age) may not be 
exclusively a product of more intense condom social marketing to teenagers and 
young adults, but may also be related to the decreased usage of condoms by 
couples in more mature (trusting) relationships and marriages, regardless of how 
heavily condoms were or are marketed to them. These two particular motivations 
for not using condoms will be further discussed in the case study in Chapter 4. 
Interestingly, agreement with the reason, ‘no condom available’ is relatively high 
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(29.8%) for the 15-19-year-old age group, but falls steadily with increasing age 
showing the importance of acknowledging motives for non-use (particularly for 
adult women) rather than simply focusing on coverage/availability of condoms as 
we currently see in prevention strategies.  Unfortunately, the DHS did not 
include the option of ‘wishing to become pregnant’ as a motive for non-use.  
However, considering the high percentage of respondents (and the decreasing 
trend with age) who indicated avoiding pregnancy as a reason for usage, we may 
postulate that the inverse may be true for non-use. This would indicate that the 
ramifications of exclusive focus on a barrier method (condoms) or abstinence 
that we find in HIV prevention campaigns deserves particular attention.  It 
cannot be ignored that both abstinence and condoms have the collateral effect of 
preventing pregnancy and an HIV prevention strategy that effectively eliminates 
the possibility to have children is unfeasible at the population level and in the 
long run.  
 
Table 5.  Reasons for Not Using Condoms by Age Group, Mozambique 2009 
 
Reasons for Not Using Condom at Last 
Intercourse* 
5-Year Age Groups 
15-19 20-24 25-29 30-34 
‘I trust my partner’ 22.2% 30.2% 28.0% 33.2% 
‘I’m married’ 27.8% 43.0% 52.5% 53.9% 
No condom available 29.8% 15.9% 13.3% 12.6% 
Partner did not want to use 13.3% 9.2% 8.8% 7.8% 
Used other contraceptive 1.6% 0.8% 1.3% 0.9% 
Condom reduces sexual pleasure 10.9% 7.5% 6.0% 4.7% 
‘I’m faithful’ 8.1% 12.0% 11.7% 13.9% 
‘Other’ (unidentified) reason 7.5% 7.1% 6.0% 5.3% 
Source: Demographic and Health Surveys, Mozambique, 2009 
*Individual responses to a series of closed (yes/no) questions; multiple responses 
possible from individual respondents. 
 
ART 
As demonstrated, ART for seropositive persons has incredible preventative 
externalities. It is the most efficacious prevention intervention currently in 
existence (for both MTCT and sexual transmission), has the smallest target 
population and, importantly, this preventative benefit does not require either the 
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participation of uninfected persons nor the explicit desire of seropositive persons 
to prevent transmission.  It also does not interfere with conception so that 
seropositive persons (and their partners) are not forced to trade HIV prevention 
for the possibility of having a family.  Though there are signs that seropositive 
persons would, in fact, like to avoid infecting others (discussed in Chapter 4), 
their primary motivation for taking ARVs (with the exception of prevention of 
MTCT) is to care for their own health.  The combination of targeting a much 
smaller national population – ‘the positives’ – and utilizing a collateral 
preventative benefit of a personal health-seeking behavior may provide the most 
pragmatic and effective way forward in generalized HIV epidemics such as 
Mozambique’s.  In terms of concerns about moral hazard or risk compensation 
behavior11, numerous studies have also shown that HIV counseling and testing 
often results in risk behavior change (lower risk behavior) in those who test 
positive for HIV while not having any significant effect on behavior for those who 
test negative, further highlighting the secondary preventative behavioral potential 
of ‘the positives’ as opposed to the difficulty of achieving behavior change in the 
seronegative population.23 
 
In terms of coverage, it also must be pointed out that while usage of condoms 
(or even more rare, abstinence) has slowly crept up over the last 30 years, the 
coverage and usage of ART in Mozambique has rapidly eclipsed the pace of 
reported behavioral change in less than a third of the time.  As of mid-2011, 
Mozambique has approximately 220,000 patients on ART, a coverage and usage 
level of approximately 58% of eligible HIV-infected persons by WHO 2006 
standards (and 39% by  WHO 2009 standards); this has been reached in just 8 
years of ART availability and approximately 5 years into the ongoing 
decentralization of ART which has greatly increased availability and uptake 
outside of the capital.24 
 
If then, we are to attempt to harness the preventative externalities of ART and 
focus on ‘the positives’, there are two main areas where paradigmatic shifts will 
be necessary.  The first is in the calculations performed to judge the effectiveness 
of specific prevention interventions where ART is currently not included (with 
the exception, again, of prevention of MTCT) and the subsequent financial 
allocations for specific interventions.  This will be discussed in the following 
section.  
                                                 
11 This is the phenomenon whereby people may increase their risk-taking behavior when 
they believe that they are protected from negative consequences, such as the classic 
example of wearing a seat belt leading to driving at higher speeds. 
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The second area deals with the socio-political issues discussed in Chapter 1 
that have led to exclusive targeting of HIV prevention messages to the uninfected 
population and an overwhelmingly negative social construction of ‘the positives’.  
It will be necessary to consider the effect of these sexual behavior prevention 
messages on people living with HIV and their treatment-seeking as well as ART 
adherence behavior.  This will be discussed in-depth in the case study in Chapter 
4 through a qualitative analysis of the experiences of adult ART patients, 
caretakers of pediatric ART patients and their clinicians in the city of Maputo.  
 
2.3.1 The Financial Reckoning 
 
Though the preventative actions of ART are an externality, and as such, will 
function whether or not they are explicitly recognized, there is still great need to 
consider this crucial externality when discussing the allocation of ear-marked 
funding and the calculations of infections prevented that underlie these 
allotments.  Currently, new cases of HIV that are prevented through ART are not 
included implicitly or explicitly within international or domestic prevention 
strategies and therefore ART is not eligible for consideration for funding that is 
earmarked for prevention. 
 
It will come as no surprise that in developing nations, foreign aid often 
constitutes a large percentage of health expenditures.  Mozambique’s Total 
Expenditures on Health (TEH)12 are relatively stagnant, having been 5.1% of 
Gross Domestic Product (GDP) in 1995 and 5.7% of GDP in 2009.25 To put this 
in perspective, internationally, this compares to an average of 8.3% of GDP 
being spent on health in the European Union in 2008; a geographic region not 
currently experiencing large-scale, generalized epidemics of any infectious disease 
and one whose expenditures on health are virtually exclusively based on domestic 
resources.26 Importantly, in 1995, only 34.6% of the TEH in Mozambique came 
from external (foreign) sources while in 2009 a full 72% of TEH was from 
external sources showing decreased relative levels of domestic resources going 
towards health in Mozambique (Figure 7).27 Approximately 96% of Mozambique’s 
HIV/AIDS-specific funding comes from external sources.28  
                                                 
12 TEH includes all expenditures on health services (preventive and curative), family 
planning, nutrition and emergency health aid in a nation; both on-budget and off-budget 
expenditures, private and public.  
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Figure 7. Total Expenditures on Health (External vs. Domestic Sources), Mozambique 1995-2009 
 
Source: OECD, 2010 
 
Much of these foreign funds are handled ‘off-budget’, meaning that they do 
not enter into the treasury or working budgets of government ministries and are 
not subject to parliamentary processes of allocation or monitoring.  ‘On-budget’ 
funds, on the other hand, are channeled through the national government 
treasury and are subject to the same government allocation and monitoring 
activities as domestic funds.  Mozambique was, in fact, the first country to put 
Global Fund resources ‘on-budget’ in 2004 (as part of Mozambique’s sector-wide 
approach, or ‘SWAp’), however, in 2008, Mozambique felt the need to take them 
‘off-budget’ again due to the sometimes unpredictable nature of Global Fund 
disbursements (the bulk of which, in 2007 only arrived in the final month of the 
year, for example) and the difficulty in harmonizing Global Fund reporting 
requirements with general government procedures and timing.29  In the 2001 
Abuja Declaration, Mozambique (along with another 26 African Union 
members) pledged to increase on-budget domestic health expenditures to 15% of 
total government expenditures, however, this goal remains elusive as 
Mozambique has not, in fact, increased domestic resources for health as a 
percentage of domestic spending once the Global Fund resources were taken out 
of the equation.30 Though the temporary inclusion of Global Fund resources into 
Mozambique’s common budget (through the SWAp) allowed the country to 
claim an increase of on-budget health expenditures from 11% to 13% of all 
government spending, this increase has now been lost.31 
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Discussing only on-budget expenditures can be misleading as, for example, 
exclusive on-budget external health financing in Mozambique is roughly 44% of 
the country’s health budget and domestic expenditures make up the other 56% 
(compared to 72% of TEH—which includes both on- and off-budget 
expenditures—being from external resources and the remaining 28% from 
domestic resources).32 Roughly 78% of Mozambique’s HIV/AIDS-specific 
funding comes from the United States government’s President’s Emergency Plan 
For AIDS Relief (PEPFAR) funds which are completely off-budget.33  However, 
the importance of on-budget versus off-budget discussions is arguably even more 
important when discussing public policy decisions as vertical, off-budget 
resources famously contribute to a weakening of a country’s capacity to design 
appropriate policies and fragmentation of planning efforts.34 
 
With external (and in particular, off-budget) financing comes, of course, a 
powerful vertical infrastructure, externally-determined earmarks and regulations 
on how and where money may be spent as well as the specific division of funds 
(for example, between various types of prevention and treatment in the case of 
HIV).  These rules, at times, go into assiduous levels of detail and are often 
cookie-cutter constructs that are applied for all financing from that particular 
organization to any nation.  These vertical structures often also require 
considerable administrative commitments from target nations, including 
extraordinary outlays of dedicated human resources (which are already in short 
supply) and reporting mechanisms that are not harmonized with the nation’s 
domestic mechanisms (nor with those of other international organizations), on 
the whole increasing transaction costs for target nations.  As the two main 
funding and implementation agencies functioning in the area of HIV in 
Mozambique are the United States government’s President’s Emergency Plan For 
AIDS Relief (PEPFAR) and the Global Fund to Fight AIDS, Tuberculosis and 
Malaria (‘The Global Fund’), the following discussion will focus primarily on the 




In 2003, United States President George W. Bush made a commitment to 
significantly increase American support for HIV/AIDS worldwide, and the US 
Congress, in May of that year, approved a 5-year USD$15 billion program that 
came to be known as PEPFAR.35 The program was re-authorized in 2008 (for 
another 5 years) with several changes including: an increase in funding from $15 
billion to $48 billion, a move away from the requirement that 33% of prevention 
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funds be spent on abstinence-until-marriage programs to a requirement of 
‘balanced funding’ of prevention activities for sexual transmission of HIV (to 
include, but not be limited to, abstinence-until-marriage), as well as new financing 
for training of health workers in partner nations.36  The new prevention directives 
also include male circumcision and targeting of multiple, concurrent partnerships 
as accepted areas of prevention intervention. 
 
Figure 8. PEPFAR Funding FY2004-FY2010 
 
Source: PEPFAR Fiscal Year Operational Plans, Respective Years37 
 
Shortly after PEPFAR was re-authorized, US President Barack Obama created 
the Global Health Initiative (GHI) whose purpose is to increase coordination of 
health and development strategies in target nations and focus on health systems 
strengthening, gender equality in health and development and promotion of 
country ownership.38  The underlying principle of the GHI is that: “Nations that 
achieve sustained development gains and tangible improvements in the health 
status of their populations make more capable partners, can engage in and 
contribute to the global economy, and provide citizens with the opportunity, 
means and freedom to improve their lives.”39  Though the GHI purportedly 
targets issues of family planning, nutrition, HIV/AIDS, malaria, tuberculosis 
(TB), maternal, newborn and child health, neglected tropical diseases, safe water, 
sanitation and hygiene40, in reality, PEPFAR continues to receive the bulk of 
GHI funds, totaling 73% of the fiscal year 2012 requests.41 An enhanced ‘GHI 
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Plus’ program was initiated in 2010 (with implementation beginning in 2011) and 
provides additional financial and programmatic resources, however, Mozambique 
is not among the initial 8 pilot nations chosen to receive the ‘Plus’ program 
benefits. 
 
In Mozambique, for FY 2010, PEPFAR committed roughly USD$269 million 
(all off-budget), 34% ($91.5 million) of which was slated for prevention, 35% 
($94.8 million) for treatment and care and 31% ($82.8 million) for ‘other’ costs 
which include things like laboratory infrastructure and health systems 
strengthening as well as management and implementation costs.  The breakdown 
of allocations in each of these PEPFAR budget areas can be found in Figures 9, 








Source: Fiscal Year 2010, PEPFAR Operational Plan 
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Source: Fiscal Year 2010, PEPFAR Operational Plan 
Figure 11. PEPFAR ‘Other’ Funding FY 2010, Mozambique 
 
 
Source: Fiscal Year 2010, PEPFAR Operational Plan 
 
 
As we can see, 34% ($31.1 million)of the FY 2010 prevention allocations go 
towards sexual behavior change in the form of abstinence/be faithful programs, 
partner reduction and condom usage.  It must be remembered that until 2008 a 
66 Chapter 2 
full 33% of PEPFAR prevention funding had to be used exclusively on 
‘abstinence until marriage’ programs. After the 2008 re-authorization, this 33% 
requirement was removed, however, focus nations must provide a special report 
to the United States Congress if less than half of prevention funds go to 
‘abstinence, delay of sexual debut, monogamy, fidelity, and partner reduction’ 
(broadly: sexual behavior programs excluding condoms). Presumably, 
Mozambique will or has provided such a report as they fell far short of this 50% 
guideline, instead dedicating more prevention funding to prevention of mother-
to-child transmission (PMTCT- 45% of PEPFAR prevention funding). 
 
One of the main criticisms of PEPFAR (in both its first phase as well as after 
the 2008 re-authorization) is the blatant push of an American social conservative 
agenda in developing nations.42  The heavy focus on ‘abstinence until marriage’ in 
the absence of any scientific evidence that this would help curb a generalized 
HIV epidemic, even were it a realistic strategy, is the most obvious example. One 
scholar characterizes PEPFAR’s socially-conservative prevention paradigm 
thusly: “PEPFAR has utterly destroyed a comprehensive approach in many of 
the focus nations”.43  Indeed, though it is difficult to quantify actions that are not 
taken, programmatic evidence from the US Government Accountability Office 
(which oversees PEPFAR) would seem to support the suspicion that these 
ideological requirements for PEPFAR prevention funds have forced cuts and 
reductions in scientifically-sound prevention programs in areas such as blood 
safety and PMTCT44. 
 
As we have seen with Mozambique’s dedication of less than 50% of PEPFAR 
prevention funding towards sexual behavior programs and more towards 
PMTCT, focus nations may, in fact, ‘bend the rules’ to some extent, as they feel 
is necessary, when it comes to PEPFAR prevention funding.  In the area of 
treatment, we have seen the same bending of the rules, only in the opposite 
direction. In 2006-2007 for example, at least 55% of PEPFAR funding was 
required to be allocated to treatment (adult or pediatric), however, Mozambique 
was one of three nations (along with Uganda and Zambia) that fell short of that 
requirement.45  In PEPFAR’s 2008 re-authorization, the treatment requirement 
was lowered to 50%, yet, in 2010, we find that only 35% ($94.8 million) of 
Mozambique’s PEPFAR funds were allocated to treatment and care.   
 
It must be acknowledged that this failure to dedicate 50-55% of PEPFAR 
funds to treatment has been due, perhaps in large part, to a lack of infrastructure 
and human resources capable of providing this treatment (this will be discussed 
further in the following chapter on human resources). The antiretroviral (ARV) 
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drugs themselves, contrary to popular belief, make up a relatively small portion of 
treatment costs as can be seen in Figure 10 above where ARVs are only 11% of 
the total treatment and care funding allocation (this does not include ARVs used 
for PMTCT). Though a thorough analysis of ARV and ART costs has not yet 
been carried out in Mozambique, a comparative study looking at these costs at 
PEPFAR-supported treatment sites in Ethiopia, Nigeria, Uganda, and Vietnam 
found average annual per patient ARV costs ranging from USD$ 472 – 685 and 
total ART provision costs (including ARVs, all site-level costs for outpatient 
ART and care as well as administrative costs) ranging from USD$ 682 – 988, 
dispelling the myth of exorbitantly high ARV or overall ART costs as the main 
barrier to ART scale-up.46  The same study also demonstrated that per patient 
ART costs decrease markedly over time with newly-initiated ART patients being 
more costly than established patients.   
 
The increase in PEPFAR funds in FY 2010 dedicated to laboratory 
infrastructure (USD$10.9 million), and Health Systems Strengthening (HSS- 
USD$42.4 million) in Mozambique, is, in a sense, an acknowledgement of the 
importance of general health system integrity as a precursor to successful scale-up 
of clinical HIV interventions such as ART.  Presumably, these investments in the 
health system as a whole will provide returns later down the road for HIV 
treatment (and therefore, prevention) as the carrying capacity and efficiency of 
the health system increases.  Once capacity catches up with treatment targets, we 
may expect to see even greater increases in treatment expenditures, eventually 
reaching the 50% target of all PEPFAR funds being spent on treatment and care.  
Though this will certainly help to increase the number of people living with HIV 
who have access to ART, it would be ideal if explicit calculations of the number 
of new cases of HIV prevented by providing ART to these HIV-positive persons 
were allowed to be included in PEPFAR prevention calculations.  As we have seen, 
Mozambique has begun to quietly disregard official PEPFAR guidelines for 
prevention funding by placing heavy emphasis on PMTCT and less emphasis on 
sexual behavior prevention without any dire consequences from an increasingly-
flexible PEPFAR bureaucracy.  Were PEPFAR subsequently to move away from 
its original social conservative ideological slant (with its irrational focus on sexual 
abstinence) and consider the benefits of ART as prevention when determining 
prevention earmarks, or simply erase the illusory boundary between prevention 
and treatment altogether, then nations such as Mozambique would not only be 
able to provide ART to more HIV-positive persons, but would also be able to 
reliably estimate the number of new infections prevented through ART 
provision, creating a righteous cycle of evidence-based prevention and treatment. 
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The Global Fund 
 
The Global Fund is a multilateral funding mechanism set up in 2002 with a 
mandate to combat HIV/AIDS, Tuberculosis and Malaria. The Global Fund is 
not an implementing agency (and so does not have a concrete presence in 
recipient nations), but rather a very specifically-focused funding agency, 
providing millions of dollars to recipients to aid in their fight against these three 
diseases and working through government, nongovernmental (NGO) and private 
sector organizations through what are called multi-sector partnerships. Requests 
for funding are written by the country organizations in question (typically in 
partnership with one another through what is known as a Country Coordinating 
Mechanism—CCM) with the CCM itself choosing priority areas and The Global 
Fund independent review panel making determinations on funding.  Grant 
agreements are signed with and funds disbursed directly to Principle Recipients 
(PRs) who receive an initial evaluation by The Global Fund to ensure they have 
the capacity and institutional skills to carry out their plans.  The CCM system has 
drawn concerns about fairness and the ability of the CCM to independently 
monitor PR activity in Mozambique (and other nations) as the Chair and Vice-
Chair of the Country Coordinating Mechanism were also the main 
representatives of the two Principal Recipients13 in the country.47 The Global 
Fund does not have explicit rules or regulations to address these types of issues.  
 
One crucial aspect of Global Fund financing is that it is meant to be 
‘additional’, meaning that during the application process and again during 
periodic reviews, recipients must prove that they are not diminishing their own 
domestic investments and using Global Fund money instead of domestic funds.  
The Global Fund finances a broad range of activities in relation to prevention, 
care and treatment of the three diseases, but will not fund basic science nor 
clinical research (though operational research meant to improve delivery of 
prevention, treatment and care services may be approved) nor will they provide 
funding for capital investments such as the building of hospitals.  Importantly, 
The Global Fund does not require that the programs it funds be solely funded by 
them and, in fact, they prefer to partially support programs in order to encourage 
the additionality concept and potential sustainability.48  
 
                                                 
13 These two original PRs were the Ministry of Health (MISAU) and the National AIDS 
Council of Mozambique (CNCS) though World Vision Mozambique and the Fundação 
Para o Desenvolvimento da Comunidade (FPDC) have now been added as PRs.  
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The Global Fund raises most of its money from the governments of affluent 
nations, though private, philanthropic organizations and even corporations and 
individuals also contribute. As of January 2012, close to USD$ 30.3 billion has 
been pledged and close to USD$ 21.5 billion has been paid to The Global 
Fund.49  The funding gap between Global Fund projections of need, money 
pledged and money paid is a constant source of concern as the Global Fund 
works within a strict budget and will only approve funding when it has the 
money needed ‘in hand’. The Global Fund has not been insulated from the 
recent global economic downturn and, indeed, in Round 9 (2011)14, they 
approved only 90% of total budgets for each of the approved proposals due to 
the funding gap.50  For Mozambique, the Round 9 grant (which began Phase 1 in 
2011), totals USD$ 41.1 million.51 
 
Proposals to the Global Fund (under the old architecture which is still partially 
in place and so will be discussed here) are typically for 5 years with an initial two-
year funding commitment (Phase 1) and, depending on satisfactory performance, 
towards the end of Phase 1, funds for the final three years (Phase 2) will be 
approved.  Figure 12 shows grant agreements from 2003-2011 for selected 
nations, including Mozambique where USD$119.8 million was approved in Phase 
1 and USD$ 100.4 million in Phase 2.52  The Rolling Continuation Channel 
(RCC) is an invitation-only mechanism for high-performing grants to be 
extended for up to 6 years beyond their initial duration and was begun in 2006. 53  
Mozambique has never been invited to participate in the RCC.  
 
                                                 
14 The Global Fund has operated on a Rounds-based system since its inception in 2002, 
typically holding rounds annually.  In 2011 (beginning with the 2012-2016 strategy), The 
Global Fund has invented a new system which they call “Invest for Impact”.  More 
information on the new strategy can be found at: 
http://www.theglobalfund.org/documents/core/strategies/Core_GlobalFund_Strategy
_en/ 
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Figure 12. Global Fund Grant Agreements 2003-2011 
 
Source: Global Fund Grant Portfolios54 
 
The Global Fund estimates that approximately half of its funding goes 
towards procurement, including ARVs.  By mid-2011, Global Fund programs 
were estimated to be supporting approximately 3.2 million people on ARVs, 
globally.55  In Mozambique, the Global Fund estimates that it supported 220,000 
people on ARVs by mid-2011.56  It is important to remember that, as The Global 
Fund does not implement programs and encourages use of its grants to partially 
support programs, the issue of double-counting tends to arise, particularly 
between The Global Fund and PEPFAR as many programs jointly support the 
same public ART programs.57  Crucially, the preventative externalities of 
providing ART to people living with HIV do not appear in any calculations of 
new cases of HIV prevented.  This means that prevention and treatment are 
handled as freestanding and unattached areas with no spillovers between the two. 
As we have seen that treatment is, in fact, the most efficacious intervention for 
prevention of sexual transmission of HIV, the fact that no calculations of the 
number of new cases prevented through treatment itself means that the vast 
funding provided for prevention of sexual transmission may not be used for 
treatment. 
 
As touched upon previously, addressing the issue of vertical vs. horizontal 
financing (often paralleling on-budget vs. off-budget) is an area where 
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Mozambique was a pioneer, being the first nation to effectively put Global Fund 
resources on-budget, including the funds in the SWAp program (in 2004) and, 
therefore, in their Common Fund for health (PROSAUDE)- an effective 
horizontalization of Global Fund resources.  Though there was much early 
enthusiasm about this approach58, it did ultimately fall apart in Mozambique (in 
2008) due to a lack of harmonization between Ministry of Finance fund 
management processes and Global Fund processes that led to late disbursement 
of funds in the last two months of 2007.59 This caused The Global Fund and 
external researchers to critically assess how Global Fund mechanisms could more 
effectively be tailored to country-specific situations, allowing for reliable 
horizontal financing.  More recently, a discourse has developed around the idea 
of so-called ‘diagonal’ financing where disease-specific results may be sought 
(typically a ‘vertical’ idea) through health system strengthening (HHS- typically a 
‘horizontal’ idea).60 Ooms et al. (2008) poetically metaphorize the vertical versus 
horizontal versus diagonal trichotomy thusly: “While the vertical approach results 
in fragile, isolated islands of sufficiency, and while the horizontal approach leads 
to generalised insufficiency, the diagonal approach aims to build islands with a 
broad and solid base, and to gradually connect those islands, by helping to fill in 
the swamp” (‘the swamp’ being under- or un-served geographical areas).  The 
Global Fund generally does not require absolute sustainability, stating in their 
2007 Call for Proposals that “applicants are not required to demonstrate financial 
self-sufficiency for the targeted interventions by the end of the proposal term”61.  
However, in order to encourage sustainability and possibly eventual autonomy (and 
also discourage ‘crowding out’), The Global Fund does attempt to firmly monitor 
the aforementioned additionality principle by requiring applicants to 
“demonstrate that the government contribution to the disease program is greater 
than or equal to the minimum threshold that applies to the applicant’s income 
level [and] demonstrate increasing contribution of government resources to the 
national disease program as well as the overall health sector”.62 
 
Generally speaking, in terms of including calculations of new cases of HIV 
prevented through ART provision for those infected with HIV into prevention 
efforts financed by The Global Fund, The Global Fund would seem to be more 
flexible, in terms of what they will pay for, than PEPFAR. Theoretically, if the 
Country Coordinating Mechanism of Mozambique were to provide solid 
reasoning for the use of ART as prevention in their grant request (and therefore, 
the use of prevention funds for ART), The Global Fund, unlike PEPFAR, has no 
specific rules or earmarks in terms of particular areas of prevention intervention.  
In this way, the paradigmatic shift for the usage of Global Fund resources to 
support prevention as treatment should be less painful than a similar 
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paradigmatic shift to utilize PEPFAR prevention funds in this way.  However, as 
The Global Fund is not the principal funding mechanism for HIV/AIDS in 
Mozambique15 and only partially funds many HIV programs, as well as the fact 
that they have no implementation arm whatsoever, it would be difficult and 
unlikely that the Global Fund Country Coordinating Mechanism would 
drastically depart from principles regarding acceptable areas of prevention 
intervention as defined by PEPFAR.  In this way, the focus of Global Fund 
resources tends to closely parallel the programmatic priorities delineated by 
PEPFAR in Mozambique as previously discussed.  
 
As long as PEPFAR retains a strict rhetorical and financial division between 
prevention and treatment—as well as ideologically-based and rigid regulations on 
acceptable programmatic areas of prevention—nations such as Mozambique will 
not have the necessary policy maneuvering space to explicitly account for the 
considerable number of new cases of HIV prevented annually with effective 
ART scale-up.  Until these financial divisions are taken into account, the 
preventative externalities of ART will remain unrecognized in terms of the use of 
prevention funds to take advantage of the most efficacious form of (sexual) HIV 




Chapter 1 focused on the social construction of HIV in sub-Saharan Africa 
highlighting how the negative social construction of infected individuals 
combined with their fairly low political and social power has helped lead us to 
continue with the dominant sexual behavior paradigm in the face of ample 
evidence showing that sexual behavior cannot explain SSA’s HIV epidemics.  
This path dependence on inefficient and ineffecacious policies has led to 
rhetorical and policy silence in several scientifically-sound areas of HIV 
prevention which were briefly discussed in the first chapter.   
 
Chapter 2 then has been dedicated to first laying out the irrefutable clinical 
evidence of the efficacy of one of these neglected prevention interventions which 
is the focus of the rest of this dissertation:  ART as prevention.  The HTPN052 
study was the first randomized clinical trial of its kind to prove what ‘common 
knowledge’ has known for over a decade, keeping in mind that the mechanisms 
                                                 
15 For the 6-year period 2003-2009, for example, The Global Fund contributed 
approximately USD$220.2 million in Mozambique (for HIV, Malaria and Tuberculosis) 
while PEPFAR from 2004-2010 contributed approximately USD$1.1 billion (for 
HIV/AIDS ). 
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behind ART as prevention of sexual transmission are virtually identical to those 
in play in prevention of mother-to-child transmission (MTCT) where 
antiretrovirals have been in use since 1994.  Despite this, HTPN052  was 
potentially game-changing as it used the gold standard in clinical science—the 
RCT—to show that early ART prevents 96% of sexual transmission of HIV.   
 
As large-scale prevention policies in high prevalence and incidence settings 
still continue to focus on the seronegative population through sexual behavior 
change campaigns, it was my goal to show that, not only are these current 
campaigns fairly ineffective (both in changing behavior and stemming the 
epidemic), but that, even at current usage/coverage of condom usage, abstinence 
and ART (access + adherence), we may already be preventing more new cases of 
HIV through ART in Mozambique than we are preventing with condom usage or 
abstinence behavior combined.  This was illustrated through the ‘prevention 
cascades’, Figures 3, 4 and 5. These cascades and the following visual 
representations (Table 3 and Figure 6) highlight how coverage/usage (or in the 
case of ART, access and adherence) are, mathematically, more important than 
efficacy in population-level prevention.  Though ART is, in fact, the most 
efficacious known intervention, it also enjoys higher levels of coverage/usage 
than both condoms and abstinence, despite decades of policies aimed towards 
these two sexual behavior-based forms of prevention.   
 
The subsequent section then advocated for a ‘Focus on the Positives’, 
meaning, a focus on the HIV-positive segment of the population in contrast to 
the current and historical focus on the uninfected population.  Even disregarding 
the WHO’s guidelines for when HIV-infected persons should begin treatment 
and considering the entire population of persons estimated to be infected with 
HIV in Mozambique, we find that the target population for behavioral 
prevention is close to 8 times the target population of ART.  Using the WHO’s 
2009 standards on when to begin ART, we find that the target population for 
behavioral prevention is 18 times larger than the target population for ART.  As 
coverage/usage is crucial to the success of any prevention campaign, the size of 
the target group is of utmost importance.   
 
With this same dichotomy of target groups in mind we then looked to a 
disregarded but arguably very important point in prevention campaigns which is 
the reasons which Mozambicans report for either using or not using condoms. 
What we find is a preponderance of respondents who report trusting their 
partner or being married as reasons for non-use and avoiding pregnancy as a 
reason for use (Tables 4 and 5  with full pertinent DHS data reported in Appendix 
1).  Though reported access increases with age, usage declines while the above-
mentioned reasons for non-usage increase sharply with age.  This highlights the 
importance of considering not only increased availability of condoms and 
pushing their usage (the current focus of many prevention campaigns), but also 
the reasons why people report using or not using condoms which is also 
discussed in the case study in Chapter 4.  A very important point which is 
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neglected in both HIV-related literature as well as in the policy sphere is that the 
two main sexual behavior-based prevention strategies which advocate condom 
usage and abstinence are both methods which prevent pregnancy.  This makes 
them not only unattractive to much of the population, but also unfeasible and 
impractical on a population level and in the long run. HIV-infected individuals 
on ART, however, seek treatment first and foremost for their own health (not 
speaking of MTCT) and, as we will see in the case study in Chapter 4, there may 
be indications that, were they to understand the preventative benefits of ART, 
they may be more motivated to begin and adhere to treatment in order to protect 
an uninfected partner.  There is also evidence that HIV testing and counselling 
often results in ‘risk behavior’ change for individuals who test positive for HIV 
while having no effect on behavior for those who test negative,63 again highlighting 
the secondary behavioral potential of ‘the positives’ as opposed to continuing to 
attempt to change the behavior of the uninfected population.  With all of these 
points in mind, we must critically and thoroughly examine why prevention 
campaigns remain focused on the uninfected population.  As discussed in-depth 
in Chapter 1, using the framework of the social construction of Africa’s HIV 
epidemics where infected individuals and groups are negatively constructed 
and/or weak socially and politically, provides us with an intuitive and insightful 
lens through which to view the illusory tradeoff that has been created between 
HIV prevention and treatment.  
 
The subsequent section then focuses our attention on the financial side of 
HIV policy in Mozambique.  Though ART as prevention will function whether 
or not the preventative externalities of treatment are acknowledged, there is still 
great need to question the ‘illusory tradeoff’ framework (prevention vs. 
treatment) that does not allow ART to be considered as an HIV prevention 
strategy.  Currently, new cases of HIV that are prevented through ART (which, 
as we have seen, may already exceed new cases prevented through abstinence or 
condom usage) are not included in any prevention calculations and, as a 
consequence, ART is not eligible for consideration for funding that is earmarked 
for prevention.   
 
As 72% of Mozambiques total expenditures on health (TEH) and a full 96% 
of the nation’s HIV/AIDS-specific funding come from external sources, we then 
focused on the main HIV/AIDS funding agencies working in the nation: 
PEPFAR and the Global Fund.  The discussion of the social construction of 
HIV, and, in particular, the importance of ‘Western’ ideas surrounding ‘African 
sexuality’ are thrown into stark relief in this section as PEPFAR has been 
accused, not only by some scholars and activists, but also by the US 
government’s own Accountability Office (GAO) of harming comprehensive 
prevention efforts which target scientifically sound areas of prevention such as 
PMTCT and blood safety through ideologically-based requirements (i.e.: large 
earmarks for absinence until marriage, partner reduction, etc…).  It was also 
noted that, while a current mandate to utilize 50% of PEPFAR funding on ART 
is in place, Mozambique has been unable or unwilling to reach this level, possibly 
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due to a lack of sufficient health infrastructure and human resources (a topic 
which is the focus of Chapter 3), areas where PEPFAR funds have only very 
recently been directed.  As discussed earlier in this chapter, PEPFAR accounts 
for 78% of Mozambique’s HIV/AIDS-specific funding which has the secondary 
effect of locking-in policies and strategies which other donors (and the national 
government) must then work with and build upon.  As PEPFAR funds are ‘off-
budget’ and therefore not subject to national policies of governmental approval 
or allocation, the national government is further disempowered in terms of 
deciding policy direction and focus.  This lock-in of policy direction also 
becomes particularly salient in the case of the Global Fund. Though the Global 
Fund does not have ideological requirements for how their resources are spent, 
they do have a strong ‘additionality’ principle which requires that Global Fund 
resources be used in addition to other sources of funding (internal or external), to 
strengthen existing programs as opposed to creating vertical programs or 
infrastructure.  As the Global Fund makes relatively small contributions relative 
to PEPFAR and has this ‘additionality’ requirement, it is unlikely that these funds 
(or other donor or national funds) would be capable of changing the trajectory of 
HIV prevention policies without a paradigmatic shift first and foremost in 
PEPFAR.  Therefore, if we wish to harness the externalities of ART as 
prevention, we cannot ignore the power of social constructions in HIV policy, 
particularly in light of the clear and explicit connections we have seen between 
the social construction of ‘African sexuality’ and the continuing focus of 
PEPFAR (and, subsequently, all national policies in target nations) on sexual 
behavioral prevention strategies despite evidence of their continuing failure, not 
only to change sexual behavior, but also to stem the tide of the HIV epidemic.  
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3 HUMAN RESOURCES FOR HEALTH AND ART SCALE-UP IN MOZAMBIQUE 
 
3.1 Mozambique’s Human Resources for Health (HRH) 
 
Mozambique is one of the 56 nations identified by the World Health 
Organization (WHO) in 2006 as having a ‘critical shortage’ of health workers.1  
The WHO defines the critical threshold for the density of doctors, nurses and 
midwives (combined) as 23 per 10,000 population, while Mozambique, as of 
2010, continues to hover around three per 10,000.16,2  According to 
Mozambique’s 2010 Annual Human Resources Report (DRH), as of December 
31, 2010, Mozambique counted 863 Mozambican physicians, 76.5% (660) of 
whom are generalists, 23.3% (200) hospitalists and 0.3% (3) physicians 
specialized in public health.  The capital city, Maputo, contains 42.2% (364) of all 
Mozambican physicians in the nation though its population accounts for only 
roughly 5% of the national population.3 Even within Maputo City, we find an 
imbalance as close to 68% (247) of all physicians in the city work at the Central 
Hospital of Maputo while the other 32% (117) staff two other general hospitals 
and close to two dozen health centers.4  On a national level, the number of 
physicians has been growing at roughly 8% since 2008 but again, the growth has 
been uneven with Maputo City alone recording increases of 14% in 2009 and 
39% in 2010.5   
 
To put these numbers in perspective, the DRH reports that by the end of 
2010, Maputo City (including the Central Hospital) had more Mozambican 
physicians than the provinces of Cabo Delgado, Niassa, Nampula, Zambézia, 
Manica, Tete, Sofala and Inhambane combined (the remaining provinces of Gaza 
and Maputo—excluding the City of Maputo—had a total of 39 and 42 
Mozambican physicians, respectively).  By the end of 2010, there were 242 
foreign physicians working in Mozambique (83% of them as hospitalists), though 
these ‘visitors’ and expatriates are not included in Mozambique’s national human 
                                                 
16 Though Mozambique’s 2010 Annual Human Resources Report (DRH) puts this ratio 
at 6.3 per 10,000 population, this is based on considering only children aged 0-5 and 
women aged 15-45 in the population as can be seen in Table 22 of the report. 
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resources plans and projections.  Figures 13 and 14 show a graphic representation 
of the distribution of Mozambican physicians and all physicians (Mozambican 
and expatriate) in the nation.  The provinces of Sofala and Nampula are 
highlighted in these figures as they contain the second- and third-largest cities in 
Mozambique, respectively, after Maputo (Beira and Nampula City). Nampula 
Province is, in fact, the most populated province in Mozambique with a 
population of approximately 4.5 million6 compared to close to 1.9 million in the 
province of Sofala7 and roughly 1.2 million in Maputo City8.  
Figure 13.  Distribution of Mozambican Physicians. 
 
Source: DRH 2010 Annual Report (2011) 
Figure 14.  Distribution of All Physicians in Mozambique (Expatriate and Mozambican) 
 
Source: DRH 2010 Annual Report (2011) 
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Putting the number of physicians in perspective relative to the population of 
each province and Maputo City, we can see in Figure 15, that Nampula province 
has over 56,000 inhabitants per physician, Sofala (provincial capital: Beira) has 
approximately 27,000 and Maputo City approximately 9,500. 
Figure 15. Inhabitants per Physician for the Mozambican Provinces and Maputo City. 
 
Source: DRH 2010 Annual Report (2011) 
 
In terms of non-physician clinicians, Mozambique has set explicit targets  in 
their National Human Resources Development Plan (HRDP) 2008-2015 for 
mid-level17 general nurses (9,453), mid-level maternal-and-child-health nurses -
MCHN- (5,951) and mid-level medical technicians (4,689).  By the end of 2010, 
Mozambique had reached 57% (5,397) of the 2015 goal for mid-level general 
nurses; 69% (4,110) of the 2015 goal for mid-level MCHN and; 71% (3,320) of 
the 2015 goal for mid-level medical technicians.  However, looking at the rates of 
growth in these professions, Mozambique expects to fall short of the 2015 goals 
for mid-level general nurses (23% deficit) and mid-level MCHN (10% deficit), 
while surpassing the planned number of mid-level medical technicians by 42%.   
 
Mozambique has also set year 2015 targets for pharmacists (2,002) and 
laboratory technicians (1,581) in the HRDP. By the end of 2010, the nation had 
61% (1,221) of the 2015 goal for pharmacists and 76% (1,206) of the 2015 goal 
                                                 
17 Mozambique disaggregates clinicians by level of education with ‘elementary’, ‘basic’, 
‘mid-level’, and ‘specialized mid-level’ all being included in calculations for so-called 
‘mid-level’ clinicians while ‘superior’ is the highest level of education and is not 
specifically targeted or counted in the national goals. 
84 Chapter 3 
for laboratory technicians. At the current rates of growth in these professions, 
Mozambique expects a to fall slightly short of the target for pharmacists (2% 
deficit) but to surpass the planned number of laboratory technicians by 47%. 
These 2015 targets, the number of health workers to reach the targets as well as 
the number of projected health workers in each category by 2015 (based on rates 
of growth in each profession through the end of 2010) can be seen in Figure 16 
below.  
 
Figure 16.  Current and Projected (2015) Human Resource Levels by Health Worker Category. 
 
Source: DRH 2010 Annual Report (2011) 
 
The regional imbalance of non-physician clinicians, pharmacists and 
laboratory technicians is slightly less marked than that of the physicians.  By the 
end of 2010, roughly 17.2% (5,919) of the nation’s non-physician health 
personnel were concentrated in the City of Maputo, however, the Central 
Hospital of Maputo continues to host the bulk of these health workers with 
54.2% (3,207) of Maputo City’s non-physician health workers concentrated in the 
Central Hospital.  Not incidentally, this means that the Maputo Central Hospital 
alone has more non-physician health workers than most of the individual 
Mozambican provinces (i.e.: Cabo Delgado, Niassa, Tete, Manica, Inhambane 
and Gaza).  
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The 2015 goal for all clinical, pharmaceutical, laboratorial and technical staff in 
Mozambique is 29,333 while, through the end of 2010, Mozambique had reached 
63.4% of that goal with personnel numbering 18,587.  Tyrell et al. 2010 estimate 
the total cost of the HRDP (2008-2015) at approximately USD$ 2 billion with 
over three quarters of those resources dedicated to the wage bill (health worker 
salaries), 14% to incentive packages for retention, motivation and deployment of 
health workers and over USD$100 million for initial training of health workers 
(28% of which would go towards infrastructure and equipment) with an 
additional USD$11 million earmarked for on-the-job training.  It is important to 
note that the HRDP is generally aimed towards HRH scale-up for health areas 
considered priorities in achieving the Millennium Development Goals (MDGs), 
namely: nursing, pharmaceutical management, laboratorial management, 
preventative medicine, hospitalist administration, anesthesiology, instrumentation 
and surgery.9  However, HRH scale-up as viewed through the lens of ART scale-
up, though often on a parallel course (HIV/AIDS is, in fact, the focus of MDG 
6), also contains specificities which deserve attention.  These specificities will be 
discussed in the following sections on HRH and ART scale-up and Task Shifting.  
 
3.2 Human Resources for Health and ART Scale-Up 
 
Though there are many HIV/AIDS-related activities that can be and are 
carried out by non-health professionals, HIV treatment remains an area which is, 
understandably, particularly health worker-dominated and the health worker crisis 
in Mozambique is considered the greatest obstacle to improving the population’s 
health as well as reaching several of the MDGs.10 Hard and fast 
recommendations regarding the number or mix of health workers required for 
effective ART provision in Mozambique have yet to be written.  With the rapid 
move towards task shifting (to be discussed in the following section) and the 
resulting shifting landscape of health workers qualified and authorized to perform 
certain HIV-related tasks, recommendations are increasingly more likely to center 
around the number of health workers needed to provide specific services (i.e. 
commencement/prescription of ART, counseling and testing, monitoring of 
CD4 levels, etc…). 
 
The Global Health Workforce Alliance (GHWA), in 2010, published a Rapid 
Situational Analysis of Mozambique’s HRH scale-up as it relates to universal 
access to HIV-related services.  This analysis mainly relied upon HIV 
epidemiological data, HIV program indicators and key informant interviews to 
identify strong and weak points in Mozambique’s HRH scale-up in relation to 
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HIV services and to elaborate recommendations to increase the efficiency and 
efficacy of this HRH scale-up.11  Unsurprisingly, the number, type, level of 
attrition and geographical distribution of health workers were cited as continuing 
barriers to universal access.  Though the report praised the Ministry of Health’s 
HRDP and the intention behind the accelerated training strategy (2006-2009), a 
marked trade-off between quantity and quality was identified as the infrastructure 
necessary (including classrooms, materials, and clinical practice sites) to properly 
train large numbers and cadres of health workers is still lacking as well as pay, 
incentives and working conditions conducive to retention in the public sector. All 
cadres of health workers are seen to suffer from problems of motivation due to a 
general lack of incentives (‘perks’), opportunities for ongoing training and career 
mobility (particularly for lower cadres of workers), low salaries, difficult working 
conditions and, ironically, a perception among health workers of very high risk of 
acquiring HIV on the job through accidents (such as needle-stick injuries).  In 
fact, HIV-related deaths of health workers remain one of the leading causes of 
workforce attrition, accounting for a large portion of the 19%-25% of the health 
workforce lost to death each year from 2008-2010 (See Figure 17).12  The relatively 
high number of leaves of absence (particularly ‘unlimited’ leaves) tends to reflect 
the clinical health workers who leave the public sector for ‘greener pastures’ as 
consultants and employees of NGOs and donor organizations where pay, 
benefits, working conditions and opportunities for advancement are considerably 
more favorable than work in the public sector. These workers have not officially 
left the public sector by permanently leaving their public employment (they may, 
indeed, return to their public sector position at the end of their leave of absence), 
but are considered ‘lost’ in terms of their concrete contributions to clinical care in 
public health facilities.  Mozambican physicians are particularly coveted by 
NGOs and, despite the fact that Mozambican physicians represent only 4.6% of 
all clinical workers (in 2010), they made up 11%, 17% and 13% of all attrition 
due to registered and unlimited leave in 2008, 2009 and 2010, respectively, and 
these leaves constituted the primary source of attrition for physicians in all three 
of those years.13   
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Figure 17. Clinical workforce attrition in Mozambique, 2008-2010 
 
Source: DRH 2010 Annual Report (2011) 
 
Though there are no systematic comparable data from Mozambique, Weller et 
al, (2011) highlight evidence from several developing nations that shows that 
donors and NGO’s working on the ground tend to “bid” against one another, 
incrementally increasing salaries for limited health workers and therefore 
poaching from one another (as well as the public sector) and leading to increasing 
distortion of salaries. In acknowledgement of this phenomenon, the Mozambican 
Ministry of Health drafted an agreement that they called the ‘Kaya Kwanga 
Commitment: A Code of Conduct to Guide the Partnership for Health 
Development in Mozambique’ in 1999. Virtually all UN agencies, bilateral donors 
and NGOs working in the health sector in Mozambique signed the commitment 
in 2000, pledging, among other things, to “[a]dhere to agreed national rates 
regarding remuneration and allowances for civil service employees, remuneration 
of consultants […and] avoid the departure of qualified personnel through the 
contracting of civil servants for donor consultancies”14. The pledge, however, is 
non-binding and Mozambican government efforts to bring remuneration by 
international agencies in line with public remuneration have failed to date, 
perhaps in part due to entrenched expectations of health workers (and those 
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training to be health workers) as well as escalating competition between NGOs 
for the limited local, qualified health workers that has led to private sector salaries 
5 to 20 times higher than public sector salaries.15 For example, Ferrinho et al. 
(2004) found that while medical students in Mozambique acknowledged that they 
would be needed in the public sector after graduation, one third of the 
respondents had post-graduation salary expectations ranging from USD$715-
1071 per month and another third of respondents expected over USD$1,429 per 
month while, at the time of the survey, newly graduated (public sector) physicians 
were earning approximately USD$350 per month. While physicians in 
Mozambique almost without exception, work at least nominally in the public 
sector, brain drain can be seen in the tendency towards dual (public and private) 
practice in order for health workers to gain supplementary income.16  Dual 
practice (otherwise known as ‘moonlighting’) is not necessarily negative if 
properly regulated; Mozambican hospitals, for example, often consider dual 
practice a necessity in order to retain senior staff.17  However, due to the 
potential for conflicts of interest and lessening of hours devoted to public health 
provision, the Mozambican Ministry of Health stated its intention to firmly 
regulate dual practice activities in 2008, though by the end of 2010, these planned 
regulations had not yet been introduced.18 
 
The Mozambican government, being well aware of this internal, public to 
private ‘brain drain’ and in addition to planning to regulate dual practice, laid out 
plans in the HRDP (2008-2015) to increase incentives for retention in the public 
sector (such as improving public sector career mobility and opportunities for 
promotion) as well as base salaries of health workers by increasing human 
resource expenditures as a percentage of health spending. The 2010 DRH reports 
that, while they Ministry of Health did, in fact, implement competitive 
promotions throughout the country, due to budgeting difficulties, they were not 
actually able to increase salaries for these promoted workers, nor for the workers 
who remained in their previous positions. The report also states that planned 
differential compensation plans for health workers who were put at higher 
occupational risk (for example, of contracting HIV on the job) meant to serve as 
a form of insurance, had also stalled due to budgetary constraints.  These failures 
in terms of increasing financial incentives to retain health workers in the public 
sector were acknowledged and attributed to an actual decrease (rather than the 
planned increase) in human resource expenditures as a percentage of health 
spending in 2010 relative to previous years19. 
 
Médecins Sans Frontières (MSF) which works extensively in Mozambique, has 
pointed out the further issue of wage bill ceilings limiting the Mozambican 
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government’s ability to hire new health workers in a timely manner 20 (not to 
mention, limiting their ability to pay competitive salaries for those they do hire).  
This led, for example, to a support plan beginning in 2002 where MSF, with the 
encouragement of the Mozambican Ministry of Health, hired and trained newly 
graduated nurses that the government could not hire itself, sometimes for up to 
four years, due to the wage bill ceiling.21 This mismatch between the HRDP 
which calls for and projects massive increases in health worker numbers in order 
to meet the MDGs and the lack of guarantees of public sector jobs for the much-
needed, newly minted workers (as well as low salaries and weak incentives for 
those who are hired) helps to reinforce the public health sector’s image as an 
undesirable sector in which to work.   
 
In terms of donor support for health worker scale-up, most donors (including 
the major players in HIV services: PEPFAR and The Global Fund) are rarely 
willing to support public health worker salaries nor their full clinical training, as 
they are concerned about the ‘sustainability’ of programs.22  For the relatively 
short period that The Global Fund contributions were included in Mozambique’s 
SWap (‘on-budget’, as discussed in Chapter 2), these contributions were, 
ostensibly, also supporting health worker training, however, this ended when 
Global Fund contributions were taken ‘off budget’ again in 2008.  What donors 
do tend to consistently support are short-term, privatized in-service training 
activities of existing staff to specialize in HIV/AIDS support services (including 
treatment).23  Though PEPFAR discontinued the practice in Mozambique (in 
2007), the Global Fund also continues to provide what are known as ‘top-ups’–
often salary supplements—for health workers’ HIV/AIDS activities and 
attendance at donor-funded workshops which have been shown to have the 
perverse effect of weakening the nation’s general health structure by siphoning 
staff from general, clinical practice to more lucrative HIV/AIDS-specific 
activities.24  Evidence suggests that, at times, health workers continuously attend 
these well-paying, donor-funded workshops, further depleting the service delivery 
in their health centers, in order to gain the significant supplementary income, and 
failing to then bring that training back into practice.25  This tension between 
HIV-specific donor initiatives and funding and national attempts to strengthen 
general health systems so that they are capable of dealing with the HIV/AIDS 
epidemic, but not limited to dealing with HIV/AIDS, continues to be an issue.26   
 
90 Chapter 3 
3.3 Task Shifting 
 
The deficit in sheer numbers of health workers as well as the ‘poaching’ of the 
most highly qualified cadres (mainly physicians) by donor organizations working 
on-the-ground in Mozambique has necessitated concerted efforts to accelerate 
what is called ‘task shifting’.  Task shifting is defined as ‘the delegation of medical 
and health service responsibilities from higher to lower cadres of health staff, in 
some cases non-professionals’27.  In terms of ART scale-up, task shifting is 
intended to help offset regional imbalances in the health workforce (keeping in 
mind that physicians are the cadre showing the most severe geographic 
imbalances in Mozambique) as well as increase the number of patients that can 
be enrolled in ART per health unit and the number of health units that can offer 
ART for a fraction of the cost (and time) it would take to scale-up physicians.  
Though Mozambique introduced the ‘medical technician’ (técnico de medicina) cadre 
shortly after independence in 1975, training of medical technicians was severely 
reduced in 1986 due to an intensifying civil war and the constraints imposed on 
the public sector wage bill ceiling by structural adjustment policies.28  Though 
Mozambique’s civil war ended in 1992, training programs for task shifting only 
resumed in earnest in 2003, concurrently with the introduction of ART in public 
facilities.  This first wave of new medical technicians (along with existing 
technicians who had received two weeks of supplemental HIV training) was 
deployed in 2006 and in February of that same year, medical technicians were 
authorized to prescribe first-line ART.  The number of facilities providing ART 
tripled in the first 6 months of the technician deployment and a full 45% of rural 
and peri-urban health centers were (and many, in fact, continue to be), managed 
by a medical technician.29  Table 6 shows the main elements of task shifting in 
Mozambique. 
 
Table 6. Task Shifting in Mozambique 
 
Task Former Cadre Cadre after task shifting 
Prescription of first line 
ART 
Physicians Physicians and Medical 
Technicians 
ART follow-up and refills Physicians Physicians, Nurses and 
Medical Technicians 
Counseling & Testing 
services and adherence 
counseling 
Psychologists Medical Technicians, 
Nurses and lay counselors 
PMCT implementation Physicians Physicians, MCH Nurses 
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Bedside Care Nurses ‘Attendants’ (similar to 
nursing assistants) 
Taking of blood samples Phlebotomists (laboratory 
health workers) and nurses 
Phlebotomists, Nurses and 
Ancillary lab workers 
(agente de lab) 
Patient follow-up and 
adherence counseling 
Psychologists Psychologists and Peers on 
ART (activistas) 
 
Source: Jaskiewicz, 2010  
 
 
Of course, with task shifting, comes the question of quality of services as tasks 
are delegated to lower cadres of workers.  As ART is our main concern, let us 
focus on the cadre of medical technicians, who now carry out the bulk of ART-
related services in Mozambique, including in the health center where interviews 
were carried out for the fieldwork portion of this dissertation (Chapter 4).  Sherr 
et al. (2010) carried out a retrospective cohort study of patients who initiated 
ART with either a physician or a medical technician between July 2004 and 
October 2007 at two public HIV clinics in central Mozambique and examined 
indicators such as the frequency of clinical visits in the first year post-ART 
initiation, adherence to ART in the first 6 months of treatment and, whether or 
not CD4 cell counts were evaluated between 90—210 and 33—390 days post-
ART initiation for each group.  Their results indicate that patients who began and 
continued care with medical technicians had similar or statistically better 
performance measures than patients who had begun their care with physicians 
for all five of the indicators they had utilized and after controlling for relevant 
covariables (i.e.: socioeconomic status, CD4 cell count at enrolment, age, 
education, distance to health facility, etc…).  Though patients were not randomly 
assigned to provider types, those who began care with medical technicians had 
less education, lived farther from the health facility and were of lower 
socioeconomic status on average; these factors are generally associated with 
poorer adherence and care outcomes, however, adherence was slightly higher for 
the medical technician group (78.9% versus 77% adherence) and the likelihood 
of death was less for the technician group compared with patients in the 
physician group (hazard ratio 0.91, 0.79<HR<1.06). 
 
Though case studies such as this show that task shifting holds great promise 
for ART scale-up in Mozambique, task shifting should not be seen as a panacea 
nor an absolution of government and donor responsibility to invest in, not only 
other aspects of the health system, but also in achieving high levels of service 
delivery within the  strategy of task shifting.  While task shifting does save 
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training time (i.e. 6 years for generalist physicians versus 2.5 years for medical 
technicians) as well as money in the form of training costs and salary, it should 
not be seen as a permanent solution to health system deficiencies in 
Mozambique.  During the training of medical technicians in ART, there are a 
number of idealistic assumptions made and included in the curriculum, such as 
that: medical technicians will only see stable, non-pregnant adult patients in the 
early clinical stages of HIV (before onset of AIDS); clinical staging of disease 
progression will be possible in the technicians’ future health facilities (clinical and 
diagnostic tests that determine status of a patient’s  progression towards AIDS 
and the need for ART as well as other prophylactic or opportunistic treatments); 
medical technicians will be supervised by physicians, etc…30 However, as pointed 
out by Brentlinger at al. (2010), newly-trained medical technicians are often sent 
to health units lacking in both clinical supervision—recall the high percentage of 
health facilities that are managed by medical technicians—as well as 
clinical/diagnostic equipment whose presence was assumed during their training.  
This same study also found that medical technicians are ill-prepared (and show 
considerable deficiencies in clinical decision-making as judged by experienced 
physicians) to deal with patients co-infected with HIV and Tuberculosis (TB), 
though HIV/TB co-infection is a common challenge in Mozambique.  The 
researchers also found that older medical technicians (those who had been 
practicing for several years and had completed the 2-week HIV training 
supplement), show significantly worse performance in terms of correctly 
identifying opportunistic infections, clinical staging, knowing when to initiate or 
continue prophylactic treatment as well as when to initiate ART itself, than the 
younger medical technicians who completed their training after HIV and ART 
management had already been included and stressed in the full, 2.5-year 
curriculum.  So while task shifting is a useful and, in some cases, revolutionary 
tool that has indeed, drastically increased access to ART in Mozambique and 
even patient outcomes in some cases, constant vigilance and improvement of the 
quality of the health system (including infrastructure, diagnostic equipment and 
continued scale-up of higher cadres of health workers) is still required in order to 
avoid the pitfall of trading quantity for quality in our quest to treat as many 
people in need as possible.   
 
Though here we have focused on task shifting among different cadres of 
clinicians, it must also be recognized that some tasks have been shifted partially 
or completely to laypersons (as briefly noted previously).  Though ‘community-
based’ care has become popular in policy circles, as we can see through 
Mozambique’s Cuidados Domiciliários (‘Home Care’) program, there is a great need 
for further research, not only into the quality of home care provided by these lay 
 MOZAMBIQUE’S HUMAN RESOURCES FOR HEALTH AND ART SCALE-UP 93 
caregivers, but also into the quality of their training in terms of minimizing risks 
to their own health.  For example, Mozambique’s training manual for these 
community-based home caregivers only briefly mentions the use of blades by 
traditional healers and unspecified cosmetic procedures as transmission routes of 
HIV, but does not include any information, instructions or warnings for 
caregivers themselves to be vigilant to any and all blood exposures that may 
occur during their caregiving activities nor does it make any mention of the 
availability or necessity for immediate post-exposure prophylaxis18 for caregivers 
who are inadvertently exposed to infected blood.31  These issues are outside the 
scope of this dissertation, but this is an area which merits explicit study as task 
shifting (including to these lay caregivers) continues to accelerate to keep up with 
increasing demand for treatment and care services in Mozambique and other 




This chapter has focused on the ‘resources’ portion of ‘human resources’, 
providing background on Mozambique’s numeric, geographic and task-based 
balance of health workers as well as the reasoning behind recent HRH policies 
including scale-up and task shifting in relation to HIV treatment.  The following 
chapter, the case study portion of this dissertation, will shift the focus to the 
‘human’ portion of human resources.  It will explore the social construction of 
Mozambique’s HIV epidemic as discussed in Chapter 1 through the lens of on-
the-ground ART treatment based on patients’ and clinicians’ experiences with 
ART.  Neither professional health workers nor patients are immune to the effects 
of the social construction of HIV and the case study attempts to show the very 
real, if at times ethereal, effects of current and historical HIV prevention 
messages on patients’ experiences with ART.  If Mozambique is truly to harness 
the preventative externalities of ART, the messages communicated to patients 
through prevention campaigns and through their ongoing communications with 
clinicians (whether these messages be found in the spoken or unspoken 
dialogues), must be examined and better understood.  We have seen in Chapter 2 
that coverage and usage of prevention interventions (including ART) is the most 
crucial factor in their population-level efficacy.  We have also explored the state 
of Mozambique’s human resources for health (and specifically for ART scale-up) 
                                                 
18 Post-exposure prophylaxis is simply the administration of antiretrovirals (usually for 1-
2 months) to a person who is exposed to HIV in order to minimize the risk that they will 
seroconvert. 
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in the current chapter. It is now time to turn our attention to not just the 
numerical and logistical requirements for effective ART scale-up and adherence 
that have been discussed in these two chapters, but also to the ‘human’ 
requirements as they manifest in beliefs and communications regarding HIV.  
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CASE STUDY: THE ROLE OF HIV 
PREVENTION MESSAGES IN PATIENTS’ 
EXPERIENCES WITH ART IN THE CITY 
OF MAPUTO, MOZAMBIQUE 
 
 
4.1 Introduction to the Case Study 
 
In 2001, with the introduction of Antiretrovirals(ARVs) in Mozambique, the 
Ministry of Health declared:  “As a consequence of the introduction of 
therapies using these substances [ARVs], multiple studies have 
demonstrated their efficacy, drastically reducing patients’ plasma viral 
loads to undetectable levels, which also brings a great decrease in sexual 
transmission of the virus [HIV];  in this way, Antiretroviral Therapy is an 
important contribution in prevention of infections”.1 
In Mozambique, approximately 1.4 million people are living with HIV/AIDS 
and roughly 90 thousand of them die of AIDS-related complications annually.2  
In the city of Maputo prevalence is estimated at 20.7% and just under 20,000 new 
cases of HIV were diagnosed in 2007 alone, an increase of 15% relative to 2006 
(though a portion of the increase may be attributable to the expansion of HIV 
counseling and testing services).3   
In terms of Antiretroviral Treatment (ART), Mozambique continues to make 
steady progress in expanding its public provision of ART.   For example, in 2007, 
all of the identified newly eligible patients in the city of Maputo (25,123) began to 
receive ART.4  At the national level, as of mid-2011, Mozambique had 
approximately 220,000 patients on ART5. 
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Figure 18. ART Provision 2004-2009 
 
Source: CNCS, 2010, p. 20 
 
In Figure 18 we see considerable increases in ART provision with the 
beginning of decentralization of HIV services, when Primary Health Facilities 
(Primary HFs) began providing ART beginning in 2006.  Until that time, ART 
had been available only in vertical ‘Day Hospitals’ dedicated to HIV services (and 
which fell under the heading of either ‘Secondary’ or ‘Quaternary’ Health 
Facilities).  This important progress in ART coverage can, in large part, be 
attributed to the integration and decentralization of HIV services adopted by the 
Mozambican Ministry of Health in 2005, with official implementation beginning 
in 2006 (concurrently with the task shifting strategy discussed in the previous 
chapter).  Recent studies in Mozambique show that the new decentralized system 
has coincided with a dramatic increase in the absolute and relative number of 
patients receiving ART, a decrease in the time between HIV testing and 
commencement of ART and a decrease in the number of patients who disappear 
or are lost to follow-up.6  From the beginning of ART provision in Mozambique 
in 2003 to the end of 2009, of the 242,854 registered patients who commenced 
ART for the first time (230,181) or who resumed ART (12,673), 17% abandoned 
treatment and an additional 8% disappeared or were lost to follow-up.7 To put 
this into perspective, a meta-analysis by Mills et al. (2006) found a pooled 
adherence (the mean adherence from all studies) estimate of 55% in the North 
American studies used and a pooled adherence estimate of 77% for the African 
studies.8  This would place Mozambique’s 25% of patients who abandon 
treatment or are lost to follow-up within the normal range for Africa and with 
much higher levels of adherence than those found in North America.  However, 





















































100 CHAPTER 4 
Mozambique continues to increase ahead of projections, if ART is to be 
efficacious, not only for individual treatment, but also for its potential 
population-level preventative benefits, we must earnestly investigate the 
experiences of patients on ART to understand how to retain the 25% of patients 
who abandon treatment or are lost to follow-up (LTF) as well as understand 
factors that may discourage people from being tested for HIV or commencing 
treatment. Many studies of ART in the developing world tend to focus on the 
necessary expansion of the availability of services,  highlighting and addressing 
financial, technical, logistical and clinical issues.9  Decentralization in 
Mozambique has, indeed, helped to address logistical barriers to ART access and 
adherence, such as distance to health facilities, and in many cases, has eliminated 
the need for some patients to pay for transport to health facilities in urban 
settings. The decentralization of, not only patients, but also many laboratory 
services has shortened wait times between counseling, testing, gauging CD4 
levels to determine eligibility for treatment and the commencement of treatment 
itself.10 Thanks to the rapid and steady progress in these areas, ART access has 
indeed increased dramatically in recent years and continues to do so.  Now 
however, it is time to turn our attention as well to some of the sociological 
aspects of ART within the wider picture of the HIV prevention environment, as 
ART is a life-long, intensive treatment regimen to which patients must faithfully 
adhere in order for its individual therapeutic as well as wider preventative 
benefits to be maximized.   
One notable aspect of recent social science-based studies of ART adherence 
in developing nations is a marked focus on characteristics and behaviors of the 
patient alone to explain non-adherence, often identifying things like being 
unmarried, consuming alcohol or having a low level of education as correlates of 
poor adherence.11  When issues of, for example, the not insignificant effect of 
stigma on adherence are discussed (such as with infected persons who are afraid 
to disclose their serostatus to their partners), the concluding recommendation is 
generally rather vague, stating that efforts to encourage disclosure of serostatus 
and counsel patients on disclosure are required; isolating the patient and the 
solution to the problem from the possible source of the stigma.12,13  When a 
social source of stigma is cited, authors invariably refrain from going into detail 
about either the source of the stigma or the recommendation to address the issue 
as we can see, for example, in one study that ultimately suggests that what is 
needed are “changes in the social milieu that make HIV less stigmatized”.14  
In contrast, one can note that many studies of adherence in more affluent 
settings focus closely on various aspects of the relations between patients and the 
medical establishment or between patients and providers of information 
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concerning HIV/AIDS.  The dynamics of these relationships between various 
parties may be a more policy-sensitive area for exploration. Interventions that 
seek to modify or improve a professional dynamic (as well as modify the 
information provided within a medical or institutional public health setting) may 
be more efficacious than attempts to change individual characteristics of patients. 
Upstream policies also have the potential to pre-emptively combat stigma and 
fear of disclosure at their possible source.   
This study seeks to explore the hypothesis that official HIV prevention 
messages in Mozambique, with their almost exclusive focus on sexual 
transmission (and, to a lesser extent, MTCT in the case of pediatric patients), may 
be a significant source of stigmatizing beliefs, whether these manifest as the 
internalized stigma of patients themselves or social stigma coming from 
uninfected (or undiagnosed) persons and clinicians.  Several studies conducted in 
affluent nations which served as a loose basis for this research address issues 
such as: (1) the effect of the ‘deviance’ discourse on HIV patients’ experiences 
with medical providers;15 (2) the importance of the relationship between the 
patient and the medical provider in adherence;16 and (3) the importance of trust 
between patients and providers, particularly in the information and 
recommendations given by providers.17   
This exploration of the effect of HIV prevention messages on patients’ 
experiences with ART is an area about which, to my knowledge, no research has 
been done to date and yet, if we wish to understand and harness the preventative 
externalities of ART, it will be important to understand the effect of HIV 
prevention messages not only on those who are as yet uninfected, but also on 
those already living with HIV; in other words, to examine HIV prevention 
messages in the context of a closed loop, rather than a linear message that 
exclusively impacts the as yet uninfected population.   
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Figure 19. Mediation Model of the Effect of HIV Prevention Messages on ART Patients’ Experiences 
 
 
Source: Author’s creation 
4.2 Objectives 
The aim of the study is to explore the possibility that social constructions of the 
HIV epidemic in Africa and particularly Mozambique, as discussed in Chapter 1, 
affect patients’ experiences with ART and, therefore, the ultimate potential of 
ART as a prevention strategy.  The primary objective is to explore the role of 
HIV prevention messages in patients’ experiences with ART.  The secondary 
objective is to investigate the role of relational dynamics between clinicians and 
patients on patients’ experiences with ART.   
 




The study is qualitative and exploratory utilizing semi-structured, in-depth 
interviews with:   
1. Medical providers (physicians, nurses and technicians) who administer 
ART in the Central Hospital of Maputo (pediatric patients) and the Health 
Center Malhangalene (adult patients);                                                                                                                                
HIV Prevention Messages 
(Sexual Behavior Modification & 
MTCT) 
Creation or Exacerbation of 
Stigmatizing Beliefs 
Trust or Disconnect Between 
Patients and the Medical 
Establishment 
Impact on Patients’ Experiences 
with and Adherence to ART 
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2. Caretakers of pediatric patients (under 18 years) receiving ART through 
the Central Hospital of Maputo and;                                                                                                                                                                                
3. Non-gestating adult patients receiving ART through the Health Center 
Malhangalene.                                                                                   
 
The interviews with medical providers were all conducted by myself in a 
private examination room at the two medical facilities in question. The interviews 
with caretakers of pediatric patients were carried out by two members of the 
research team, one a physician completing ‘post-graduate’ rotations in the Central 
Hospital of Maputo and the other in the final year of medical studies at Edoardo 
Mondlane University at the time of the interviews.  Interviews with adult patients 
were carried out by another member of the research team who was also in his 
final year of medical studies and by myself.  All interviews with patients and 
caretakers of pediatric patients were carried out in a private examination room at 
the two medical facilities. 
 
Study questionnaires contained several open-ended questions and patients (or 
caretakers) and providers were encouraged to speak freely and explain their 
responses.  They were not provided with a list of possible responses to these 
questions. Interviewers frequently followed-up patients’ answers with ‘why?’ or 
‘how do you mean?’ types of questions to further explore topics. Responses to 
these questions are characterized as ‘spontaneously reported’ in the discussion to 
follow.  There were also several ‘closed’ questions that inquired into self-reported 
adherence (for the preceding days and weeks) and when non-adherence was 
reported, interviewers requested further details as to why patients had missed 
doses and what, if any, self-medicating behaviors they had engaged in (i.e. 
traditional healers, over-the-counter medicines, etc…).  Though this study 
focuses on sociological aspects of ART, patients were asked about any difficulties 
they might have in adhering due to logistical or clinical issues (i.e.: unable to 
travel to health center/hospital; side effects of ARVs; stock-out of ARVs at the 
pharmacy; need to share ARVs with another person) in order to better 
understand the relative importance for this population of the sociological aspects 
in which we are interested versus logistical or clinical issues. 




The study population included twenty-six (26) caretakers of pediatric patients 
aged 3-12 who were receiving ART through the Pediatric Day Hospital of the 
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Central Hospital of Maputo during the interview period and twenty-two (22) 
non-gestating adults who were receiving ART through the Health Center 
Malhangalene.  Fourteen (14) medical providers (physicians, nurses and 
technicians) who were working directly in the provision of ART in both 
participating health facilities were interviewed.  The selection of patients was 
pragmatic and opportunistic, drawn from patients who presented at the 
participating health facilities for a clinical check-up and/or to pick up their refill 
prescription of ARVs during the interview period and who consented to 
participate in the study.  The selection of providers was also opportunistic, based 
upon clinical staff who were working in the health facilities during the interview 
period and who consented to participate. Medical providers and caretakers of 
pediatric patients were interviewed from March through July 2011 while adult 
patients were interviewed in March and September 2011. 
 
Adult patient characteristics from the Health Center Malhangalene can be 
seen in Appendix 2, Table 1. There were 2,619 adult patients enrolled in ART at 
Malhangalene as of July 2011, 68% of whom were female (1,793).  Of the 22 
adult patients interviewed for this study, 77% are female.  Four adult men 
declined to participate after having the study explained to them, citing fears that 
the audio recording of the interview would be broadcast on the radio.  No 
women declined to participate.  The median age of adult ART recipients at the 
health center as of July 2011 was 35, while the median age of the adult 
interviewees is 35.5 (the median age of adults in Maputo City in general was 27.5 
according to the 2009 DHS).   More detailed data on all adult ART recipients at 
the health center (ie: level of education, profession, etc…) are not available.  The 
median number of years of schooling for Maputo City in the 2009 DHS is 6 years 
while the adult patients interviewed here had a median of 8.5 years of schooling.  
82% of adult patients interviewed identified as Protestant/Zion/Pentecostal and 
9% as Catholic and Muslim (each) compared to 48% 
Protestant/Zion/Pentecostal, 29% Catholic and 6% Muslim in the 2009 DHS 
for Maputo City.  Again in Maputo City, 65% of respondents in the 2009 DHS 
reported that the closest ART-providing facility to their home was less than 30 
minutes away and an additional 26% reported that the facility was between 30-60 
minutes from their home.  
 
During the study period, in order to better manage the vast increase in 
patients as a result of decentralization, the Health Center Malhangalene was 
beginning a series of initiatives specifically aimed at patients on ART such as the 
‘Community ART Group’ (CAG) program in partnership with Doctors Without 
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Borders19 and a scale-up of the ‘fluxo rápido’ (rapid flow) program which allows 
clinically-stable and adherent patients on ART for at least 6 months to present 
for a clinical consultation only once every six months rather than every month 
(though they still must pick up monthly medication refills at the pharmacy).  No 
patients participating in the CAG were interviewed so as not to interfere with the 
monitoring actions of Doctors Without Borders while three patients who 
participate in the ‘fluxo rápido’ program were interviewed. 
 
Pediatric patient characteristics (as well as their caretakers’) can be found in 
Appendix 2, Table 2.   As of September 2011, there were 899 pediatric patients 
enrolled in ART at the Maputo Central Hospital, 51% of whom were female 
while 46% of the pediatric patients whose caretakers were interviewed for this 
study are female. The median number of years of schooling of the caretakers is 
6.5 years, slightly higher than the Maputo City median of 6 years. 65% of 
caretakers identified as Protestant or Evangelical and 23% as Catholic.   
 
It is important to note that the Pediatric Day Hospital of the Central Hospital 
of Maputo was in the midst of the process of down-referring pediatric patients to 
their local health centers to continue treatment (the final phase of Mozambique’s 
decentralization) during the interview period and so the interviews with these 
caretakers will have been just before they were referred to a health center or just 
before they were permanently assigned to the outpatient pediatric unit of the 
Central Hospital for the patient’s ongoing treatment (if they reside in the 
geographical jurisdiction of the Central Hospital, they will remain there).  
 
In terms of the representativeness of the clinicians interviewed for this study, 
all of the interviewees were female.  Though detailed data on nurses and 
technicians are not available for Mozambique, looking at the data on physicians, 
we see that approximately 67% of the physicians in Mozambique’s southern 
provinces (which includes the province of Maputo) are, in fact, female while, in 
Maputo City, a full 83% of physicians are female.18 There was only one male 
clinician working in the Health Center Malhangalene (a senior nurse) and he does 
not work directly with HIV patients on ART.  At the Day Hospital of the 
Maputo Central Hospital (pediatrics), only one male pediatrician was identified 
                                                 
19 The Community ART Group (CAG) project was piloted by Doctors Without Borders 
in Tete Province beginning in 2008 and arrived at the Health Center Malhangalene in 
2011. The program facilitates groups of 6-8 stable patients on ART from the same 
neighborhood who send one member of the group to the health center monthly to 
report on adherence for all members and pick up refill prescriptions for all members so 
that each member goes to the health center approximately once every six months. 
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during the interview period by our research team and he was not available for an 
interview.  All of the nurses at this facility were female.  Clinical provider 
characteristics can be found in Appendix 2, Table 3. 
4.5 Ethical Considerations 
 
The study protocol was approved by the Mozambican National Bioethics 
Committee and the Mozambican Ministry of Health as well as the Maputo City 
Health Directorate, the Central Hospital of Maputo and the Health Center 
Malhangalene.  Participating hospital and health center clinical staff gave written 
informed consent. Participating patients gave written informed consent after 
being read aloud the study consent form.  All health provider and patient data are 
confidential and have been anonymized for inclusion here.  All interviews were 
digitally audio recorded, transcribed verbatim (in Portuguese) shortly after and 
the voice recordings destroyed 120 days from the date of the interview, per the 
ethical protocol approved for the study. 
 
4.6 Limitations of the Study 
 
It would be impossible to discuss patients’ experiences with ART without 
pointing out one of the main limitations of this study which is that only patients 
still enrolled in treatment and with a certain basic level of adherence (who are 
presenting to the health center for a clinical checkup or medication refill) were 
interviewed.  However, while it may be the case that patients who have 
abandoned treatment or have been LTF have a completely different set of 
challenges which determine their non-compliance with treatment, it would seem 
more likely that the adherent patients have faced or are aware of at least some of 
the same issues.  In this spirit, the challenges and dynamics identified by adherent 
patients will be discussed.  These topics will also be explored from the 
perspective of the clinicians interviewed who often have valuable insight on both 
groups of patients that, when combined with patients’ narratives, can help us to 
construct a more complete picture of the dynamics of patients’ experiences with 
ART.  
 
As the study was conducted at only two health facilities in the central area of 
Maputo, findings cannot be generalized to peri-urban or rural areas where 
logistical issues may be more likely to affect abandonment and loss to follow-up 
as well as difficulties in presenting for initial HIV testing.  The selection of 
patients and clinicians was not random nor is the sample large enough to be 
representative of the participating health facilities and, as such, the data collected 
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may be used only as an in-depth snapshot of the detailed experiences of some 
patients and clinicians in order to understand areas that merit further, large-scale 
study and exploration, particularly in similar urban environments where progress 
in overcoming logistical hurdles is relatively advanced. 
 
The study also includes a strong sex bias in terms of the caretakers of pediatric 
patients that were interviewed (all female).   Pediatricians mentioned, anecdotally, 
that they very rarely see fathers or male caretakers of their patients and, when 
they do, they are virtually always together with the mother of the patient.  
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4.7 Health Center Malhangalene- Adult ART Patients 
 
The Health Center Malhangalene is located in the north-central area of 
downtown Maputo City and has been receiving HIV patient transfers since 2008.  
It is an outpatient facility where patients are seen in the mornings from 
approximately 7:30 am until 1 pm (though clinicians remain in the health center 
until approximately 4-5 pm).  Neighborhoods where participating patients live are 
highlighted on the map (Map 1) in orange and the health center is marked with a 
large red and white cross.  Patients in the outlying neighborhoods highlighted in 
orange are seen at Malhangalene by request. Some work or have family near 
Malhangalene while others travel to Malhangalene to avoid seeing neighbors at 
the health center nearer their home. The national decentralization process has 
been carried out in phases so that Malhangalene first received adult patient 
transfers from the Day Hospital of the Central Hospital of Maputo in 2008, the 
Day Hospital Primeiro de Maio in 2009 and the Day Hospital of the General 
Hospital of Mavalane in 2010.  Adult patients have also been tested and begun 
treatment at Malhangalene since 2008. Only in late 2010/early 2011 did pediatric 
patients begin to be officially transferred to Malhangalene and other health 
centers in Maputo.  See Figure 20 and Table 7.  The pediatric ART patients listed 
for earlier years in Table 7 were seropositive children of adult patients receiving 
treatment at Malhangalene who requested that their children be able to receive 
treatment at the same facility to facilitate logistical matters (simultaneous clinical 
checkups, medication pickup, etc…).   
Table 7.  ART Recipients, Health Center Malhangalene 













794 7 801 -- -- -- 
July 2009 1499 8 1507 63.5 13.4 63.2 
July 2010 2135 14 2149 35.4 56.0 35.5 
July 2011 2619 53 2672 20.4 133.1 21.8 
Source: Mozambican Ministry of Health, National ART Database19 
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Figure 20. ART Recipients, Health Center Malhangalene 
 
Source: Mozambican Ministry of Health, National ART Database20 
Map 1. Geographic Distribution of Patients Interviewed: Health Center Malhangalene 
 
110 CHAPTER 4 
4.7.1 Human Resources 
 
In line with Ministry of Health guidelines on decentralization, task-shifting and 
human resource management as discussed in the previous chapter, Malhangalene 
assigns adult ART patients to medical technicians who are responsible for 
chronic disease management (diabetes, hypertension, Kaposi sarcoma and HIV) 
and are authorized to prescribe ARVs.  This is, in part, so that technicians will be 
prepared for the specific challenges of attending to patients on lifelong 
treatments, but it is also a strategy to decrease stigma for HIV-positive patients.  
However, in practice, the director of Malhangalene reports that on any given day, 
90% of patients seen at the health center are HIV-positive and though chronic 
illnesses such as diabetes and hypertension seem to be on the rise, these patients 
still make up a very small proportion of the patients seen at the center.  The 
director of the health center is also the only physician on staff20.  In addition to 
the administrative duties of the health center director and clinical duties, this 
physician, at the time of the interviews, was also assigned the role of ‘District 
Director’ which entails oversight and reporting for five ‘areas’ in the medical 
district (Malhangalene, Alto Maé, Porto, Maxaquene and Polana Cimento).  
Three technicians attend to (non-pregnant) adult ART patients, referring 
complicated cases to the head nurse and/or physician when necessary, based on 
national clinical guidelines and personal judgment.  Two of these technicians 
were interviewed for this study while the third was temporarily absent from the 
health facility during the interview period.  As many women are diagnosed with 
HIV during pregnancy (testing is highly encouraged during pre-natal visits), three 
mother and child health nurses who work specifically with HIV-positive patients 
in the maternity department were interviewed  to better understand the early 
treatment period for many female ART patients at the center. 
 
4.7.2 What effect do sources of HIV/AIDS information and their perceived 
reliability have on patients’ experiences with ART? 
 
Much focus in the HIV/AIDS literature is placed on ‘knowledge’; what people 
know.  However, relatively little is mentioned in terms of the specific sources of 
respondents’ knowledge or the perceived reliability of the information received 
from different sources, with a few notable exceptions in studies conducted in 
developed nations21,22,23,.  This study takes advantage of the potential depth of 
                                                 
20 Through a partnership with Doctors Without Borders (Médicos Sem Fronteiras), the 
health center is assigned a visiting expatriate physician who assists with clinical visits two 
days per week and brainstorms weekly on complicated cases with the senior clinical staff.  
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qualitative interviews to explore patients’ knowledge about HIV in conjunction 
with their sources of information and the sources which they consider more or 
less reliable and why.  While the aforementioned studies on the reliability of 
information sources have focused particularly on sexual behavior change in 
relation to HIV prevention, this study instead explores the possible impact of 
reliability of information on the internalization of HIV prevention messages and 
their effect on patients’ experiences with ART.  As discussed in Chapter 1, the 
social construction of the HIV epidemic is powerful, if surreptitious, and it will 
be important to understand possible repercussions of sexual behavior-based 
prevention campaigns on persons living with HIV and receiving treatment as well 
as on clinicians’ beliefs and communications about HIV.   
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As we see in Table 8, patients’ reported sources of HIV information are primarily: 
television (82%), radio (68%), friends/family (59%), health facilities and 
workers/health lectures (50%) and ‘on the street’ (38%).  This is remarkably in 
line with what we find in the 2009 Demographic and Health Survey for the adult 
population of Maputo City.21  However, patients were also asked to identify 
which of the sources of information that they consider most and least reliable of 
those that they had named.  The main sources of reliable information identified 
                                                 
21 In Mozambique’s 2009 DHS, the following sources of HIV/AIDS information were 
reported by Maputo City respondents:  Television (83%), Radio (69%), Friends/Family 
(46%), Health Lectures/Health Workers (49%) 
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are: television (68%), health facilities and workers/health lectures (50%) and 
radio (32%).  ‘On the street’ or otherwise ‘person-to-person’ (including 
friends/family members) was overwhelmingly identified as the least reliable 
source of information (82% of total respondents, 100% of respondents who 
identified ‘on the street’ or ‘friends/family’ as a source of information).  When 
asked why the above-mentioned sources of information are the most or least 
reliable, responses mainly centered around the idea of seeing and/or hearing first-
hand the ‘reality’ of HIV on the one hand (reliable) and the existence of 
widespread denial, rumors and myths on the other (unreliable) as in the examples 
below: 
 
“I think they [television and radio] show reality…especially 
television. But as far as the rumors, ‘in the neighborhoods’, 
[they’re not reliable] because there are a lot of myths out there. Certain people 
lie and others...” [35-year-old, female respondent- #108, on ART for 10 
months] 
 
“Television [is reliable] because on TV, they speak directly. 
They don’t hide that this disease exists. It could be a friend or 
acquaintance of yours [that talks about HIV], and you can’t 
trust what they say as long as the person doesn’t have HIV.  
Or, whether or not they have it, you’re not going to believe in 
what they say because many people talk a lot about this 
topic…”  [29-year-old, male respondent #101, on ART for 3 years] 
 
“Here in the hospital, yes [the information is reliable], because 
here we sometimes have lectures on HIV…but out there ‘in the 
neighborhood’, from friends, I still haven’t heard anyone tell 
the truth about this disease […]I think that people are afraid to tell the 
truth…we’re afraid to speak the truth, even if we know the truth….we’re afraid 
to speak the truth and face the truth”.  [37-year-old, female respondent 
#108B, on ART for 6+ years] 
 
“From person to person [is unreliable]…like when you meet up with 
someone on the bus, it’s possible that they’re giving you inexact information. But 
if it were a person, for example a health technician, I think that 
would be an appropriate person to give you precise 
information.” [36-year-old, male respondent #080, on ART for 5 
years] 
 
Clinicians’ responses in regards to the sources of information that they believe 
patients find reliable largely matched patients’ own responses: television, health 
lectures (‘palestras’) and, to a lesser extent, radio.  However, some clinicians also 
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reported that they believe that information from friends, family, ‘people in the 
neighborhood’ and traditional healers is also reliable for patients, and often more 
reliable than information from official sources.  This contrasts with the patients’ 
own reports of ‘other people’ as largely unreliable.  One possible explanation for 
this disconnect can be seen in the response of one clinician who spoke of many 
patients’ initial unwillingness to believe that they are HIV-positive so that, before 
accepting their serostatus and ‘delivering themselves’ fully over to the medical 
system, they are more heavily influenced by non-medical people in their lives and 
less influenced by the medical establishment; a phenomena which this clinician 
believes reverses once the patient has accepted his/her serostatus.  This idea of 
‘delivering oneself over’ and fully trusting the medical system is one that echoes 
through many of the interviews – both patient and clinician – and will be 
discussed more in the section dealing with respondents’ impressions of HIV 
prevention messages either before and after HIV diagnosis (for patients) or 
before and after working with HIV-positive patients (clinicians).  As patients 
were interviewed only after being enrolled in and adherent to ART, it could be 
that their identification of reliable versus unreliable sources of information had 
already undergone this transformation as is corroborated by many patients’ 
narratives regarding their inability or unwillingness to initially believe medical 
personnel regarding their HIV diagnosis. 
 
 “Well, they receive more information from their community 
leaders, their churches… They trust these people more [than 
they trust health professionals].” [physician respondent #812. 
Working with HIV patients for 2 years] 
 
“They trust a lot in information from outside [of formal 
healthcare settings]…So, for us here, it becomes difficult. Some 
[patients] go so far as to almost hit us, saying ‘hey! You’re 
lying! You’re lying! Get real nurse- this is not true!’. So to me, it 
seems like the information from their communities is stronger, 
from traditional healers for example. They believe more in traditional 
healers than they do nurses. It seems like their trust in the community is 
stronger.” [nurse respondent #808. Working with HIV patients for 9 
years] 
 
“I think that the information gets across [to patients] best 
through television. Many times, with many patients, when 
they’re still not very informed on the subject [of HIV], they 
doubt everything that we [health professionals] tell them. Even 
here in the health center, we’re totally trustworthy, but, at some point, after 
finding out their HIV test result, they say that the result isn’t trustworthy. This 
just shows that they’re not yet very informed about the topic.” 
CASE STUDY: THE ROLE OF HIV PREVENTION MESSAGES IN PATIENTS’ 
EXPERIENCES WITH ART IN THE CITY OF MAPUTO, MOZAMBIQUE 115 
[technician respondent #711. Working with HIV patients for 3 
years] 
 
The sources of information identified by patients as reliable and unreliable will be 
a recurrent theme in the sections that follow as self-stigmatization, cognitive 
dissonance, knowledge and beliefs about modes of transmission and the 
preventative benefits of ART are discussed.  The idea, expressed by both patients 
and clinicians, of delivering oneself over to the official public health 
infrastructure in order to successfully adhere to ART becomes particularly 
important, as we will see, when matters of incomplete information being 
communicated to patients are discussed.  
 
4.7.3 Do incomplete discussions about modes of transmission contribute to self-
stigmatization and cognitive dissonance between patients’ ‘knowledge’ and clinicians’ 
beliefs about patients? 
 
When we consider the importance of sources of HIV information on the 
perceived reliability of information we can see the central role of official sources 
(including health workers and health facility communications) in ART patients’ 
ideas about HIV.  Though, as mentioned, it may take some time for patients to 
fully ‘deliver themselves over’ to the formal health system and prioritize the 
information given there, it would seem that this ‘surrender’ may be quite 
important in order for patients to adhere to ART. As we will see in the following 
sections, patients often report learning certain, often correct, information from 
unofficial sources and not receiving this information from official sources.  Once 
patients are enfolded into the health system (beginning with counseling and HIV 
testing), the pressure for them to accept the extant social construction of HIV 
which is ubiquitous in prevention messages, as discussed in Chapter 1, becomes 
very strong.  This may lead to high levels of cognitive dissonance between what 
patients believe to be true of HIV from unofficial sources and possibly personal 
experience, and what they are being told (or not told) by health workers and 
official HIV prevention messages.   
 
In terms of the discourse surrounding modes of transmission, looking at Table 8, 
we can note that all patients spontaneously report sexual relations as a mode of 
transmission of HIV when asked how people can acquire HIV and over 50% of 
patients spontaneously report knowledge of blood-borne modes of 
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transmission.22  However, when these patients who reported knowledge of 
blood-borne transmission were asked about the source of that particular 
information, they stated that they had heard it ‘on the street’ (or other similar 
‘person-to-person’ sources) and, crucially, not from health workers or HIV 
prevention campaigns (on TV, radio, etc…).  So, though they indeed have factual 
information that HIV is a blood-borne infection that can be transmitted through 
unsafe injections, cutting instruments, transfusions, etc… they attribute this 
information to sources which they already identified as being unreliable.  When 
patients were further asked to reflect on their beliefs about 1) how they may have 
become infected and, 2) how their clinician(s) believes they may have become 
infected, not only do we find some disconnect, but we also find that many 
patients report that no clinician has ever discussed with them how they may have 
become infected.   
 
[in response to question on how patient believes she may have 
become infected] “It wasn’t through sex. It was…how can I say this? 
I believe that I was infected with HIV through a treatment I 
received in the hospital” [when asked how she thinks her clinician 
believes she became infected and why] “Through sex [laughs]. 
Since many people are infected through sex… but it’s not 
always that way.” [29-year-old, female respondent #900, on ART 
for 22 months] 
 
Here we see a marked dissonance between this patient’s beliefs about how she 
may have become infected with HIV and the way she believes her clinicians think 
she was infected.  When asked the open-ended question of how she believes she 
may have become infected, the patient begins her response with a nod to the 
perennial assumption that, as an adult, she was infected through sex, and only 
after this pre-emptive defense, does she identify what she believes to be the 
source of her own infection (through a hospital treatment).  Then when asked 
how she believes that her clinicians think she might have been infected, she 
immediately identifies sex and again, defends her point of view that it is not 
always that way.  It is disturbing that this patient’s very legitimate concerns that 
she may have been infected in the hospital seem to be disregarded by clinicians. 
Though this patient has continued with ART, it is not difficult to imagine that 
others, in a similar situation of dissonance between their own beliefs about how 
they may have become infected and the health establishment’s stated belief that 
                                                 
22 In the 2009 DHS, 95% and 98% (respectively) of Maputo City respondents report that 
HIV can be transmitted through vaginal sex and sharing needles or blades with an 
infected person, however, this was in response to closed questions, rather than 
spontaneously reported. 
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virtually all adults are infected due to their sexual behavior, could feel that they 
had to choose between the official establishment (which includes ART) and what 
they strongly believe to be correct (that they were infected through a non-sexual 
route).   
 
“...when it started, I heard in the health lectures that a person 
becomes infected through sex. Now, they say ‘out there’ 
[outside of the health facility], that it may not just be sex… it 
could be blades, a person who has a wound and you can 
become contaminated with that blood, blah, blah, blah.” [49-year-
old, female respondent #110, on ART for 6 months] 
 
[modes of transmission] “...through sexual relations and 
contamination through blades, needles. When a person is wounded, 
and you also have a wound/cut, when it’s bleeding, you can be contaminated… 
[in response to how she believes she may have become infected] I 
don’t know…I don’t know… [in response to how clinicians believe 
she became infected] Sexual relations. But my husband doesn’t 
have [HIV]…but they only talk about sex.” [39-year-old, female 
respondent #100, on ART for 10 months] 
 
In this patient’s comments, we can see that she also identifies blood-borne routes 
of transmission and states that though her husband doesn’t have HIV, her 
clinicians believe that she acquired HIV sexually (as they ‘only talk about sex’).   
 
“Here, they say you get [HIV] when you have sex. Out there 
[on the street], they say through blades, needles, and when 
people have wounds and they touch another person, that blood 
is contaminated…[in response to how she believes she may have 
become infected] I don’t know how I got it [laughs]…I don’t ‘play 
around’ [have sex outside of the marriage], have 
lovers/boyfriends, and neither does [my husband]. We’re at home 
together. He always says how people can’t play around, that when they do, they 
pass HIV to other people…That’s why we don’t play around with other people- 
not him, not me. We’re at home together. [in response to how clinicians 
believe she became infected] I don’t know…through sex, through 
blades…I don’t know. They never really said.” [38-year-old, 
female respondent #908, on ART for 2 years] 
 
[in response to how she believes she may have become infected] “I 
don’t know...or through food...or...I don’t know, it’s just me and 
my husband, alone at home….[in response to how clinicians 
believe she became infected] I just don’t know.” [52-year-old, 
female respondent #210, on ART for 14 months] 
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Within these patients’ responses, we find a strong dichotomy between modes of 
transmission communicated to them through official sources (sexual relations) 
and what they’ve heard ‘on the street’.  The blood-borne modes of transmission 
that they report are, indeed, correct, however, as they already identified this 
source of information as being unreliable, holding onto these beliefs about 
blood-borne transmission could create cognitive dissonance between a patient’s 
beliefs and the official message that they are virtually required to internalize in 
order to adhere to ART.   
 
Respondent #210’s response is interesting in that she is an older woman (52 
years old) who was diagnosed and began ART only 14 months before the 
interview.  Her only idea for how she may have become infected was through 
food.  Though she did not explicitly express doubt that she may have been 
infected sexually, she does qualify her uncertainty about how she may have been 
infected by stating that she doesn’t know as she and her husband are always at 
home together, alone, a kind of refutation of the implicit idea that she may have 
been infected sexually (which would also imply infidelity by at least one partner). 
This patient and many others reported that they don’t know how their clinicians 
think they may have become infected; that it had never been discussed.   
 
Simply the absence of discussion on this topic can cause dissonance as the 
‘default’ message of HIV transmission from official sources (including the 
healthcare system), is that it is almost-exclusively through sexual transmission.  
The lack of discussion between clinicians and patients on modes of transmission 
or, when the topic comes up, the focus on sexual transmission, would lead one to 
believe that clinicians, perhaps, do not understand or accept blood-borne 
transmission.  However, this is not confirmed by the clinicians’ responses below.  
All clinicians spontaneously reported knowledge of blood-borne transmission 
routes, but here again we find a disconnect, this time between 1) the various 
modes of transmission identified by clinicians and the modes they discuss with 
patients and, 2) the official messages on transmission routes to which clinicians 
are also exposed versus what they see in their daily experience with patients. 
 
[clinician in response to question about the most common mode of 
transmission of HIV for her patients] “It’s not easy to define the mode of 
transmission in most patients because, lately, we’re seeing a lot of cases 
of discordant people, discordant couples for example. So, before 
they always said that it was through sexual relations, but 
something, at least for me, is telling me that it’s not so much 
through sexual relations. Now, as to what the principal mode of 
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transmission is…I don’t know what to tell you.” [nurse respondent #106. 
Working with HIV patients for 2 years] 
 
[clinician in response to question about the most common mode of 
transmission of HIV for her patients] “Sexual relations.” [in 
response to question regarding other modes of transmission and if 
these are discussed with patients] “…through needles, piercing 
objects, cutting tools, blood transfusions… no, no, it’s not our 
custom to discuss these [transmission] routes with patients”  
[nurse respondent #808. Working with HIV patients for 9 years] 
 
[clinician in response to question about the most common mode of 
transmission of HIV for her patients] “The most publicized way, 
that everyone confirms, is through sexual transmission. Besides 
that, there are those who may have gotten [HIV] through, for example, 
transfusions—people who suffer accidents—also through cuts, 
using the same blade on different individuals. In the hospitals, 
through injections, needles, if we don’t always use disposable 
materials, we can transmit HIV…Ever since [HIV] became widely 
spread, they’ve limited the use of non-disposable materials, though, really, we 
should be using all disposable materials to decrease even more the probability of 
transmission through needles. But still, it’s a way that a person can 
become infected. But we don’t talk about that.” [technician 
respondent #711. Working with HIV patients for 3 years] 
 
“I think for many adults, it’s through unprotected sexual 
relations. [in response to question regarding other modes of 
transmission] … cutting materials, blades, needles, in the 
hospitals, those that do traditional medical treatments, those 
that get tattoos [scarification] – it could be with non-disposable 
materials…” [technician respondent #605. Working with HIV 
patients for 2 years] 
 
All of the clinicians interviewed did in fact, identify blood-borne transmission 
routes.  Some (such as respondent #106) explicitly identified their own cognitive 
dissonance with the official message of predominantly sexual transmission (based 
on day-to-day clinical experience) after also identifying blood-borne modes of 
transmission.  Others clearly state their belief that almost all adult patients are 
infected through sex and identify blood-borne routes as rare or negligible.  It is 
significant that these clinicians also specifically stated that they do not discuss 
these non-sexual modes of transmission with patients.  These communications 
between clinicians and patients regarding modes of transmission may be seen by 
some as superfluous, in other words: ‘Who cares how these patients were 
infected? They are already infected and we should just move forward with 
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treatment.’.  However, this type of reasoning views HIV prevention as a linear 
phenomenon where prevention messages (including discussion of modes of 
transmission) are for uninfected people only and where those who are already 
infected are those that failed to heed the warnings, and so contracted HIV.  If 
HIV prevention messages provided the general public with information on how 
to protect themselves from all modes of transmission of HIV, then perhaps this 
more linear model would be practicable. However, the social construction of the 
HIV epidemic often ‘monsterizes’ infected adults as discussed in Chapter 1, and 
this monsterization is built upon the exclusive focus on supposedly deviant 
sexual behavior as the exclusive driver of Mozambique’s HIV epidemic.  This 
makes it particularly important that we consider the possibility of sexually-
focused prevention messages creating dissonance between patients and the 
formal healthcare system (and to some extent, between some clinicians and the 
healthcare system) which continues to provide only partial information in the 
area of modes of transmission. 
4.7.4 How are shame and fear propagated by prevention messages and what effect 
does this have on patients’ experiences with ART? 
 
Though there is much discussion of ‘stigma’ in the HIV/AIDS literature, 
researchers have little to say in terms of possible institutional sources of stigma in 
sub-Saharan Africa’s HIV epidemics.  Numerous studies, including a recent one 
in Mozambique, have demonstrated the important role of stigma (as measured by 
patients’ fear of disclosure, for example) in accessing and adhering to 
treatment.24,25,26  However, to the extent that the sexual behavior causal story of 
HIV in SSA has largely remained unchallenged, so has the popular idea that the 
root of stigma is simply an unfortunate collateral effect of an incurable and 
potentially lethal ‘sexually transmitted’ disease.  If, however, one questions the 
social construction of HIV as an almost-exclusively sexually transmitted disease, 
this would then imply that the root of stigma in the case of HIV/AIDS in SSA is 
not necessarily the (scientific) nature of the disease itself, but may rather stem 
from the social construction of the disease epidemic.  As discussed in Chapter 1, 
HIV is a sexually transmissible infection (with modes of transmission including, but 
not limited to, sex), but in official HIV prevention messages in Mozambique, has 
been constructed as an almost-exclusively sexually transmitted disease.  Also, 
considering that patients themselves identify incorrect modes of transmission of 
HIV (i.e.: mosquitos, tuberculosis, food, etc…), and uninfected people’s fear of 
infection through non-sexual routes is cited in some studies of social stigma27, it 
must also be recognized that only providing partial information on modes of 
transmission may feed into stigma in this way as well.  A full 20% of Maputo City 
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adults in the 2009 DHS reported their belief (when prompted by a closed 
question) that HIV can be transmitted through mosquito bites and an additional 
6% were not sure.28  Similarly, close to 9% reported their belief (when prompted) 
that HIV can be transmitted through sharing a cigarette with an infected person 
and an additional 11% were not sure.29 If people are only provided with partial 
information through official sources (i.e. sexual transmission), but their own 
experience shows them people who are unlikely to have been infected sexually 
(including, in some cases, themselves), then it logically follows that they would 
continue to look for alternative explanations; hence, suspicions of transmission 
through things like saliva (sharing a cigarette) or other bogus sources which leads 
to increased social stigmatization of HIV-infected persons.   
 
Many of the adult patients interviewed for this study talk of shame, blame and 
fear of judgment, and several provided in-depth perspectives on these 
phenomena.  An examination of patients’ narratives together with clinicians’ 
comments might give us some further insight into how past and current HIV 
prevention messages focused on sexual behavior may be feeding into deeply-
internalized stigma which can affect patients’ experiences with ART.   
 
“Before [my husband] knew that he was infected, he would tell me ‘if it’s with 
you that this disease begins, I’m going to send you away’ [...] 
That’s why I hesitated [to get tested]. […] What did he expect? That if 
this disease had begun with me, here [in Mozambique], he 
would blame me and say that it was ME that brought this 
disease because it’s me who hooks up with men here? When, 
really, it was HIM who started the disease with this other woman [in South 
Africa]. Well...God helped me. Because this disease didn’t start with me. It 
started with him.” [49-year-old, female respondent #110, on ART for 6 
months] 
 
In the above commentary, the patient’s fear that she could be diagnosed with 
HIV before her husband was diagnosed (and consequently be thrown out of her 
home) implicitly draws on the idea that the only way that either one of them 
could have become infected is through sexual relations outside of the marriage.  
For this couple, being tested for HIV became akin to a game of ‘chicken’ with 
each partner distrusting the other and fearing that an HIV diagnosis (particularly 
on the part of the woman) would be the equivalent of admitting to infidelity and 
would be grounds to end the marriage (throwing the woman out of their home).  
This patient, in fact, waited not only for her husband to admit to being diagnosed 
with HIV, but for his death (from AIDS) before she herself would be tested, 
though she reported that she was also quite sick by the time she was tested.  
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Clinicians reportedly expressed exasperation that she had put off being tested 
once they had confirmed that her husband had had HIV, reportedly saying to 
her: “And why did you wait to come take the test? You were waiting to die?”  It 
is clear in this example how prevention messages that focus exclusively on sexual 
transmission of HIV can help to create deep mistrust and stigma between 
couples and seriously impact the willingness of either partner to be tested and 
begin treatment.  Considering the importance of early treatment to the potential 
of using ART as prevention (as discussed in Chapter 2), this dynamic is worrying. 
When HIV is characterized as a disease stemming from sexual deviance and 
infidelity, the consequences in terms of stigma require attention.  In the following 
narratives we will see how HIV prevention messages can contribute to fear of 
disclosure and the potentially lethal consequences that may follow: 
 
“[...] there are those who take the [HIV] test and say ‘ah! These nurses are 
lying!’.  The person is afraid to tell her husband: ‘I have 
[HIV]’…until the moment arrives to give birth to her baby...the 
baby dies, as happened to me one time. […] I only went to register 
for pre-natal care when I was 8 months pregnant. I, without knowing, said ‘ah, 
okay’ [to be tested for HIV].  When I went and took the test they told me I was 
HIV-positive. I said ‘ah! They’re lying! I don’t accept it! This means nothing- all 
this that these nurses are saying!’. I didn’t do anything… on the day I gave birth, 
I went to the hospital [in Maputo], then went home. I never did any treatment, I 
didn’t do anything, no medications, no nothing. I went home to stay with my 
baby. The baby got sick…she died when she was 3 months old. 
When I took her to be admitted to the hospital, they came in to 
ask me [about HIV]. I was afraid to tell them that I had taken 
the test. I went to take back my baby and they said ‘You didn’t take the test! 
You see now? The baby is sick’. But I didn’t take any medication during 
pregnancy...This is how my baby died at 3 months old, here at the hospital in 
Maputo. They told me it was [from AIDS]. [33-year-old, female 
respondent #100, on ART 10 months]  
 
[clinician in relation to a female patient] “[I asked her] ‘Why don’t you do 
the treatment like you should? To be able to feel better?’ She wouldn’t 
accept it, said that her husband couldn’t know.  So, okay, she 
decided to become pregnant. [...] We prescribed AZT and she picked it up but 
wouldn’t take the medicine. There you go. The day of the baby’s birth arrived. 
Her husband didn’t know any of this. She gave birth. The baby was well for only 
2 months.  After that she [the baby] was getting sicker and sicker 
and after 3 months... after three months the baby went away 
[died]… When I asked if she [the mother] took her 
medications [AZT] she said ‘eh no. I was afraid.’ The baby 
died and she was unable to tell her husband- her first baby died 
at 3 months old! In the end, she discovered that her husband had already 
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been on ART for 3 years at [another hospital]. But he felt bad in the end too- 
he was afraid to tell her and she was afraid to tell him and the 
baby died.” [nurse, respondent #808. Working with HIV patients 
for 9 years] 
 
 
The two narratives above tell the story of HIV-positive pregnant women who felt 
such shame and fear to admit their HIV serostatus (either to themselves or their 
partners) that they allowed their newborn babies to die of AIDS rather than face 
the perceived shame of being seropositive.  In the clinician’s narrative 
(respondent #808), we see that this patient’s husband was also keeping his 
serostatus and the fact that he had already been on treatment for 3 years, a secret.  
No doubt both partners were aware that they could infect the other (and perhaps 
the baby) if they did not disclose their serostatus and take protective measures, 
however, both remained silent (and the woman did not accept treatment, so 
worried was she about being ‘caught’), and they ultimately allowed their infant to 
die rather than reveal their serostatus or risk being seen taking ARVs (which 
would lead to involuntary disclosure). Numerous studies have shown that 
patients who disclose their serostatus at least to their partners, have better 
adherence to treatment,30,31,32 however, if patients are so stigmatized by the 
purported mode of transmission (deviant/extramarital sexual relations) that they 
can have difficulty admitting their serostatus to themselves and consenting to 
treatment, then disclosing to their partner and eventual adherence becomes an 
even more remote possibility.  In the following narratives, we will see how self-
stigmatization (also referred to in social psychology as ‘perceived 
discrimination’33) in relation to involuntary disclosure to neighbors and 
acquaintances can play out for patients on ART and affect their adherence to 
treatment as well as people’s willingness to even be tested for HIV.: 
 
[in response to a question regarding the greatest challenge to ART 
adherence] It’s in the person coming here [to the health center] to know that 
they have HIV.  They’re afraid to come here to the hospital, see 
people from their neighborhood.  Many people don’t come. [...] For 
many people it’s difficult. They’re thinking ‘that guy is going to see 
me and is going to tell that other guy and they’ll all know that I 
have HIV’. […] The person is afraid to face his reality, afraid that everyone is 
going to know…[26-year-old, female respondent #010, on ART 2+ 
years] 
 
“Other people feel ashamed... ‘How are other people going to 
see me? What will they think of me?’”  [27-year-old, female 
respondent #090. On ART for 1 year] 
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[In relation to travelling a long distance to the health center when 
there is a health center near patient’s home] “I leave my house very early, 
at 6 am, to come here because I think it’s better…because of my [female] 
neighbors.  There’s a hospital there [near home] but I prefer to 
come here...there are always those people. I’m afraid that 
they’ll see me at the hospital there, so I prefer to come here”  
[33-year-old, female respondent #100. On ART for 10 months] 
 
[clinician in relation to challenges to adherence that patients face] 
“Another thing is the fear there at home, fear of family, that 
someone will see her taking the medication...if her husband 
doesn’t know...if her family doesn’t know. [...] And another part is, 
for example, having neighbors… running into a neighbor who is HIV-positive. 
She’s also afraid to show her face [around a health center] 
because this neighbor is going to know she is HIV-positive... 
so, this aspect of discrimination between patients...” [nurse respondent #510. 
Working with HIV patients for 11 years] 
 
These four commentaries encapsulate the shame that many patients express in 
regards to family members, neighbors or acquaintances seeing them going to the 
hospital or taking medications and deducing that they have HIV.  
 
In all of the above stories, it is not impossible to imagine an alternative scenario.  
As mentioned previously, stigma has been treated as an unfortunate but 
unavoidable collateral effect of a ‘sexually transmitted’ disease and as something 
that can be combatted by, for example, further education in the form of 
convincing people that HIV cannot be transmitted by sharing food or utensils.34 
It is quite remarkable that, even in such a discussion of stigma that focuses on 
fear of transmission through casual contact (sharing food in this example) leading 
to stigma, we still do not see any hint of the possibility that the mode of 
transmission on which we do, in fact, focus (sex), could be creating the very 
stigma we purport to want to avoid.  If we were to imagine that official sources 
of information that are generally seen as reliable and truthful by patients (ie: TV, 
radio, health workers/facilities) included information on all modes of 
transmission, we can imagine that perhaps some of this overwhelming shame 
expressed by patients and the stigmatizing beliefs of some clinicians could be 
mitigated.  For example, had the young pregnant patients mentioned here been 
counseled about non-sexual modes of transmission as a matter of course and had 
they and their spouses already been exposed to prevention campaigns focused on 
non-sexual modes of transmission, it then becomes possible to imagine a 
situation where perhaps these young mothers could have gone home to their 
husbands and discussed their HIV status without fear of being labeled sexually 
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deviant or unfaithful.  They would have had an alternative explanation for their 
infection that did not involve deviant sexual behavior.  The patients who 
identified shame and fear as serious barriers to ART adherence and who went on 
to describe thoughts such as ‘what will people think of me?’, could, conceivably 
live in a place where this was not the default and where being tested or treated 
for HIV would not be an admission of engagement in devious sexual behaviors 
but would rather be the same as being tested and treated for something as 
uninspiring of shame as malaria.  While causal stories were mentioned in Chapter 
1 as a large-scale political phenomenon, we can see with these examples that 
causal stories can, in fact, be quite pertinent at the inter-personal level, potentially 
providing an alternative narrative for HIV infection that could help to mitigate 
the shame and stigma that continue to interfere with, not only efforts to 
implement so-called ‘Test and Treat’ strategies, but also individual adherence to 
ART.  
4.7.5 What do patients’ and clinicians’ impressions of ‘HIV Prevention 
Campaigns: Before and After’ reveal about patients’ experiences with ART? 
 
Patients were asked their general impressions of HIV prevention campaigns 
before and after their HIV diagnoses and clinicians were asked the same in 
relation to when they began working with HIV patients.  Their narratives may 
help us to better understand the ongoing effect of prevention campaigns on both 
clinicians’ beliefs about patients as well as patients’ ‘relationships’ with the formal 
healthcare system.  
 
[General thoughts on prevention campaigns (before and after 
diagnosis)] “Ah- well, to start, it was very much a ‘man’s thing’, you 
know? For when they had sex, they should use 
this…condom…thing. But now, for married people at home, 
we came to distrust this message: ‘How are we going to use 
this condom when we’re always together here?’ Like, my 
husband could never tell me ‘we’re going to use this condom’ 
because I would ask ‘why are we going to use this thing?’… 
This is also difficult for many women, you know? And if he doesn’t want to use 
it [the condom], I can’t force him to now can I? […] These condoms 
already existed [before HIV] for when they didn’t want the 
woman to get pregnant or whatever. But it was more for sex 
before marriage, not for married couples at home. But now, 
with this disease, no one knows anymore why people want to 
use them [condoms]. He thinks ‘when I use it [a condom], 
then this woman isn’t going to trust me [will think I have 
HIV]” while the problem isn’t even that! It could be to avoid 
other STDs or pregnancy. But now- it’s all ruined. Yeah- that’s 
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it. [Using a condom] sends a signal that ‘I don’t trust you’.” 
[49-year-old, female respondent #110. On ART for 6 months.] 
 
This narrative succinctly describes one of the main issues of the perpetual and 
almost-exclusive promotion of condom usage for HIV prevention.  It is notable 
that this patient is 49 years old and so would have been exposed to these 
prevention messages (as an adult) from the beginning of the HIV response in 
Mozambique. There are numerous discussions in the academic literature about 
women’s interpersonal bargaining power (in relation to a woman’s ability to 
‘make’ her partner use a condom)35,36, however, these discussions leave out an 
important issue, which is that of feelings of trust between partners.  This 
respondent describes how condoms make sense for people (her first impression 
was, for men) to use when having sexual relations outside of or before marriage.  
However, she discusses the perverse outcome of constantly linking condoms to 
HIV prevention in that couples that may have used condoms previously (to 
prevent pregnancy for example) are now afraid to suggest that one be used 
because the message sent by condom use these days is ‘I don’t trust you or you 
won’t trust me: either I think that you have HIV or you will think that I have 
HIV’.  If either partner suggests that a condom be used, thanks to HIV 
prevention messages that have indelibly linked condoms and HIV, the other 
partner will invariably believe that one of these statements is true; that the person 
suggesting condom use is either untrusting or untrustworthy. 
 
This is a sort of collective self-stigmatization where people have been 
conditioned to believe that a sexual partner (any type, including a husband or 
wife) is lying and unfaithful by default and is bringing HIV into the home. Either 
way, trust between partners may have been severely corroded by the decades-old 
message of HIV prevention campaigns that all people must ‘protect themselves’ 
at all times, even those in monogamous partnerships.  It is very possible that this 
intense link created by prevention campaigns between condoms and HIV has 
actually harmed prevention efforts focused on sexual transmission of HIV as it 
has created this ‘signal’ of either mistrust in one’s partner or guilt about one’s 
own actions (where the person suggesting condom use must be HIV-positive and 
was infected sexually outside of the partnership).  As discussed in Chapter 2, in 
Mozambique’s 2009 DHS, we find that respondents in Maputo City who had 
reported not using a condom in their last sexual encounter commonly reported 
‘being married’ and ‘trusting in their partner’ as their reason for not using one. 
This further corroborates the perverse effect of linking condom usage to 
promiscuous sexual behavior (which, in this story leads to HIV infection) in that 
those who are married and/or feel that they trust their partner are unlikely to use 
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condoms.  Looking at widely-acknowledged ‘high risk’ sexual behavior, we can 
see that, while only 8% of Maputo City respondents reported paying for sex in 
the 12 months preceding the DHS, 95% of them reported using a condom 
during that sexual encounter.  
 
[Before diagnosis] “I was always...frightened...to tell my husband 
that we needed to take the test.” [Now- after diagnosis and on 
ART] “…I like to be able to sit and watch TV with my husband… they’re 
always saying that to ‘andar fora’ [be unfaithful or ‘sleep 
around] is very risky, that these days there are lots of diseases 
around…you can encounter a ‘fat’ [healthy-looking] woman who tells you that 
people with HIV are skinny people when it’s not like that. Even ‘fat’ [healthy-
looking], a person can be sick, and knowing this, you can avoid many diseases. 
It’s not easy. Even we go for months [without sexual relations] 
with each other because we’re afraid. The way that they 
counsel us is: ‘you’re already HIV-positive, so this is the way 
you need to live if you want to survive for years’.” [33-year-old, 
female respondent #100. On ART for 10 months.] 
 
In the response above, the fear inspired by the prevention messages seems to get 
mixed-in with post-diagnosis ‘lifestyle counseling’ (which typically includes dire 
warnings about having sexual relations, drinking alcohol, the need for exercise, 
etc…) that patients receive in health facilities so that this patient and her (also 
infected) husband are even afraid to have sex with one another. 
 
[Before diagnosis] “I always heard people saying- especially in 
the hospital- they told me ‘You’re pregnant- you have to take 
the test!’ It annoyed me! I thought: ‘What disease IS this?! …” 
[Now- after diagnosis and on ART] I was annoyed in those first days when 
I found out [my serostatus], I wouldn’t eat… I didn’t believe it. But I got to a 
point where I said ‘sheesh! I have to adhere to this treatment- the 
people who talk about this stuff aren’t crazy’.  Now I feel proud 
because I’m adhering well to the treatment.” [32-year-old, female 
respondent #010b. On ART for 16 months.] 
 
[Before diagnosis] “I felt horrible.” [Now- after diagnosis and on 
ART] “In my case, I feel good because I’m receiving 
treatment.” [28-year-old, female respondent #808. On ART for 3 
years.] 
 
[Before diagnosis] “Wow- I felt...like...upset, you know? I felt 
like…well…like a person who knows nothing. Ignorant...” 
[Now- after diagnosis and on ART] “Now...I feel good because I’m already 
used to it all. It’s my life, you know? It’s my life. Now that I’m 
living with the virus and my daughter was born HIV-
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negative… it gave me strength.” [26-year-old, female respondent 
#010. On ART for 2+ years.] 
 
[Before diagnosis] “Whoa.... [long pause] I felt okay...but on the other hand, 
I was frightened: ‘What kind of mystery is this? This AIDS? 
Maybe this doesn’t even exist!’ In another moment I thought 
‘This is true! It’s on TV...’. I felt like that: doubting. But it got 
to the point where I believed that [HIV] exists.” [29-year-old, 
male respondent #101. On ART for 3 years.] 
 
[Before diagnosis] “Wow...I thought that it was…that it 
was…well- a joke. I thought they were messing with us.” [Now- 
after diagnosis and on ART]“I’m...certain that this disease exists. 
Yeah.” [37-year-old, female respondent #090. On ART for 1 year.] 
 
 
As briefly touched upon earlier, we again see this recurring theme of initial 
disbelief in HIV, a feeling that someone is ‘playing a joke’ on everyone, intense 
fear, and a sense of dread that ‘one day it could be me’; these feelings lace almost 
all of the patients’ responses to the question about how they felt when they saw 
HIV prevention campaigns before their own diagnosis with HIV.  In response to 
a question about how they feel now that they are living with HIV, many mention 
that they feel good since they are receiving treatment or because they feel that 
others can avoid their fate.  One woman (respondent #010) ties her newfound 
acceptance of the disease and in the treatment to the fact that her daughter was 
born uninfected.   It must, of course, be remembered that these patients are, in 
fact, adherent to ART. In order to attempt to understand what might be 
happening with patients who drop out of treatment or are LTF, we could 
conceivably imagine that this leap from disbelief in the disease itself and in 
prevention messages to an acceptance, not only of the disease, but of the bio-
medical treatment paradigm and all that it entails, sociologically, is a necessary 
step in order for patients to adhere to treatment. Clearly this would not be 
sufficient to ensure adherence, but it would seem to be necessary, nonetheless.   
 
Clinicians’ responses in regards to their impressions of prevention campaigns 
before and after working with HIV-infected patients are also quite revealing. The 
overwhelming majority report having felt a need for more information and 
intense fear both due to the apparent scale of the epidemic as well as the fact that 
HIV has no cure, as in this example:  
 
[Before working with HIV+ patients]“...When this [epidemic] 
began, in the world, people first tried to understand ‘but what 
CASE STUDY: THE ROLE OF HIV PREVENTION MESSAGES IN PATIENTS’ 
EXPERIENCES WITH ART IN THE CITY OF MAPUTO, MOZAMBIQUE 129 
IS this?? What’s it all about?’ This pathology that everyone 
complains about, is infected with…and also, knowing that it’s 
a disease that has no cure… it creates amazing FEAR in 
anyone… I understood that people really have to learn control 
over their behavior…” [Now- after working with HIV+ patients] 
“…We have to just present this person with another chance to 
live in a way that the person can accept.” [technician, respondent 
#711. Working with HIV patients for 3 years] 
 
It is also interesting to note here that this technician credits her understanding 
that ‘people really have to learn control over their behavior’ to prevention 
messages (before she worked with HIV-infected patients) and that her response 
now that she works with patients centers around presenting patients with another 
chance to live.  Though it is not explicit, this narrative again seems to draw 
strongly on the idea of HIV patients being those who apparently did not ‘learn to 
control their behavior’ and are now being given a second chance at life by the 
medical establishment (through ART).   
 
Another striking point in many clinicians responses is how many of them 
immediately equated prevention messages (before they worked with HIV-
infected patients) with the idea that ‘HIV equals death’ as in the following 
examples:  
 
[Before working with HIV+ patients]“I heard about HIV in health 
lectures, theatre performances, TV... it was…I was very afraid of the 
disease, because right from the start, when I heard about it, I 
thought HIV equals DEATH…I think this was a lot of 
people’s impression…” [Now- after working with HIV+ patients] 
“Well, changing people’s mentality is difficult. Campaigns are 
campaigns. ‘You have to take the test, because the earlier you do…etc… you 
have to take your medications at the right time…” All these things. So, yeah. I 
think that…treatment is difficult, but for that reason, I think 
we have to continue…continue to do health 
lectures…campaigns” [technician, respondent #605. Working with 
HIV patients for 2 years] 
 
[Before working with HIV+ patients] “Well. That HIV/AIDS 
equals death.” [Now- after working with HIV+ patients] “I think 
they [prevention campaigns] shouldn’t be so pessimistic. It’s not 
all bad. There are good things too- like HIV doesn’t equal death. 
That people get treatment, people live normal lives like any 
other person.” [physician respondent #812. Working with HIV 
patients for 2 years] 
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“Here, it was...how can I say it?... We were really scared. I was also 
scared because... the publicity that they used back then – it’s 
different now- but then it was ‘AIDS KILLS’…if you catch it, 
‘AIDS kills’.  It was the only thing ‘AIDS kills’.  But now...it’s 
different. They say more like: ‘AIDS, you just need to deliver 
yourself over to medical treatment; there’s treatment’.  So now 
there’s not that same intense fear in the messages that there 
used to be. Before, if you saw a person with HIV, you crossed the street and 
let the person with HIV pass by on the other side. You didn’t even say ‘hello’, 
you couldn’t say ‘hello’. If a person with HIV entered [into a room], everyone 
went ‘ah! It’s that person with HIV!’ We were all afraid. But that wouldn’t 
happen today.”  [nurse, respondent #510. Working with HIV patients 
for 11 years] 
 
[Before working with HIV+ patients]“I think I was still in school 
when I first began to hear about ‘Jeito’ [the Mozambican 
government’s condom social marketing program in partnership 
with Population Studies International] But for me, it seemed 
like it was more about STDs…I didn’t understand, just thought 
that AIDS was another STD…So I thought, at the time that it was just 
about condoms.” [Now- after working with HIV+ patients] “Now, 
working as a physician, I think these campaigns should be 
carried out, but not only on TV and what not, but in all pre-
natal consultations…Because when it’s a public campaign, on 
TV or whatever, she’s never going to get to the consultation 
and say ‘look, nurse, I want to take the HIV test’ because if she 
says that she wants to take the test, the nurse will automatically 
think that she’s done something bad. So, I think these campaigns are 
very important, but they have to be integrated in the health lectures for everyone. 
The person has to already get to the private consultation and 
have heard them tell EVERYONE to get tested. That everyone 
should be tested.” [physician respondent #410. Working with HIV 
patients for 6 years] 
 
 
Though the nurse respondent (#510) who has worked with HIV patients for 11 
years states that her idea that ‘AIDS kills’ came from older prevention messages 
that no longer exist, one must wonder as respondent #812 who is over a decade 
younger and has been working with HIV patients for only 2 years clearly recalls 
also getting the message that ‘HIV/AIDS equals death’ before she worked with 
HIV-infected patients.  Now that these respondents work with HIV patients, 
they seem to have moved away from the initial fear that ‘HIV equals death’ and 
towards a more biomedical point of view that stresses the importance of 
treatment. However, we still see the recurring idea of people needing to ‘change 
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their mentality’ (in reference to prevention) and ‘deliver themselves over’ to the 
medical establishment.  
 
Again, in speaking of their ‘after’ impressions of prevention campaigns, though it 
is not stated explicitly, we can see a recognition from some clinicians of the 
stigmatizing effect of prevention campaigns that focus, for example, on ‘risky’ 
sexual behavior and encourage people to ask for testing if they engage in said 
behavior. As clinician respondent #410 stated, this discourages many people 
from asking for the test because the clinician receiving the patient’s request will 
think that the patient has ‘done something bad’ if she is worried about having 
HIV.   
 
Just as in the patients’ narratives, we can see the thread of disbelief in HIV that 
many clinicians felt upon seeing and hearing HIV prevention messages before 
they worked in healthcare. Some of the older clinicians remember a time when 
one could not even say hello to an HIV-infected person on the street.  We can 
also note again the repeated mention of patients delivering themselves over to 
the medical system, whether this be in the form of presenting to be tested or 
enrolling for treatment.  The importance of patients making this leap from 
disbelief in the fact that the disease exists at all to fully trusting in the bio-medical 
system in order to have the possibility of living and long and fruitful life is 
significant.  
 
Another point worth mentioning in the clinicians’ responses is the theme of HIV 
becoming (or needing to become) ‘just any other disease’.  Though most 
clinicians believe that prevention campaigns are generally a good thing and that 
information about HIV needs to be communicated to the populace, we can also 
sense from many of their responses, a desire for a little less focus on fear and 
‘moral censure’ and more focus on HIV as a disease like any other.  Some of 
these clinicians, after working with HIV patients have, in fact, come to think of 
other faster-progressing illnesses (such as malaria) as more worrisome in terms of 
fears of death and it seems that they would prefer to see more focus on the ‘good 
things’ as one clinician phrased it; the idea that HIV is just any other disease and 
that, with treatment, patients can live normal lives.  
4.7.6 Do patients and clinicians know that ART functions as prevention and how 
would that knowledge affect adherence? 
 
Patients and clinicians were asked if ART (with faithful adherence) has any effect 
on the probability of transmitting HIV to others and, if so, what effect it has.  
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Patients were then asked how they would feel in terms of their motivation to 
adhere to treatment if they were told that adhering faithfully to ART would help 
protect an uninfected partner. Those who were already in monogamous 
relationships with an infected partner were asked to think of the question 
abstractly. Clinicians were asked how they believe that patients might feel in 
terms of their motivation to adhere to treatment if they were aware of the 
drastically lower probability of transmission of HIV for patients on ART.   
 
As we can see in Table 9 below, approximately 46% (10 of 22) of adult patients 
correctly believe that ART decreases sexual transmission of HIV. Again, it is 
significant that these patients who thought that ART may decrease sexual 
transmission of HIV attributed this knowledge to non-healthcare sources.  
 
Incredibly, less than 30% (4 of 14) of clinicians knew that ART decreases the 
probability of sexual transmission. Of these 4 clinicians who knew the correct 
answer to this question, 3 were physicians and one was a technician. None of the 
nurses interviewed believed that ART decreases the probability of sexual 
transmission—this is notable as these nurses regularly see pregnant female 
patients and so are very familiar with ART to prevent mother-to-child-
transmission (MTCT). The one clinician who reported that ART increases 
transmission was a physician. Many clinicians, while responding to this question, 
discussed not only transmission efficiency, but also their concerns about 
‘Superinfection’ (infection with more than one strain of HIV) and the possibility 
of patients spreading more resistant strains of HIV between infected partners. 
Several patients themselves expressed concern about this same point, suggesting 
that the possibility of Superinfection and infection with resistant strains is quite 
effectively communicated to patients.  
 
This becomes important when we consider the idea of moral hazard or risk 
compensation; the fear that, if patients know that ART decreases the probability 
of sexual transmission, they will then further decrease condom usage and engage 
in ‘riskier’ sexual behaviors, effectively offsetting the benefits of ART as 
prevention.  As many patients (including those in monogamous partnerships) 
qualified their answers to these questions with comments about how they would 
continue to use condoms so as not to risk infecting themselves with another 
strain of HIV, it would seem that this fear of Superinfection may, in fact, help 
calm concerns about moral hazard. It does however, raise interesting questions 
about the popular argument that if both members of a couple have HIV, then 
this is a sort of proof that sexual transmission is particularly efficient and 
accounts for a large majority of cases of HIV with one partner being unfaithful 
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and bringing HIV into the home and infecting the other.  Were that strictly the 
case, then concerns of Superinfection in monogamous couples would be 
superfluous as both members of the couple would have the same strain of HIV.  
Therefore, the stress on Superinfection implies either assumptions of mutual 
infidelity (the only way that both infected members of a couple could have 
different sexually-transmitted strains of HIV) or unspoken suspicions that 
perhaps non-sexual transmission is greater than is officially acknowledged with at 
least one partner having acquired HIV non-sexually.  As HIV prevention 
messages stress issues of infidelity, it would seem more likely that this is yet 
another perverse outcome of HIV prevention messages: even within 
monogamous partnerships where both partners are infected, patients have been 
taught to always use condoms as their partner could still bring home another 
strain of HIV, leading to Superinfection. 
 
 













10 (45.5%) 5 (22.7%) 3 (13.6%) 4 (18.2%) 




Table 10.  Effect of Knowing ART Decreases HIV Transmission on Motivation to Adhere. 


















13 (92.9%) -- 0 1 (7.1%) 
 
 
“When taking [antiretroviral] medications faithfully, the ‘bug’ 
sleeps, the virus…It sleeps, falls asleep. But, when it’s asleep, even 
though it’s asleep, we can’t ever imagine neglecting the methods that they counsel 
us to use which means, having sex without a condom. But I think that we 
couples, we don’t always accept condom use […]. So…I think 
the best measure to take is to take the medications faithfully. 
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Why? Because taking them, I think the…‘bug’ decreases and 
it’s not so easy to make the other person sick. I think it’s better 
this way.” [37-year-old, female respondent #010c. On ART for 11 
months] 
 
“It’s less [the probability of transmission], because if I’m 
complying with the treatment, at that point, I think the virus is 
asleep, even though there’s still a risk. It’s still possible to contaminate 
the other person.” [35-year-old, female respondent #108. On ART for 
10 months] 
 
“I think there’s...less risk [to transmit HIV]. Because if the person is 
adhering to the medications and he has high CD4 levels, there’s less risk to 
transmit […]I would feel more motivated [to adhere to ART] to 
protect the other person. Knowing I could protect the other 
person.” [40-year-old, female respondent #308. On ART for 4+ 
years] 
 
“I think that I, taking the medications, have a greater chance of 
infecting my partner because I’M already in treatment and maybe the other 
person doesn’t know. Maybe I hid my serostatus from that other person, so the 
other person doesn’t know. I think it’s very risky, especially if you have sex 
without a condom because…the medication…I think the medication is cleaning 
out or… decreasing the intensity of the disease, of the virus. So I think that that 
‘stuff’ that’s going to come out of me and go into the other person’s body, my 
partner’s body… will make it a lot heavier for him…he will get sick very 
quickly. It would be a lot quicker now that I’m in the middle of 
treatment…a lot quicker for me to contaminate someone else 
because the medications are clearing the virus out of my body, 
so I’m passing more on to my partner. […] [knowing that ART 
decreases transmission]…I would feel more motivated to adhere. 
I really would.” [37-year-old, female respondent #108b. On ART 
for 6+ years] 
 
“To begin to respond to this question: I’ve never been with any man other than 
my husband. I’ve never been with another and I’m not with any other… I’ve 
heard from other infected people…they say that if we’re taking 
these medications [ART], it will make the virus go to sleep and 
they say that then you won’t transmit. But, [sheesh], to tell you 
the truth, I don’t believe it. I have doubts. [knowing that ART 
decreases transmission]… I would feel really good...proud to be 
able to protect the other person, not transmit my disease.” [26-
year-old, female respondent #010. On ART for 2+ years] 
 
One striking facet of the patients’ responses to the question regarding ART and 
transmission efficiency is the impeccable logic of many of their responses. The 
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patients who believed that HIV decreases transmission efficiency correctly and 
spontaneously identified viral load (metaphorically) as the key factor in the 
process. Most of them made reference to how ARVs ‘make the virus sleep’—
therefore lowering the amount of virus in their bodies and the amount that they 
will then pass on to their partner. The logic of respondent #108 is also well 
reasoned, even if it is not correct: the patient believes that ARVs function by 
effectively flushing HIV from the patient’s body (rather than the other patients’ 
more correct metaphor of putting the virus to sleep). This then leads respondent 
#108 to believe that her bodily fluids will actually have more viral material while 
she is taking ARVs.  As previously mentioned, none of the patients had been 
counseled on this issue in either direction by clinicians and, when some mention 
an actual source of information here, it is from outside of healthcare settings. 
However, the remarkable factor here is the excellent reasoning that seems to 
underlie many patients’ beliefs in terms of ART’s effect on transmission.  Again 
though, we find that, despite the fact that their own reasoning leads many 
patients to the correct conclusion that ART decreases HIV transmission, as they 
have never heard this from a health professional (and, indeed, some have heard it 
from previously-identified unreliable sources of information), they are unlikely to 
trust the information that ART decreases transmission.   
 
In terms of moral hazard, it is notable that many patients, without prompting, 
mentioned their strong belief that even if ART does decrease transmission, it is 
still not 100% effective as prevention and, as such, patients on ART should still 
continue to use condoms.  This suggests that fears of strong moral hazard 
expressed by clinicians (and policymakers, both international and domestic) may 
be overblown. The patients’ responses suggest that patients are quite able to hold 
a more nuanced view of ART as prevention and as a risk-reduction strategy as we 
see in respondent #101b’s response when she explicitly states that, though 
condom-usage should not be abandoned, ART as prevention would be 
particularly useful for monogamous couples that will not (or do not) use 
condoms anyway.  As condom usage in Mozambique remains rather low (as 
outlined in Chapter 2) in spite of intense, decades-long campaigns to increase 
usage, these responses, and this ability of patients to understand (without 
information from healthcare professionals) the logic behind ART as 
prevention—including the fact that it is not 100% effective—is certainly 
encouraging and should help us to develop a less apocalyptic view of the 
possibility of moral hazard.  
 
In terms of clinicians’ ideas about ART’s effects on the probability of 
transmission, we find several interesting points. First, it quickly becomes clear 
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that clinicians have not been explicitly taught about the preventative benefits of 
ART, regardless of the Ministry of Health’s 2001 decree that Mozambique would 
seek to maximize these benefits.  The majority of clinicians (seven), believe that 
ART makes no difference in transmission, with several expressing certainty in 
this belief as in the following example:  
 
“…the principal is that it [ART] doesn’t change anything [in 
terms of transmission]. I’m absolutely certain that it doesn’t 
change anything.” [technician respondent #711. Working with 
HIV patients for 3 years]  
 
Others expressed a more nuanced view, so that, though they may have said that 
ART would not affect transmission, they went on to reason through the issue, 
touching upon analogies between prevention of MTCT and ART as prevention 
of sexual transmission or recalling patients on ART who, despite not using 
condoms with their partner, did not transmit HIV, as in these examples: 
 
“I think it [transmission] would happen just the same because 
there is no cure. Here, we don’t have a cure- even taking 
antiretrovirals, we counsel patients ‘even when you’re taking 
antiretrovirals, you have to use condoms’.  But there’s a patient 
here in the pre-natal ward, her husband is uninfected, she’s 
infected, they never use condoms….they have 2 or 3 kids, some 
of them conceived when she already had HIV and, there you go, 
sometimes the husband ends up infected, sometimes not. [nurse respondent 
#808. Working with HIV patients for 9 years] 
 
“For me, without knowing which patient it is, without knowing their viral load... 
the probability of transmitting is the same as if he wasn’t taking antiretrovirals. 
That’s my opinion. I’ve not yet heard anything like ‘okay- if you 
take antiretrovirals, the probability to transmit [HIV] is 
decreased’…as we see in pregnant women, when they’re taking 
antiretrovirals, they have high CD4 levels, low viral loads… 
But, in relation to adults [and sexual transmission], no… I’ve 
never heard anything about that. I think it’s passed on just the 
same as with a person who’s not on ART. [physician respondent 
#704. Working with HIV patients for 4 years] 
 
Only one clinician reported believing that ART would increase the probability of 
sexual transmission of HIV.  The reasoning, in particular, is slightly disturbing as 
it shows a lack of understanding that the crucial action of ART is not just to 
‘make the virus sleep’ as it is often simplified for patients, but to keep the virus 
from replicating, hence lowering patients’ viral load over time:  
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“I think [the probability of transmission] is greater.  Because if 
he’s taking ARVs, in his own body, the virus is toned-
down/suppressed…this virus is going to be passed to his 
partner who doesn’t take ARVs and it’s going to ‘wake up’. 
[physician respondent #410. Working with HIV patients for 6 years] 
 
And finally, the four clinicians who reported knowing that ART decreases the 
probability of transmission all included an aside to the perceived danger in telling 
patients about this benefit, while, conversely, responding that if patients were to 
be made aware of the preventative benefit, the clinicians believe they would be 
more motivated to adhere to treatment:   
 
“The chance [of sexual transmission] is decreased. BUT, they 
can’t think like that because infected people have to know that, 
if they’re going to have sex, they always have to use condoms. 
So, it’s not perfectly safe, but the chance of transmission is less. [physician 
respondent #503. Working with HIV patients for 7 years] 
 
“It [sexual transmission] is decreased. But we’re not 
accustomed to telling them that. Because they might think: 
‘I’m already taking medication, my partner isn’t yet 
infected…so we have less probability of transmitting’. It’s just 
that we don’t tell patients this…because they would think ‘If 
I’m taking medications, why use condoms?’ Though their viral load 
may be low when they’re on ART, they always have to use condoms.” 
[technician respondent #905. Working with HIV patients for 2 
years] 
 
In terms of clinicians’ beliefs about patients’ motivation to adhere to ART if they 
knew it would help protect uninfected partners, we find that almost all clinicians 
(13 of 14) believe that the information would improve patient motivation.  Most 
mention that this would be especially useful in monogamous partnerships, and 
particularly where the couple has children, as in the following examples:  
 
For adults, if it’s within a couple, I think it would help because 
adults always look to the future, if they have kids…they think: 
‘why let both of us die?’” [physician respondent #410. Working 
with HIV patients for 6 years] 
 
I think they would be more motivated because I think that we 
all have that desire to take care of our partner. So, I think if we 
explained it correctly, they would be more motivated.” [physician respondent 
#503. Working with HIV patients for 7 years] 
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However, we do find that several clinicians include caveats to moral hazard as 
well as the idea that it would be complicated to manage this kind of information 
and be sure that patients understand that ART would not prevent transmission 
100% of the time, as in the following examples:  
 
 [Thoughts on patient motivation to adhere if they knew that ART 
decreases transmission] …I think if she [a patient] really loves 
someone and she understands that [adhering] would help to 
not pass [HIV] on to anyone else, I think that would help her 
feel more motivated. I also think especially men would be more 
motivated to adhere because that way they could think ‘hey- I 
don’t need to use condoms’ and they wouldn’t think about how 
they could also get another virus from one of the people with 
whom they don’t use condoms. So…it’s a complicated piece of 
information. There could be many good things, but also many 
bad things…”  [physician respondent #704. Working with HIV 
patients for 4 years] 
 
 [Thoughts on patient motivation to adhere if they knew that ART 
decreases transmission] I don’t know…maybe for some…for example, 
couples where one partner is positive, the other negative. Here, it’s generally like 
this: when a couple has one person with HIV and the other is 
negative, they usually separate. So, for couples that don’t 
separate in this situation, you know it’s really about love. The 
[infected partner] really knows that ‘this person is with me 
even though I’m seropositive’, so really, there’s a strong motive 
to take the medications if you really know that they would help 
you not transmit [HIV to the other partner]…But it’s very 
complicated. If people already don’t normally use condoms, if 
this information [about ART as prevention] circulates…I think 
it’s going to cause a lot of disturbance here.” [physician 
respondent #410. Working with HIV patients for 5 years] 
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4.8 Maputo Central Hospital- Pediatric ART Patients 
 
The Day Hospital of the Maputo Central Hospital (MCH) is located on its own 
floor within the pediatric ward of the hospital and will be integrated into general 
pediatrics once the process of decentralization of HIV patients has been 
completed (projected for 2012).  As mentioned earlier, patients who live within 
the geographic jurisdiction of the Central Hospital will continue to be seen as 
outpatients at the MCH pediatrics department while the rest will be referred to 
the health centers nearest their homes.   
 
Figure 21 and Table 11 show the number of pediatric patients on ART at the 
MCH as well as the number of these patients who abandoned treatment or died 
while on treatment each year.  It is important to note that these deaths are not 
representative of the number of children who died at the MCH of AIDS in any 
given year, but rather, only the number of those children who were already 
enrolled in ART at the MCH.  If an HIV-infected child was not officially enrolled 
in ART at the MCH, then her death would not appear in these figures.  
 
In Table 11 we can see a spike in the number of patients who were classified as 
having abandoned treatment in 2008 (22).  Not surprisingly, this was the year that 
adult patients began to be referred to their nearest health centers.  As we have 
seen with Malhangalene, some parents receiving treatment requested at their new 
health center that their infected child be able to be seen at the same facility.  
Fearing that the child would fall through the cracks and go without  treatment if 
the requests were not granted, many health centers accepted these children on 
ART.  As children were not yet being officially referred to health centers for 
treatment (under the decentralization plan), these children would appear in 
official records to have abandoned treatment at the MCH. From anecdotal 
evidence recounted  by pediatricians in the MCH, it would also seem that the 
spike in deaths in that same year may have been at least partly attributable to this 
phenomenon of children being seen at health centers with their parents.  
Pediatricians recounted stories of these children who had been classified as 
having abandoned treatment at MCH, later showing up in the pediatric 
emergency room of MCH with advanced AIDS and their parents reporting that 
the children were receiving treatment at a health center.  Though this study is not 
clinical and so cannot hope to address the complexities of pediatric HIV relative 
to adult HIV, both the pediatricians interviewed and the physician director of the 
HC Malhangalene stressed that pediatric HIV care is considerably more 
complicated and sensitive than adult care.  They generally attributed this to the 
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fact that HIV, being an immunological disorder, is much more difficult for a 
child’s body to handle, as children have not yet had the chance to develop a 
mature immune system before being infected.  This means that children generally 
have viral loads an order of magnitude higher than adults and they tend to 
progress (from HIV to AIDS) much more rapidly than adults.  The pediatricians 
interviewed explained this and attributed the spike in deaths in 2008 to those 
pediatric patients that were transferred to health centers by their parents before 
the health center staff had received any special training in pediatric HIV.  As no 
health centers in Maputo have pediatricians on staff and the one physician 
assigned to each health center tends to have a heavy administrative as well as 
clinical burden, many MHC pediatricians expressed deep reservations about the 
health system’s readiness to absorb pediatric ART patients into the health 
centers. The director (and only physician) at the Health Center Malhangalene also 
expressed the feeling that she, having only received a one-day ‘crash course’ in 
pediatric HIV and with the weight of all her other responsibilities, did not feel 
capable of caring for pediatric ART patients. 
 
As regards the geographic distribution of the caretakers interviewed, we can see 
from Map 2 below that they travel to the Central Hospital from a greater number 
of neighborhoods than the adult patients at the Health Center Malhangalene and, 
in fact, several caretakers live in areas (including the neighboring city of Matola) 
that are outside of the boundaries of the Maputo City map.  This is unsurprising 
as interviews were conducted before decentralization of these pediatric patients.  
 
Figure 21. Pediatric ART Recipients: Maputo Central Hospital 
 
Source: Maputo Central Hospital 
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Table 11. Pediatric ART Recipients: Maputo Central Hospital 








2006 647 -- 1 26 
2007 854 27.8 1 17 
2008 1031 18.8 22 14 
2009 1043 1.2 4 4 
2010 937 -10.7 0 1 
2011 (through 
August) 
899 -4.1 29 1 
Source: Maputo Central Hospital 
 
Map 2. Geographic Distribution of Caretakers Interviewed: Maputo Central Hospital 
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4.8.1 Human Resources 
 
The Day Hospital is assigned three dedicated nurses who do not rotate or change 
(one was on holiday during the interview period and so was not interviewed), 
while pediatricians from the Central Hospital pediatrics department as well as 
‘post-graduate’ physicians who are completing specialized training in pediatrics 
serve one month rotations.  Pediatric patients are seen twice in their first month 
of treatment then once per month during the beginning of treatment or until the 
patient is clinically stable. From there, they have appointments every three 
months, being seen by a pediatrician each time  and, later in treatment, once it 
becomes clear that adherence is high and the patient is doing well clinically, some 
patients may be seen as infrequently as once every six months though clinicians 
must be very certain that adherence is indeed, optimal, in order to recommend 
this regimen.   
 
 
4.8.2 What effect do sources of HIV/AIDS information and their perceived 
reliability have on caretakers’ experiences with ART? 
 
We can see from Table 12 that, in contrast to the adult patients discussed earlier 
in this chapter, the caretakers of pediatric ART patients are more likely to report 
friends/family or ‘person-to-person’ as a reliable source of information.  All adult 
patients who reported ‘person-to-person’ sources of information also stated that 
they are unreliable.  20 out of 26 caretakers reported friends/family or ‘person-
to-person’ sources of information in general. Of these, 25% (5 out of 20) 
consider ‘person-to-person’ sources of information reliable, 55% (11 out of 20) 
consider these sources unreliable and the remaining 20% (4 out of 20) are 
indifferent regarding their reliability. It is notable that, as in the examples below, 
many who identified ‘person-to-person’ sources of information then went on to 
state that they believe that all sources of HIV information are reliable: 
 
[radio, church, friends/family, hospital identified as sources of 
information] “There are no [unreliable sources]. What they 
say… I believe.  [35-year-old mother of 8-year-old patient, 
respondent #677, on ART for 4 years] 
 
[TV, school, health lectures, ‘in the neighborhood’ identified as 
sources of information] “I believe that they’re speaking the truth, that HIV 
exists. I think that they are all reliable.” [42-year-old mother of 5-
year-old patient, respondent #419, on ART for 4.5 years] 
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[TV, radio, health lectures, ‘from other people’ identified as sources 
of information] “I don’t see, I really don’t see, sources of 
information that aren’t reliable. They’re all reliable.” [{uninfected} 
44-year-old mother of 9-year-old patient, respondent #690, on ART 
for 3 years]  
 
[friends/family, TV, hospital identified as sources of information] 
“Everyone who talks about HIV is reliable. I believe that HIV exists 
and everything that everyone says, I believe.” [28-year-old mother 
of 3-year-old patient, respondent #568, on ART for 3 years] 
 
While it would be impossible to draw any hard and fast conclusions from these 
stories, perhaps caretakers of children with HIV may be more likely to believe in 
‘person-to-person’ information, as caring for children is a communal activity to a 
certain extent.  Mothers may have a tendency to rely upon female relatives and 
other mothers for guidance on raising their children (and several mothers 
interviewed do, in fact, live with extended family) whereas adult patients may be 
more likely to discount unsolicited information from sources outside of health 
facilities.  Several pediatricians’ responses show that they also believe that sources 
of information outside of health facilities are reliable for caretakers: 
 
“I think that they believe more in people from their 
community, their church. They believe more in people from a 
group where they belong […] They don’t believe much … in 
health workers. Maybe it’s because of the way that health workers deliver 
information…the type of language that we use.  [physician respondent 
#410. Working with HIV patients for 5 years] 
 
“Family influence is very strong because we can counsel 
[patients] to do a certain thing and when they come back here, 
it turns out they’ve been doing something completely different 
because the family influence is what they believe in much more 
[than in health professionals]. But there also exists a type of patient that 
I’ve seen that has been on ART for a long time, knows a lot about this disease 
and very much trusts what we say. It’s mainly when they’re beginning 
treatment and don’t understand things very well [that the 
family influence is strongest].” [physician respondent #704. 
Working with HIV patients for 4 years] 
 
It is also possible that the caretakers who identify ‘person-to-person’ sources as 
reliable have not yet received much ‘controversial’ information from these 
sources that contradicts the advice they receive from health workers and official 
sources.  Looking at the responses of the 11 out of 20 respondents who 
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identified ‘person-to-person’ sources as unreliable, we can see that several 
attribute pressure to stop taking ARVs to ‘person-to-person’ sources as in the 
following examples and this could help explain why they do not believe (or no 
longer believe) in these sources: 
 
[in regards to unreliable sources]“You have to comply with the 
medication…not listen to people from outside [the health facility] 
who tell you ‘no- you have to stop taking these pills. We can give 
you a person who can find you a cure...’” [33-year-old mother of 7-year-old 
patient, respondent #736, on ART for 6.5 years] 
  
[in regards to unreliable sources] It’s people because people are gossips- one 
says ‘this’, another one says ‘that’, that these pills [ARVs] will only 
speed up the disease. That’s why, when it comes to other 
people, I don’t believe anyone.” [38-year-old mother of 6-year-old 
patient, respondent #706, on ART for 4.5 years] 
 
 
All caretakers reported health facilities, health workers and health lectures as 
sources of HIV information—this is in stark contrast with the 50% of adult 
patients interviewed and the 49% of Maputo City adults in the 2009 DHS who 
reported these sources of information.23  It is not clear exactly why we find such a 
marked difference, however, we could hypothesize that the intense outreach (in 
particular through health lectures) to educate women about preventing MTCT 
and encourage all pregnant women to present for pre-natal care (where HIV is 
invariably discussed) may help contribute to this phenomenon.  A full 25 out of 
26 caretakers reported that these formal healthcare sources are reliable.  
Information from churches also figures slightly more prominently in caretakers’ 
responses than adult patient responses with 5 out of 26 caretakers identifying 
their church as a source of information (3 as reliable and 2 as unreliable). These 
reports show that, apart from the 5 respondents who trust in ‘person-to-person’ 
sources of information (who, in fact, stated that they trust in all the sources of 
HIV information that they named), the vast majority of caretakers trust in official 
sources of HIV information including health workers, facilities and lectures as 
well as, for many, TV and radio.  As with the adult patients, we get the sense that 
the fact of seeing or hearing reality (or ‘the truth’ of what is happening in their 
                                                 
23 In Mozambique’s 2009 DHS, the following sources of HIV/AIDS information were 
reported by Maputo City respondents:  Television (83%), Radio (69%), Friends/Family 
(46%), Health Lectures/Health Workers (49%) 
 
CASE STUDY: THE ROLE OF HIV PREVENTION MESSAGES IN PATIENTS’ 
EXPERIENCES WITH ART IN THE CITY OF MAPUTO, MOZAMBIQUE 145 
lives) underlies the responses of many patients in regards to why these official 
sources of information are reliable, as in the following examples: 
 
[radio, TV, hospital identified as sources of information] “TV [is 
reliable] because I’ve seen that only people who have this 
disease are there talking. But for me, all these sources are trustworthy.” 
[30-year-old mother of 7-year-old patient, respondent #930, on ART 
for 2 years] 
 
[hospital, TV and radio identified as sources of information]“The 
hospital [is reliable] because they tell the truth. TV and radio 
[are unreliable] because sometimes they lie.” [27-year-old 
mother of 4-year-old patient, respondent #516, on ART for 3 years] 
 
Overall, these caretakers of pediatric patients present a slightly more mixed bag 
than the adults in terms of the sources of information they find reliable. It is 
notable that many of the caretakers express greater trust in the formal health 
establishment than the adult patients interviewed.  This will be discussed in 
greater depth in the sections to follow as we consider how this high level of trust 
in the formal health establishment and official prevention messages may affect 
caretakers’ interactions with clinicians as well as their children’s’ eventual 
relations with the health establishment. These children will, after all, grow up and 
be absorbed into adult care and will, inevitably have to confront the social 
construction of adult HIV, but uniquely, they will do so as adults who were 
certainly not infected through sexual relations.  They will be a part of the first 
generation in Mozambique to do so (as before pediatric ART was available, HIV-
infected children would die before becoming adults).  It will, therefore, be 
important for us to gain insight into their current caretakers’ experiences and, 
combined with the perspective we have gained from the adult patients, attempt 
to anticipate issues that may arise for these children as they become adolescents 
and adults. 
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* Injections, syringes, needles, cutting instruments, tattoos/scarification, nail clippers, 
contaminated blood from wounds of infected person, unsterilized materials in healthcare settings 
§ Faithfully attending appointments, picking up medications, adhering to once-every-12-hour pill 
regimen,  following doctor’s instructions 
 
 
4.8.3 Do incomplete discussions about modes of transmission contribute to self-
stigmatization (of caretakers) and cognitive dissonance between caretakers’ ‘knowledge’ 
and clinicians’ beliefs about caretakers? 
 
From caretakers’ responses to questions on modes of transmission, we can see 
that all spontaneously reported sexual relations as a (general) mode of 
transmission and 85% of them (22 of 26) reported MTCT. A majority of 
caretakers (16 of 26) reported blood-borne modes of transmission such as 
syringes, needles, cutting instruments, blades, contact between the wounds of 
infected persons and uninfected persons, etc… though, again, as we saw with the 
148 CHAPTER 4 
adults, this knowledge is not attributed to official sources of HIV information.  
All of the pediatricians and nurses working in the Day Hospital reported that 
they believe that MTCT is the primary mode of transmission for their pediatric 
patients while all also reported the existence of blood-borne routes of 
transmission within formal and informal healthcare (traditional healers). In terms 
of how caretakers believe that the patient in their care was infected, we see that 
58% report through MTCT (15 of 26) while an additional 19% (5 of 26) report 
‘through the mother or father’.  Analyzing the responses of those who report the 
latter, we do not find any hint of suspicions of sexual abuse by the patients’ 
fathers, but rather a general misconception that HIV can be transmitted from 
father to fetus through conception, sexual relations with the mother during 
pregnancy or perhaps through casual contact later in life.  Again, as with the adult 
patients, we find a disconnect between the modes of transmission reported by 
clinicians and the modes which are communicated to patients.  We also continue 
to find the majority of caretakers reporting that the possible mode of 
transmission for the child in their care had never been discussed with them by 
clinicians. This becomes particularly important with these pediatric patients as the 
biological mothers of 19% (5 of 26) of the patients interviewed report that they 
do not have HIV themselves. For an additional 19%, the mother’s serostatus 
during pregnancy (and the possibility of MTCT) is ambiguous as will be 
illustrated with examples below.  
 
 
[modes of transmission] “…through unprotected sexual relations, 
unsterilized syringes…that kind of thing. Maybe from blades, 
cutting instruments that another person already used. I think 
that’s about it.” [in relation to how mother believes her own child 
became infected] “…well, she [the patient] was tested because, I, her mother, 
didn’t receive treatment during pregnancy. At that time [during 
pregnancy], I did take the test, there at the testing center…I 
went and took the [HIV] test, but it didn’t show any disease” 
[Interviewer: the HIV test was negative?] “Yes. It was 
negative. But then I gave birth to my baby and 3 months later she began to get 
really sick, high fevers at night, that kind of thing…I always brought her to the 
hospital and they’d say that it would go away, it would go away, they’re just 
fevers. After a while, I requested that they do exams [blood tests], but they said 
they couldn’t do them because she was still a little baby and we had to wait a 
while…The time came for her to take the [HIV] test. She took it. 
It came out positive. From there she began treatment right away.” 
[Interviewer: So how do you believe she became infected 
then?] “Through me, right? Maybe I was… maybe it was me 
who was infected but it didn’t show up in the [HIV test] 
results…” [Interviewer: You believe that your child was 
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infected by you?] “Yes…because, you see, I didn’t do the 
treatment during pregnancy. I know lots of kids who have seropositive 
mothers [who do treatment ] and the babies don’t have HIV…so I think she got 
it from me, because I didn’t do the treatment.” [in relation to clinician’s 
beliefs about how child infected] “I’ve always heard, about 
children, you know, that it’s always from a lack of treatment 
during pregnancy” [Interviewer: Have you been told any particular 
belief specifically for your own daughter?] “No.” [31-year-old 
mother of 5-year-old patient, respondent #674, on ART for 4 years] 
 
In this mother’s narrative (#674), we can see that she was tested for HIV during 
pregnancy and the test was negative. However, though the mother identifies 
blood-borne modes of transmission earlier in the interview and acknowledges 
that she, herself, did not have HIV during pregnancy, never does she hint that 
her baby could have been infected in any way other than MTCT.  Though she 
says that it was never explained to her how her own child could have become 
infected, she says that she has always ‘heard’ that when children are infected, it’s 
because their mothers were not on ART during pregnancy.  It is rather vexing 
that this mother continues to effectively blame herself for not avoiding MTCT 
(by enrolling in treatment for a disease she did not have) when there is a very real 
possibility that her daughter could have been infected horizontally.  It is 
important to note here that, though no specific explanation was ever given to this 
mother about the source of her child’s infection, she is quite aware of the official 
message about pediatric HIV that is conveyed in Mozambique which is that all 
pediatric infection is the result of MTCT despite evidence to the contrary.  For 
example, Mozambique’s 2009 DHS, which included concomitant HIV testing of 
both children and their mothers, showed that 31% of infected children (aged 0-
11) were born to uninfected mothers.  This would be a lower bound estimate of 
horizontal transmission in children as no linking of infections between infected 
mothers and children was carried out.   
 
[In regards to question about how people become infected with 
HIV] “That I don’t know.” [Interviewer: No one ever explained to 
you how people can become infected with HIV?] “Well- they 
explain but I can’t say if it’s the truth” [Interviewer: That’s 
okay. Tell me how you believe that people become infected] 
“They say it can be from the traditional healers, through sexual 
relations….various routes to transmit this virus.”[how mother 
believes patient became infected] “This is what I really don’t know.” 
[Interviewer No one ever explained how your child may have 
become infected?] “No” [Interviewer: But what do you think it 
might have been? Any ideas?] “I don’t know” [clinicians beliefs 
about how patient infected] “I don’t know” [Interviewer: No one ever 
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spoke to you about this…?] “No. Nothing” [{uninfected} 47-year-
old mother of 7-year-old patient, respondent #034, on ART for 2.5 
years] 
 
The first point that begs our attention in the narrative above (#034) is this 
mother’s wariness to speak of modes of transmission in a general sense. She 
seems distrustful of what she has heard and learned and even when she mentions 
some modes of transmission, she finishes with the rather vague ‘various routes’.  
She also claims to have no idea of how her child may have become infected nor 
how clinicians believe her child may have become infected.  Let us put this into 
context to try to make sense of her responses: This mother and her husband do 
not have HIV, nor do their other four children.  The patient in question is the 
only person in the household with HIV.  Interestingly, this mother reported TV, 
radio and the hospital as sources of information about HIV (earlier in the 
interview) and stated that all of these sources of information are reliable. 
However, when the topic turns to routes of transmission (which she certainly 
would have seen or heard on TV, on the radio or in the hospital) she seems loath 
to discuss the topic.  This is not particularly surprising considering that the 
patient is the only member of the household with HIV, possibly making this a 
sensitive topic, however, what is perplexing is that even in a situation such as this 
one where the patient most certainly was not infected through MTCT, no 
clinician has ever explained to this mother how her child may have become 
infected.  Considering that she has four more children (not to mention herself) to 
protect from infection, one would have hoped that modes of horizontal 
transmission would have been thoroughly explained to this mother when her 
child was diagnosed with HIV.  An analysis of Mozambique’s 2009 DHS data 
carried out by Devon Brewer shows that people who reported knowledge of 
blood-borne transmission of HIV (via infected blood or sharing razor blades or 
injection needles) were not only less likely to be infected themselves, but that 
mothers who identified these risks were also less likely to have HIV-infected 
children, making this topic more than academic.37 
 
[in relation to how mother believes her own child became infected] 
“I really don’t know because…he’s the only one [in the family 
who has HIV]” [regarding clinicians beliefs about how patient 
infected] “He got it...well….talking about this, my heart pounds 
in my chest like this [beats on chest to demonstrate]. When it’s 
a child, generally speaking, it’s from the parents, but in my 
case, it’s not that so I don’t know what to say.”  [Interviewer: So, 
they don’t know how he got it?] “They don’t know” [Interviewer: And 
the whole family was tested?] “Yes, yes, yes. We’re all negative” 
[Interviewer: And no one here has ever explained how he could 
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have become infected?] “No. Nothing.” [{uninfected} 44-year-
old mother of 9-year-old patient, respondent #690, on ART for 3 
years]   
 
Again, we see that this mother of five has one infected child while she and her 
husband (the patient’s father) are also uninfected. Again we find that this mother 
reports that the possible mode of transmission in her child’s case has never been 
explained to her and, indeed, she becomes quite emotional just speaking of the 
subject of how her child may have been infected.  The only mode of transmission 
for children that she is able to identify is MTCT, leaving her with anxiety and 
confusion as to how her own child may have become infected. 
 
[in relation to how mother believes her own child became infected] 
“When I went to take the [HIV] test, nothing showed up. 
While I was pregnant, I had blood tests done and it was 
negative again. Suddenly, when I was breastfeeding her [the 
patient], when she was about a year-and-a-half old, I came here 
to the hospital with swollen breasts and they operated. 
Afterwards, I got…I got…from there, after they operated, I 
came again and they did the [HIV] test again and it was 
positive but it was only a year later that I began treatment.” [Interviewer: 
So how do you believe that your child became infected with HIV?] 
“Well, that’s what I don’t know. I’m now positive too, but her 
[the patient’s] father, my husband, isn’t.” [clinicians beliefs] “I 
don’t know. I don’t know.” [25-year-old mother of 6-year-old 
patient, respondent #938, on ART for 1 year]  
 
This particular response is especially disturbing as this mother of two young 
children tested negative for HIV both before and during her pregnancy with the 
patient (her second child is four years old, and uninfected; it was during that 
pregnancy that she began ART).  It was only after she underwent a surgical 
procedure that she tested positive for HIV and close to 4 years later that the 
patient tested positive for HIV after presenting with opportunistic infections.  
Following this sequence of events, we may speculate that this mother could have 
been infected nosocomially, especially considering that her husband is uninfected, 
and, if she continued breastfeeding after the surgical procedure, could have 
infected her first child (the patient) at that time. Again, no clinician has ever 
discussed how this mother’s older child may have been infected and she remains 
perplexed on the issue.  She does not explicitly identify the surgery as a possible 
source of the HIV infection (either her own or her child’s), however, as she 
spontaneously mentions it as having preceded her own positive test, we could 
surmise that she may harbor suspicions.  This mother also identified the hospital 
and health lectures as the most reliable sources of information while not 
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mentioning any ‘person-to-person’ sources of information whatsoever. This 
further highlights the double-edged sword of trust in the formal healthcare 
system: on the one hand, this trust facilitates seeking and adhering to ART, but 
on the other hand, this places a particularly heavy burden on the healthcare 
system to communicate effectively and thoroughly about HIV, including 
communicating accurate and complete information on modes of possible 
transmission. 
 
[in relation to how mother believes her own child became infected] 
“Through his mother, through his father. Through me…his father 
had HIV as well…his father got sick, died here in the hospital, and after that 
the child also got sick. Before my husband died, I also wasn’t feeling 
well and the child was sick. They said we had HIV…just 
before his father died…” [in relation to clinician’s beliefs about 
how child infected] “I don’t know that either. They never talk 
about that” [42-year-old mother of 12-year-old patient, respondent 
#202, on ART for 2.5 years] 
 
[in relation to how mother believes her own child became infected] 
“I can say through blood because when I was pregnant, I took 
the test and they told me I was [HIV] positive, so, for me, 
when it came out that she had HIV as well…for me it was from 
the mother’s blood…my blood. [in relation to clinician’s beliefs 
about how child infected] [long pause] I have to say that the 
doctors…they say it can’t be through other blood [not the 
mother’s], you know? [Interviewer: But for your child...?] “Through 
blood. Because she is still a child, she’s not a person who…she doesn’t know 
things about life, about this world, you know? I’ll put it like that [speaking of 
sex]. So, I think the doctors must believe that she got it from the 
mother’s blood…my blood. I don’t know.” [43-year-old mother 
of 7-year-old patient, respondent #450, on ART for 1 month] 
 
In both of the above narratives, the mothers are HIV positive. However, the first 
mother (respondent #202) notes that both she and her child were sick and 
diagnosed with HIV when the child’s father was in the hospital, dying of AIDS.  
The child was 9.5 years old at that time. This mother attributes her child’s 
infection to herself and/or the child’s father (again, she makes no reference to 
any suspicions of sexual abuse by the child’s father but rather seems to believe 
that perinatal transmission can come from an infected father).  The second 
mother (respondent #450) did, indeed, test positive for HIV during pregnancy 
and, though she refers to transmission from her own blood infecting the patient, 
it would seem that she is referring to MTCT (and not horizontal transmission 
through blood exposures).  This child first became sick with opportunistic 
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infections at 7 years old.  While it is conceivable that both of these children were 
infected through MTCT and it is understandable that the mothers, being HIV 
positive themselves by the time of the child’s diagnosis, would attribute the 
infection to MTCT, the notable point here is that the issue of how their children 
may have become infected was never discussed with them by clinicians.  
 
Clinicians working with pediatric patients would be aware, both from their own 
experience with HIV infected children, as well as through their medical training, 
that long-term survival, and particularly symptom-free survival, of perinatally-
infected children in the absence of ART is extremely low. For example, a paper 
based on the French Pediatric Cohort looked at 348 HIV-1 infected children 
born before January 1, 1994, and showed that only 2% of the perinatally infected 
children were classified as long term non-progressors (LTNPs), defined in this 
case as not showing signs of clinical nor immunological progression by age 10.38  
Another important study of perinatally- and neonatal transfusion-infected 
children in Los Angeles found that the average symptom-free period from birth 
to disease progression (symptomatic infection) was considerably shorter for 
perinatally-infected children (6.4 months) versus neonatal transfusion-infected 
children (17.8 months).39  Differences in survival between the two groups in this 
study were also quite dramatic with 75% of perinatally-infected children dying by 
44 months of age while 75% of transfusion-infected children survived until 71 
months.40 Studies of known nosocomial outbreaks of HIV in children in 
Romania and Russia have also found strong evidence of child-to-mother 
transmission of HIV through breastfeeding41,42. In cases (such as respondent 
#202) where the child only exhibits symptomatic infection and tests positive for 
HIV at an advanced age (7 years old in this example) and the mother is also 
diagnosed at that time, it is not impossible that this child is an LTNP and was, 
indeed, infected through MTCT. However, clinicians should have considerable 
doubts about this scenario. At the very least, the possibility that the child or 
mother was infected nosocomially and then transmitted HIV to the other during 
breastfeeding should be considered.   
 
In light of the extremely low probability of perinatally-infected children surviving 
to 7-11 years of age, symptom-free no less, we should be very concerned about 
Mozambique’s 2009 DHS data which show that 7.9% of 7-11-year-olds and 8.9% 
of 9-11-year-olds tested for HIV during the survey were found to be seropositive.  
These children’s mothers, who were also tested during the DHS, were found to 
be seropositive themselves so that these children are often excluded from 
discussions of possible nosocomial transmission as children whose mothers are 
also HIV-positive at the time of the DHS test are assumed to have been infected 
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vertically.  The possibility that these children were infected horizontally (which 
could include transmission through injections, transfusions, circumcision, 
scarification, etc…) and could have passed HIV on to their mothers through 
breastfeeding is rarely spoken of in academic and policy circles and would seem 
to be completely excluded from communications within the Mozambican health 
sector.  This lack of communication about horizontal transmission in children, 
whether between clinicians and mothers or in public health campaigns, 
perpetuates the social and political construction of mothers as negligent when 
their children are infected with HIV, as discussed briefly in Chapter 1.  Only one 
caretaker in this study attributed her child’s infection to blood-borne 
transmission, yet it is telling that she does not believe that clinicians attribute her 
child’s infection to blood-borne routes, despite the fact that she herself is not 
infected: 
 
[in relation to how mother believes her own child became infected] 
“through ‘cutting’, blood.” [Interviewer: during childbirth?] “No. 
It’s only during childbirth when the mother is infected” [in 
relation to clinician’s beliefs about how child infected] “from lots of 
things…maybe they think that the mother…that I, have [HIV], 
or other family members at home…I don’t know.” [{uninfected} 
32-year-old mother of 7-year-old patient, respondent #013, on ART 
for 14 months] 
 
Though this mother, herself, attributes her child’s infection to a blood-borne 
route, the topic does not seem to have been discussed with her by clinicians as, 
when asked how the child’s clinicians believe that he was infected, she guesses 
that they might think that she [the patient’s mother] is infected (MTCT) but 
finishes her response with ‘I don’t know’.  This situation raises two red flags: 1) 
an HIV-negative mother with an HIV-positive child and, 2) a child presenting 
with HIV at a relatively advanced age (6 years old at first symptoms).   
 
Though MTCT of HIV is a real and urgent problem for which we should 
continue to expand pre-natal HIV testing and treatment for all infected women24, 
it is just one more area of HIV prevention in Mozambique that suffers from the 
distorting effects of partial information.  The probability of transmission of 
MTCT in Africa in the complete absence of ART ranges from 25-35%43, yet here 
we find mothers who not only blame themselves for not treating their HIV 
infection during pregnancy to avoid MTCT (believing that transmission is 100% 
                                                 
24 According to UNICEF’s 2010 Country Report, by September 2010, 50% of HIV-
infected women in Mozambique received ART for PMTCT and sites offering this 
service in Mozambique increased from 388 in 2007 to 903 by September 2010.   
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in the absence of treatment), but mothers who themselves were not infected 
during pregnancy and who believe that their children were infected with HIV 
because they (the mothers) did not go through a treatment regimen for a disease 
that they did not have, as in the further example below:   
 
[modes of transmission] “they say that the origin [of HIV] is 
from sexual relations. But kids…how…how is it that they have 
it? This here… I just don’t know...if it comes from some other 
place...because there are kids who have [HIV], women who are 
12, 17 or 50 years old have it, but women who have never had 
sex” [in relation to how mother believes her own child became 
infected] “…the child was infected with HIV/AIDS because of a lack of… 
how is it… eh…medical care. The mother didn’t do the treatment 
during pregnancy.” .” [in response to question about how clinicians 
think baby was infected] “From the mother…from me” 
[{uninfected} 28-year-old mother of 9-year-old patient, respondent 
#163, on ART for 5 years] 
 
In this narrative, we can see an example of another interesting facet of many of 
these caretakers’, and specifically mothers’, responses.  Although they themselves 
in these examples are the mothers of the patients, when asked about their or their 
clinicians’ beliefs about how their child may have become infected with HIV,  10 
out of 24 biological mothers interviewed invariably refer to themselves in the 
third person, as in: “the mother didn’t do the treatment” (respondent #163); “it certainly 
can only have been transmission through his parents…” (respondent #525); “through her 
mother…because I’m her mother and I know she got it from her mother” (respondent 
#676); “because the mother was contaminated [infected] and, her being pregnant, the child also 
became infected during childbirth” (respondent #070); “from her mother…I guess from her 
mother…me” (respondent #202). Social psychologists have long been interested in 
the so-called ‘self-conscious emotions’ of pride and shame and how they manifest 
in speech.  Speaking of oneself in the third person is considered a grammatical 
indicator of one of these emotions, though it is probably safe to assume that, in 
the narratives being discussed here, pride (in the action being described), is most 
likely not a factor. Crozier (1998) explains it this way: “shame involves taking an 
‘other’ perspective on the self […] it is experienced when the individual 
recognises that his or her action gives rise to a particular kind of interpretation by 
others even if he or she does not believe that interpretation to be justified”44  
Rochat (2003) describes how “[t]he self is now recognized not only from a first 
person perspective, but also from a third person’s[…] The public outlook on the 
self is simulated for further evaluation of how one is perceived and valued by 
others. The result of this evaluation, more often than not is either a devaluation 
or a delusion, linked to so-called “self-conscious” emotions or attitudes such as 
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pride or shame.”45  The caretakers interviewed in this study only refer to 
themselves in the third person when the mode of transmission of HIV to their 
child is discussed and, tellingly, not in response to any other questions.  This 
indicates that they feel shame in articulating the idea that they, themselves, have 
transmitted HIV to their children, whether they are expressing their own belief or 
their ideas of how clinicians believe their child was infected.  The issue of shame 
and how HIV prevention messages produce or propagate this shame, as well as 
the potential effects on ART enrollment and adherence for children, will be 
discussed further in the following section.  
 
 
4.8.4 How are shame and fear propagated by prevention messages and what effect 
does this have on caretakers’  experiences with ART? 
 
Discussing shame and fear in the context of pediatric ART patients necessarily 
includes some elements that have already been discussed in the section on adult 
patients. This is because the caretakers of these pediatric patients are, particularly 
for younger children, responsible for seeking medical care and making sure that 
their children adhere to the prescribed appointment and medication regimen. 
Issues of discrimination against the children themselves do, of course, exist.  In 
Mozambique’s 2009 DHS, for example, we find that close to 7% of Maputo City 
residents believe that HIV-infected children should be separated from other 
children to avoid transmission.  However, it would seem from responses here 
that caretakers of very young children with HIV do not, in fact, explain to the 
child exactly why (s)he is taking medications, and, indeed, many report that 
administering medications is sometimes trying as the children tend to argue 
things like: “I’m not sick, but you always make me take medicine” (respondent 
#690).  This withholding of at least the name of the illness in question serves a 
protective purpose for the children themselves so that they do not talk about 
having HIV/AIDS with other children (or their relatives) partially shielding them 
from possible discrimination.  Presumably, this dynamic would be quite different 
for pre-adolescents and adolescents, however this older age group which certainly 
merits study, is outside of the scope of this particular research.  
 
Here we will examine issues of shame as they apply to the caretakers, and 
especially mothers, of HIV-infected children.  Unlike what we have seen with the 
adult ART patients, the caretakers of pediatric patients did not identify shame to 
be seen going to the health center (by neighbors, acquaintances, etc…) as a 
challenge to ART adherence.  Though it seems unlikely, this could be because 
caretakers of HIV-infected children do not feel shame to have their neighbors 
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know about their children’s HIV infections. It would seem more realistic, 
however, that this could be directly linked to the fact that these caretakers were 
interviewed during the ongoing decentralization of pediatric patients and many of 
them, as mentioned earlier, travel from other, sometimes distant, neighborhoods 
and even from the neighboring city of Matola, to get to the Day Hospital (as seen 
in Map 2 at the beginning of this section).  Very few of the caretakers interviewed 
live in the immediate vicinity of the Central Hospital.  The Central Hospital is 
also a large and sprawling compound and several entrances (which pass through 
general pediatrics, for example) will take one to the Day Hospital.  This 
combination of factors makes it unlikely that caretakers who do not live in the 
immediate vicinity of the hospital would be observed by neighbors or 
acquaintances taking their children to appointments at the Day Hospital.  One 
pediatrician, in fact, questions the idea that decentralization was meant to 
diminish discrimination as she believes, from her experience, that caretakers 
bringing children to the Day Hospital have both more anonymity (being in the 
Central Hospital which sees thousands of patients for varying ailments from all 
over the city and province) as well as more specialized attention from physicians 
and, in particular, pediatricians (respondent #410).   
 
From caretakers’ responses in these interviews (as well as clinicians narratives), 
we see that the shame and fear that they express is more connected to disclosure 
of their HIV status to their husbands or partners (the fathers of the infected 
children) as well as disclosure to family members.  Previous studies have focused 
on issues of disclosure for pregnant women or new mothers, often providing 
valuable insight into the barriers to disclosure (such as fear of domestic violence, 
abandonment and accusations of infidelity) these women may face.46,47 However, 
these studies stop short of examining any possible upstream causes of fear of 
these types of discriminatory events. 
 
Responses from several women interviewed here demonstrated that the fear of 
disclosure is often justified as in the following example: 
 
“it was scary...because you never know, for all that you’re faithful…I was living 
with [the patient’s] father, but after he found out that I had gotten HIV, he 
preferred to distance himself from me. Because I took the test again 
[after the patient tested positive] and, obviously, I opened up, 
told him that I’m like this [HIV positive]. So he went and did 
the test and he was negative. So he began to distance himself 
from that point on. There was nothing to be done, right?” [31-year-old 
mother of 5-year-old patient, respondent #674, on ART for 4 years] 
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This young mother was not, in fact, HIV-positive during pregnancy, however, 
when her child became sick and tested positive for HIV at 1 year old, the mother 
also took the test again and was found to be positive.  She is unsure of where she 
became infected as she had only been with her partner (the patient’s father) who 
was uninfected.  However, she gives an implicit nod to the common and highly-
publicized belief that adults are infected through (high risk) sex and infidelity 
when she says that ‘you never know, for all that you’re faithful…’.  Her narrative 
shows that the fear of disclosure is not unjustified; upon disclosure to her 
uninfected partner he did, indeed, leave her and their child.   
 
Another mother (respondent #930) recounts how she had to travel for work the 
month before our interview.  The father of her 7-year-old son [the patient] is no 
longer alive, and the patient stayed with his paternal grandmother and other 
extended family members.  Though the grandmother was aware of the patient’s 
condition and his medication schedule, the other extended family members were 
not.  The grandmother reportedly did not want to administer the medications in 
front of the other family members who might suspect that the child had HIV. 
The patient chimed-in during the interview, telling his mother: “I wasn’t taking 
them [the medications] when you went away. I don’t know how”.  His mother 
reports that he became very ill after approximately two weeks off of his 
medications and was hospitalized just before she returned to Maputo.   
 
This fear of disclosure (whether it relates to the child’s or the parent’s serostatus) 
presents special challenges for the mothers of seropositive children.  As we can 
see in Table 12, 42% (11 of 26) of caretakers reported that the greatest challenge 
to ART adherence (in regards to the child’s adherence) is what I have 
characterized as “dedication to the regimen”.  Caring for any young child is 
already a challenge, particularly in a country such as Mozambique which has no 
governmental social safety net to assist these parents (though at times they may 
receive assistance from NGOs working in partnership with health facilities).  
Adding the additional responsibilities of caring for a child with HIV who must be 
given medications every twelve hours (meaning, they also must eat well every 
twelve hours), attend frequent medical check-ups and pick up medication refills, 
not to mention caring for the child should (s)he fall ill, highlights the importance 
of social and familial support.  Many caretakers spoke of the difficulty and 
sacrifice inherent in keeping these children on ART: 
 
“...I worked as a housekeeper, but afterwards it became difficult because he [the 
patient] had to go to appointments all the time…so I gave up working to 
take care of him. I gave up many things; there was just no 
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way…I needed to take care of him.” [36-year-old mother of 9-
year-old patient, respondent #177, on ART for 6 years] 
 
“[the challenge is…] the child grows up, but you can’t let her disappear…you 
have to take her aside and be firm about the hours that she 
takes the pills…take care of her constantly because she’s still a 
child and you’re the mother” [39-year-old mother of 6-year-old 
patient, respondent #348, on ART for 4 years] 
 
“[the challenge is…] to comply with the hours [to take the pills], 
comply with the check-ups, consultations, analyses…and also to 
love the child, not punish the child for being sick” [27-year-old mother of 4-
year-old patient, respondent #516, on ART for 3 years] 
 
“The difficult part is in eating well...the child has to eat well to take the 
medications like adults have to. Eh! It’s difficult. When you don’t do 
anything [don’t work] and there’s no one to help you and this 
disease is always there…always there…It’s difficult. It’s really 
difficult.” [47-year-old mother of 7-year-old patient, respondent 
#450, on ART for 1 month]  
 
Nine of the caretakers interviewed here are single and six are widowed, meaning 
that close to 58% of the interviewees are without a partner to assist with the 
child’s care or provide income or other tangible support. 65% of interviewees 
have no formal occupation and report being ‘housewives’.  Several of the widows 
and single mothers live with extended family. As we have seen with the widowed 
mother who had to leave her young, infected child in the care of his grandmother 
while she travelled for work, issues of disclosure and fears of stigma enter into 
the child’s care in a direct and important way. Crucial social and logistical support 
from family and friends butts up against a certain level of guardedness on the 
part of caretakers to reveal the child’s serostatus, even to other family members.  
As the child himself has obviously done nothing ‘wrong’ to be stigmatized, this 
would lead us to believe that the perceived stigma is handed down, in a sense, 
from the shame and stigma surrounding adult infection.  As MTCT is seen as the 
almost-exclusive mode of transmission of HIV to children, we can imagine that 
the issues of stigma that arise for women affect their own disclosure of their 
serostatus and, by extension, that of their child as well.  Recall in the section on 
adult patients, the mother (respondent #100) and the clinician telling a mother’s 
story (respondent #808); they both spoke of the mothers allowing their infants to 
die rather than admit their serostatus to their partners and obtain treatment 
themselves or for their babies. One pediatrician sums up this fear of disclosure 
thusly: 
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“…I think adults are often bad at heart. If they already have 
[HIV], it’s like they want to give it to someone else. We have 
lots of seropositive mothers that, when they get to us, say: 
‘Don’t tell my husband that I’m seropositive and that my child 
is on ART’, so you can tell that this mother, at home, has a 
relationship with her husband where she pretends like nothing 
is going on. And from there, it gets more complicated. We have a lot of 
mothers here where we ask ‘Why didn’t you give the 
[antiretroviral] syrup to your child?’ and her: ‘because his 
father was always with me and he can’t know that our child is 
on ART’.  Now, working with mothers who actually care about 
their kids- that’s different…” [physician, respondent #410. 
Working with HIV patients for 6 years] 
 
This physician recounts what seems to be a common theme of adults hiding their 
(and their child’s) serostatus from their partner for fear of judgment and censure, 
however, the physician explicitly attributes the patient’s non-disclosure to the 
patient’s being ‘bad at heart’ (wanting to pass HIV on to her partner) and her 
failure to give her child his medications (due to the issue of non-disclosure to the 
child’s father) as ‘not caring’ about her child.  Another clinician tells a similar 
story of fears of disclosure at home interfering with the administration of the 
child’s medications, though with a markedly different tone: 
 
“I think it’s difficult for them [to administer the medications correctly]. Or the 
child’s father doesn’t know or someone else in the home can’t 
know, so I think there are huge problems at the household 
level to administer these medications to the child.” [physician 
respondent #704. Working with HIV patients for 4 years] 
 
As Hejoaka (2009) succinctly describes in her study of mothers of HIV-positive 
children in Burkina Faso: “HIV/AIDS-related stigma adds an additional layer to 
the burden of care, compelling mothers to deal with tension between the secrecy 
surrounding the disease and the openness required in providing care and 
receiving social support”.48   As long as receiving social support hinges on 
disclosure of the child’s serostatus (and, by implication, the perception of the 
mother’s serostatus), then tracing this stigma, perceived or real, to its source will 
continue to be an area that requires urgent attention.  We can see, both from the 
adult patient accounts as well as the caretakers of pediatric patients, that mothers 
are doubly stigmatized when their children are infected with HIV as it is 
presumed that: 1) they acquired HIV sexually themselves, possibly through 
promiscuity and unfaithfulness and, 2) they passed HIV to their child(ren) 
through negligence; through not having done ART to prevent transmission to 
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their child(ren).  These two presumptions are also intimately connected, as we 
have seen, in that pregnant women who are found to be HIV-positive may not 
enroll in ART to prevent MTCT for fear of involuntarily disclosing their own 
serostatus to their partner (by being ‘caught’ either taking the medications or 
having them in the home).  Both of these messages are very apparent, not only in 
the patients’ and caretakers’ accounts, but also in the clinicians’ narratives; both 
messages also precisely echo the thrust of HIV prevention messages that give the 
impression that all adult transmission is sexual (and due to ‘risky’ sexual behavior) 
and all transmission to children is via MTCT.   
 
4.8.5 Do caretakers know that ART functions as prevention and how would that 
knowledge affect their and the child’s experiences with ART? 
 
As we are speaking of pediatric patients, the knowledge (or lack thereof) on the 
part of their caretakers of ART as a tool for prevention of sexual transmission of 
HIV may seem irrelevant. However, we must keep in mind two things: 1) the 
mechanism behind ART as prevention of sexual transmission is the same as the 
mechanism behind  prevention of MTCT which can give us an idea of the 
reasoning carried out by caretakers who are aware of ART for  prevention of 
MTCT and; 2) these children will eventually be told what disease that they have 
been treating for all these years and their caretakers will be in a unique position to 
provide them with information about their disease and on how they can live long 
and healthy lives while also protecting their future partners and children from 
infection. 
 
As clinicians’ beliefs regarding ART as prevention have already been discussed 


















14 (53.8%) 4 (15.4%) 6 (23.1%) 7.7%(%) 
Clinicians 4 (28.6%) 1 (7.1%) 7 (50%) 2 (14.3%) 
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As we may have expected, knowing that the mechanisms behind PMTCT and 
ART as prevention of sexual transmission are virtually the same, a greater portion 
of the caretakers interviewed correctly believe that ART will decrease the 
probability of sexual transmission of HIV (53.8%) than what we saw for the adult 
patients (45.5%).  Fewer caretakers incorrectly believe that ART increases the 
probability of transmission (15.4%) versus adult patients (22.7%) and a larger 
proportion of caretakers believe that ART has no effect on sexual transmission 
(23.1%) versus the adult patients (13.6%).  Some caretakers drew an explicit link 
between PMTCT and the probability of sexual transmission of HIV as in the 
following example:  
 
“It’s like this: When someone’s sick, they have HIV/AIDS, it doesn’t mean 
that…well, [saying they couldn’t have sex without a condom] it 
would be like saying that a person with HIV/AIDS can’t have 
children.  But when a person is adhering to the medications, 
maybe they get to a phase where they want to have a baby, they 
talk to the people who are providing them with treatment, and 
they can have a child. And that child can be born without any 
problems [HIV]. I’m completely sure, because of that, that it’s 
the same idea. The chance [of sexual transmission] is less” [43-
year-old mother of 7-year-old patient, respondent #450, on ART for 
1 month] 
 
Others who reported that the probability of transmission is lower added caveats 
similar to those we saw in the adult patient interviews, mentioning that the child 
(when (s)he is an adult) will still always need to use condoms, such as in this 
example:  
 
“The risk [to transmit] is less, but as he’s seropositive, he will 
always have to use condoms” [35-year-old mother of 8-year-old 
patient, respondent #677, on ART for 4 years] 
 
While still others, whether they believed the risk of transmission to be greater or 
the same, repeated, almost verbatim, the thrust of HIV prevention messages 
directed at adults as in the following example:  
 
“...she has to take antiretrovirals…and…use condoms, avoid 
going out, sleeping with people, smoking, drinking…” 
[Interviewer: but taking the antiretrovirals faithfully, if she has sex 
without a condom…?] “She’ll pass HIV to the other person just 
the same.” [39-year-old mother of 6-year-old patient, respondent 
#348, on ART for 4 years] 
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Overall, we see, again, that the reasoning behind the correct belief that ART 
reduces the probability of sexual transmission is well-grounded, this time in 
frequent analogies to PMTCT.  Interestingly, none of the caretakers mentioned 
the metaphor that was common among the adult patients of ARVs ‘making the 
bug sleep’.  It would seem that this imagery is either more commonly presented 
to adult patients to explain the effect of ART on their own bodies, or that the 
imagery of prevention of MTCT is simply stronger or more visceral for 
caretakers of pediatric patients. Again, it is worth noting that, of the six 
physicians interviewed at the Day Hospital, only two reported that ART 
decreases the probability of sexual transmission of HIV.  Apart from the 
importance of caretakers being given accurate information that they will 
eventually pass on to the infected children in their care, we must of course, 
remember that many of these caretakers are adult patients themselves.  As we 
saw with respondent #674, HIV-positive mothers in particular, run the risk of 
abandonment by their husbands if they disclose their serostatus.  This 
abandonment not only affects the mother, but also the couple’s child or children.  
Were these women and the general public to have both an alternative narrative 
for how they may have become infected (as discussed in the section on adults) as 
well as medical advice as to the effects of ARVs on sexual transmission of HIV, 
perhaps abandonment would gradually become less of an issue, making 
disclosure less of a concern.  As we have seen that fears of disclosure can directly 
affect the administration of ARVs to infected children, we should not 
underestimate the downstream effects of HIV prevention messages on caretakers 
and, ultimately, the experiences of children on ART.  
 
4.9  Conclusions 
 
The primary objective of this fieldwork was to explore the impact of HIV 
prevention messages on the experiences of people living with HIV or caring for 
children living with HIV.  This impact has been framed as being mediated by two 
mechanisms: 1) creation or exacerbation of stigmatizing beliefs and; 2) 
accordance or disconnect between patients (or caretakers of pediatric patients) 
and clinicians representing the medical establishment.   
 
4.9.1 Adult Patients 
Through the narratives of the adult patients and their clinicians we can see that, 
for adults with HIV, ‘delivering oneself over’ to the official health establishment 
is repeatedly mentioned as an important step to both being tested for HIV and 
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ultimately enrolling in and adhering to ART.  As the HIV information that these 
patients receive from unofficial sources (such as ‘on the street’ or from family 
and friends) sometimes contradicts official health messages, the patients must 
then accept the official messages or live with a fairly high level of cognitive 
dissonance. This dissonance may be a cause for people to either not present for 
testing or a contributor to eventual loss to follow-up for some non-adherent 
patients.  This dynamic of ‘delivering oneself over’ to the health establishment 
also places a particularly high burden or responsibility on clinicians to be sure 
that they communicate openly with patients about the scientific facts of HIV.  
Many of the patients’ scientifically correct beliefs about HIV (such as those 
concerning blood-borne modes of transmission and the efficacy of ART as 
prevention of sexual transmission) are based on information they report having 
received from unofficial sources which they overwhelmingly identified as 
unreliable and not from official sources which they identified as more reliable.  In 
contrast, clinicians, though they all report awareness of blood-borne modes of 
transmission, clearly state that they do not discuss these modes of transmission 
with patients.  The clinicians also do not report having received information on 
the preventative benefits of ART during their medical training and very few (far 
fewer than the patients) report knowledge of this benefit.  Those that are aware 
of the benefit stated that they do not discuss it with patients for fear of moral 
hazard or risk compensation behaviors (i.e. decreasing condom usage or 
increased ‘promiscuity’).  There is compelling qualitative evidence from these 
interviews that consideration of the impact of HIV prevention messages (that 
historically and currently focus on sexual behavior) on PLWH and clinicians is 
needed if policymakers truly wish to implement combination prevention 
strategies. This will be an important prerequisite to achieving further scale-up of 
ART with early testing and treatment as well as optimal adherence. Researchers 
and policymakers should explicitly concern themselves with the possible 
stigmatizing effects of current sexual behavior prevention messages as well as 
with the scientific accuracy of prevention messages in general.  
 
4.9.2 Caretakers of Pediatric Patients 
 
Mozambique also urgently needs to address the issue of babies and children with 
HIV born to seronegative mothers or presenting later in childhood with first 
symptoms: both strong indicators of much higher than estimated levels of 
horizontal transmission.  However, whether or not the mother of an HIV-
positive child is seropositive herself, clinicians should be trained to discuss all 
modes of transmission with mothers for several reasons: 1) to avoid the pitfall of 
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creating or exacerbating stigma and fear of disclosure (related to adult sexual 
behavior prevention messages) which has been shown to impact not only the 
mothers’ own treatment seeking behavior and adherence, but also that of their 
children and; 2) to assure that mothers have all the facts at their disposal to 
protect their other children from possible horizontal transmission.  Despite 
strong evidence of high levels of horizontal transmission in babies and children 
in Mozambique, none of the caretakers interviewed reported having received 
explanations from clinicians of how their own child may have become infected so 
that we saw several mothers who are not (or were not) seropositive blaming 
themselves for their child’s HIV infection, believing that because they did not 
take antiretrovirals to prevent MTCT, they themselves had infected their 
children. This kind of self-stigmatization has observable consequences for 
voluntary disclosure to partners and family members and has been shown to not 
only isolate mothers of seropositive children, but also to lead to negative effects 
on adherence for the children themselves (for example, when the infected child’s 
mother must leave the child with relatives, all of whom may not be privy to 




While the discussions here regarding the disconnects found between patients’ and 
caretakers’ (often correct) knowledge of topics related to HIV that go 
undiscussed and clinicians’ own knowledge (or what clinicians discuss with 
patients), may seem to vilify clinicians, that was not at all the purpose.  The social 
construction of HIV in Mozambique is powerful and manifests itself in many 
ways.  Professionals, such as clinicians, are not immune to these social 
constructions and, indeed, are bound within the same framework of partial 
information as patients.  It could even be said that clinicians may be more tightly 
bound than patients as they are trained in an atmosphere laden with implicit 
political and social priorities that are frequently out of step with the scientific and, 
in this case, clinical reality as discussed in Chapter 1.  They are taught, for 
example, that UNAIDS estimates that blood-borne transmission accounts for 
less than 2% of transmission in sub-Saharan African nations, are hard facts.  
They are indoctrinated that 95% of transmission of HIV in sub-Saharan Africa is 
through unprotected (‘high risk’) sex and that MTCT is the almost-exclusive 
mode of transmission of HIV for infected children.   
 
Though the Mozambican Ministry of Health, in 2001, officially acknowledged the 
preventative benefits of ART and claimed a dedication to their usage in this 
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manner (as seen in the quote at the beginning of this chapter), this knowledge is 
not imparted to clinicians, whether they be medical technicians, nurses or 
physicians.  While patients may be free to muse about possible ‘truths’ in regards 
to HIV, clinicians carry a heavy burden of responsibility and are not free to 
express their opinions (however well-reasoned) to patients, particularly when 
those opinions contradict the official messages concerning HIV in Mozambique.  
Indeed, several clinicians at both health facilities expressed their own internal 
struggles to harmonize the ‘conventional wisdom’ on HIV with their own daily 
experiences with patients that, at times, seem to repudiate what they have been 
taught to believe and to impart to patients.  Recall, for example, nurse respondent 
#106 who expressed doubts about how she has always been told that HIV 
transmission happens primarily through sexual relations, but due to her own 
experience with so many discordant couples, she feels that there is something 
amiss with the official message.  Others express a general sort of disquiet with the 
way that prevention campaigns are carried out and with the messages imparted as 
in the following example: 
 
“Now that I’m working directly with patients, I really see that, if we had done 
something MORE, who knows if we would have fewer infected people, you 
know? But I think that these campaigns really… they need to 
change something in their prevention strategy, their 
information, for people to be able to trust a little more and for 
us to really be able to decrease the number of new cases.” 
[physician respondent #306. Working with HIV patients for 4 years] 
 
While one physician, in her analysis of Mozambique’s HIV situation, questions 
not only the thrust of prevention campaigns, but also the possible intentions or 
ulterior motives of the ‘international development community’ in allowing HIV 
to rage out of control in Africa for decades, pushing what she sees as toothless 
prevention campaigns, while lamenting the fact that a cure remains elusive. 
Though we may not agree with this physician’s musings on the possible ulterior 
motives behind the formulation of sexual-behavior based prevention policies 
(which she, herself, states have no basis in scientific fact but are, rather, her ‘gut’ 
feeling), it is nonetheless a strong signal that some clinicians in Mozambique feel 
that largely internationally-imposed policies stressing sexual behavior are 
disconnected from the clinical and social reality found in Mozambique, while 
many scientifically-sound, clinical interventions (such as a cure) remain out-of-
reach: 
 
“HIV looks a lot like a cold war to me. We still haven’t gotten HIV 
under control. It’s a huge issue with huge amounts of money, many people, and 
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involves many areas...The people who die the most are the 
underprivileged, and that’s us: Africans…And we die because 
we’re the poorest… We know that the world is overcrowded...we already 
had the 1st and 2nd World Wars and many people died. We can’t have a third, 
we can only have this kind of thing. So, when I forget medicine, lots of times, I 
have this opinion. Even if the virus [HIV] wasn’t ‘manufactured’, 
it’s a form of cold war...so many people dead from this and 
what do we do? Prevention campaigns! Ahhhhhh- prevention 
campaigns! But there’s still no cure. We’re so developed in all 
areas. Is it really possible that a cure doesn’t exist? Could it be? 
…I think that the time has already come for us to have a definitive treatment 
[cure]. A lot of us have died, but we still don’t have a cure.” 
 
It is my hope that readers will recognize that most criticism embodied in this 
study is a criticism of upstream policies concerning HIV rather than a criticism of 
the mainly well-meaning and hard-working clinicians who see patients every day.  
Indeed, both adult patients and caretakers of infected children who were 
interviewed largely report that their clinicians frequently treat them well and with 





While decentralization was discussed here through the lens of logistical issues, it 
also undeniably impacts and is impacted by the social construction of HIV. 
Decentralization of HIV services has the potential to be a double-edged sword in 
that it undeniably improves potential access to ART, particularly in urban areas 
with numerous health centers that can now offer ART.  However, as long as the 
issues of creation and exacerbation of stigma through official HIV prevention 
messages (and, by extension, the medical establishment) are not addressed, we 
run the risk of training an increasingly large cadre of clinicians (mainly medical 
tecnhicians) in a way that will continue to enhance stigma.  If we couple these 
stigmatizing messages with proximity to patients’ homes and an increased risk of 
involuntary disclosure of patients’ HIV status to neighbors and acquaintances, we 
chance offsetting some of the benefits of more proximate ART availability with 
the possible pitfall of increased negative social consequences for patients on 
ART.  
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It was my hope, with this doctoral dissertation, to explore the socio-political 
economy of antiretroviral treatment (ART) as an HIV prevention strategy in sub-
Saharan Africa (SSA) and, specifically, in Mozambique. As decentralization plays 
such a large role in efforts to scale-up HIV services (including treatment), some 
of the potential ‘human’ consequences of bringing treatment for a stigmatized 
illness closer to patients’ homes has been briefly explored as well within the case 
study. 
 
We began with a look at the social construction of HIV in SSA as a ‘sexually 
transmitted disease’ despite the biological fact that it is, instead, a sexually trans-
missible infection with very low transmission efficiency through heterosexual sex 
of only 1 in 10001.  This inordinate focus on sexual transmission in SSA to the 
exclusion of other routes of transmission (i.e.: blood-borne transmission in for-
mal and informal healthcare settings and even during cosmetic procedures) in the 
face of evidence that sexual transmission is less important than previously be-
lieved, not only allows new infections to continue to occur in areas that do not 
receive attention, but also has both fed and been fed by a political and social cli-
mate that blames individuals for their infection.   
 
The political discourse surrounding HIV relies heavily on this sexual ‘causal 
story’2,3 so that phenomena such as target groups and risk groups in HIV policy 
are consistently determined by perceived sexual behavior (‘lifestyle risks’) rather 
than any acknowledgement of environmental (or institutional level) risks.  These 
target and risk groups are more than theoretical constructions; they determine 
both the recipients of beneficial or punitive policies and, perhaps more im-
portantly, the rationales that are deployed to justify said policies.  Domestic and 
global HIV policies that remain rooted in a rights- or justice-based discourse 
(such as with commitments to the ephemeral ‘universal access to HIV preven-
tion’) ignore instrumental logic for implementing effective HIV policy, allowing 
politicians and society as a whole to continue to frame the issue of providing uni-
versal ART, for example, as an altruistic service of a government (or international 
 CONCLUSION 173 
 
 
donor) that is attempting to mitigate a problem caused by the irresponsible and 
self-destructive behavior of individuals4.   
 
This constructed dichotomy, therefore, has created a world where those in-
fected with HIV are often ‘monsterized’ and the remaining population is taught 
that they must always be vigilant and ‘protect themselves’ from these virtual 
monsters.  This socio-political construction assists us in the critical analysis of 
HIV policy, such as the discussion in Chapter 1 of the political minefield of post-
exposure prophylaxis (PrEP: things like vaginal gels for uninfected women to 
avoid contracting HIV) versus ART for infected persons.  Practical issues such as 
the financial, logistical and human resource constraints that are being tackled to 
attempt to provide ART to the 10-15% of the adult population that is infected 
with HIV and what these constraints would mean in terms of attempting to pro-
vide these same medications to the 85-90% of the population that is uninfected 
are not on the table for serious policy discussion.  The issue is consistently 
framed as one of providing disempowered potential ‘victims’ with a way of pro-
tecting themselves from the infected population living with HIV and an honest 
discussion of the feasibility of the PrEP approach is not politically viable as it 
would pit the interests and ‘rights’ of the monsterized group against those of the 
‘victims’.   
 
Chapter 2 then explored, in depth, the most efficacious form of HIV preven-
tion currently in existence: ART for infected persons.  As proven beyond a doubt 
by the HTPN 052 trials, the first randomized clinical trial to test the efficacy of 
ART as prevention, early ART is 96% effective in preventing sexual transmission 
of HIV to an uninfected partner5.  This compares to the 80-90% efficacy of con-
doms for HIV prevention6,7.  However, though ART is the most efficacious in-
tervention, it was my hope to also demonstrate that, even with the logistical bar-
riers to large-scale ART provision, the all-important coverage and usage factor 
cannot be ignored.  ART is more efficacious than condoms for HIV prevention, 
but as we have seen only slow growth of condom usage over the preceding three 
decades in Mozambique, ART, which is being rolled-out at an astonishing pace, 
may already be preventing more new infections in Mozambique than those that 
are being prevented by condoms due to this difference in coverage.  Condoms 
are a barrier method of HIV prevention, meaning that they will also prevent 




ther the infected or uninfected partner) is a population-level dead-end.  It must 
also be acknowledged that there are perverse consequences in terms of trust be-
tween partners of the concerted (and successful) effort over the last 30 years to 
link condoms to HIV prevention. This has caused many Mozambicans who do 
not use condoms to report that they avoid their usage because they are married 
and/or trust their partners8.  Suggesting condom usage in a monogamous rela-
tionship has become akin to either showing your distrust in your partner or your 
own untrustworthiness.  
 
For these reasons, I have encouraged what I call a ‘focus on the positives’; 
that is, HIV policy that focuses on the relatively smaller HIV-infected population, 
rather than the uninfected population.  However, to do so, a dramatic paradig-
matic shift would be necessary, particularly in terms of earmarked funding from 
the US government’s PEPFAR program which provides the bulk of HIV-specific 
funding in Mozambique and much of the developing world. 
 
The rules surrounding PEPFAR funding remain strict in their determination 
of what ‘counts’ as HIV prevention (abstinence/‘be faithful’ programs, male cir-
cumcision, and targeting of multiple and concurrent partnerships)9.  This means 
that the most efficacious prevention intervention known to humankind (ART for 
infected persons) may not be considered as prevention under PEPFAR rules and 
so may not receive prevention-specific funding.  While 35% of FY 2010 
PEPFAR funds in Mozambique were channeled towards treatment and care, this 
fell far short of the PEPFAR rule that 50% of total funds must go towards 
treatment and care10.   Rather than simply being a matter of financial allocation, 
these types of issues show the ongoing dichotomy and political trap discussed 
earlier where governments and institutions must seem to care more about pro-
tecting potential ‘victims’ of the HIV epidemic than the ‘monsterized’ infected 
persons.   
 
Though ART as HIV prevention will function with or without official 
acknowledgement, it will be important to reconsider the artificial boundary drawn 
between prevention and treatment that perpetuates the negative social construc-
tion of those living with HIV.  The allocation of resources is an explicit manifes-
tation of government and international donor priorities as well as the ‘philoso-
phy’ underlying those priorities.  Were ART to be officially considered a 
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prevention strategy, this would help to ‘de-monsterize’ and empower those living 
with HIV, showing that ‘the positives’ have the power to turn around the HIV 
epidemic through a behavior (adhering to ART) that is also in their own, person-
al, health-seeking interests.  Though the fear of moral hazard manifests whenever 
discussions of ART as prevention are broached, there is very little (and often 
contradictory) evidence that patients on ART would compensate for the preven-
tative effects of ART by becoming more promiscuous or decreasing condom us-
age.  Indeed, the qualitative evidence from the interviews conducted with patients 
and clinicians during the fieldwork portion of this study (Chapter 4) shows a 
quite different scenario; one where patients express a nuanced understanding that 
ART as prevention would never be 100% certain (and condoms should still be 
used) but also the patients’ sense of pride and self-worth to know that adhering 
to ART could help one’s partner remain uninfected.  
 
Though a paradigmatic shift to ‘focus on the positives’ would greatly facilitate 
ART scale-up (and therefore the utilization of ART as prevention), the issue of 
human resource constraints cannot be ignored and is the topic of Chapter 3.  
Mozambique’s human resources for health (HRH) are considered to be in a state 
of ‘critical shortage’ by the WHO11.  Though human resource projections 
through 2015 call for massive increases in clinical personnel (and some categories 
such as technicians, both medical and laboratory are set to exceed official goals)12, 
entrenched issues of public to private brain drain and a general lack of incentives 
for public sector health workers must be addressed systematically.  In particular, 
the physician cadre remains undervalued in the public sector and highly-coveted 
in the private, donor-funded sector.  Though Mozambique attempted, in 2000, to 
address this issue with the non-binding ‘Kaya Kwanga Commitment’13, a code of 
conduct that was signed by virtually all the major international organizations 
working in Mozambique’s health sector, strong financial incentives continue to 
pull clinicians (and particularly, physicians) into the private sector14.  Mozambique 
must make a concerted effort to truly implement regulations and incentive pro-
grams to avoid this internal brain drain, following through on governmental 
promises to increase human resource expenditures as a percentage of health 
spending (rather than decreasing them as we have seen in recent years)15.   
 
Though the strategy of ‘task shifting’ which delegates clinical responsibilities 




technicians)16 has allowed for the crucial decentralization and expansion of HIV 
services (including ART provision), it cannot be considered a panacea to 
Mozambique’s critical health worker shortage.  Mozambique risks training an in-
creasing horde of medical technicians (those to whom the responsibility of initia-
tion and follow-up of ART has been delegated since 2006) who are steeped in the 
negative social construction of HIV-positive persons as discussed in Chapter 1.  
As, with the process of decentralization, patients are treated for HIV closer and 
closer to their homes, we must consider more closely the ‘human’ side of the 
human resource issue to be sure that we are not simply bringing stigma and cen-
sure closer to patients’ neighborhoods.  
 
Chapter 4 then is a culmination of the previous chapters that attempts to ex-
amine the practical effect of the social construction of HIV in Mozambique on 
persons living with HIV and seeking treatment. By carrying out the fieldwork 
portion of the dissertation in the capital, Maputo, I have attempted to minimize 
the logistical and human resource constraints that are more severe in peri-urban 
and rural areas and instead focus on the more intangible aspects of patients’ ex-
periences with ART.  Through a number of semi-structured, qualitative inter-
views with adult patients, caretakers of pediatric patients and clinicians (physi-
cians, nurses and medical technicians) in two medical facilities, the case study 
uses a mediation model to explore the effect of HIV prevention messages (fo-
cused on sexual behavior and mother-to-child transmission) on patients’ experi-
ences with and adherence to ART.  The mediating factors identified are creation 
or exacerbation of stigmatizing beliefs and the trust or disconnect between pa-
tients and the medical establishment created by these aforementioned HIV pre-
vention messages. 
 
Through an examination of patients’ knowledge and beliefs about HIV, their 
sources of information and, importantly, which sources of information they be-
lieve are credible, we find that many patients (and caretakers of pediatric patients) 
indeed have received correct information about HIV (for example, concerning 
blood-borne transmission and the efficacy of ART as prevention), but that they 
have received this information from sources which they identify as unreliable and 
not, crucially, from official sources of information (i.e. health workers, TV and 
radio) which they largely consider reliable.  In fact, though the clinicians inter-
viewed were aware of issues of blood-borne transmission, for example, we find a 
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severe disconnect between their knowledge and the knowledge that they impart 
to patients, with an unwillingness to discuss non-sexual (or non-MTCT) modes 
of transmission with patients.  We find that communications with patients 
(whether directly through patient-clinician interactions or indirectly through pub-
lic health campaigns) remain ensconced in the ideologically-tinged information 
base of the sexual behavior (and, to some extent, the MTCT) paradigmatic causal 
story of the HIV epidemic.  Though some patients and clinicians expressed 
doubts about the accuracy of this paradigm based on their own experiences, the 
dominance of this paradigm is paramount and seems to be creating considerable 
cognitive dissonance for patients who must disregard the (correct) information 
they sometimes receive from unofficial sources in order to ‘deliver themselves’ 
over to the medical establishment with its  life-saving potential. Not incidentally, 
we also find clinicians who seem to be experiencing a certain level of disconnect 
between the official HIV causal story that they have been taught (both in and out 
of their medical studies) and what they see in their day-to-day experience.  
 
This continued focus on sexual transmission in HIV prevention campaigns 
seems to be feeding into perceived stigma among ART patients so that they re-
peatedly and consistently expressed shame in their seropositivity (or in the belief 
that they infected their child, in the case of the mothers of pediatric patients in-
terviewed).  This seems to lead to issues surrounding disclosure, both voluntary 
disclosure to partners and family members as well as involuntary disclosure (for 
example, by being seen going to the health center regularly or taking medica-
tions).  As numerous studies have demonstrated the importance of disclosure to 
ART initiation and adherence17,18,19, these issues of stigma being created by our 
very own HIV prevention messages and communications between patients and 
clinicians can no longer be ignored.  Patients’ stories of how their fear and shame 
of disclosing their serostatus concretely impacted their experiences with ART 
ranged from young mothers who forwent treatment during pregnancy allowing 
their newborn infants to die of AIDS rather than admit their serostatus, to a 
young child who was admitted to the hospital with an AIDS-defining illness after 
his grandmother (with whom he was left while his mother traveled) failed to give 
him his ARVs for fear that other family members in her household would guess 
that the child was infected with HIV.  We saw uninfected mothers whose chil-
dren are on ART who blame themselves for their child’s infection, believing that 




not have – that was responsible for their child’s infection.  We heard the bewil-
derment of numerous patients when asked how they may have become infected 
(with some positing through bogus routes of transmission such as ‘food’) and, 
more significantly, their confessions that no clinician had ever discussed the pos-
sible mode of transmission with them.  These patients, however, almost invaria-
bly believe that those around them (including their clinicians) think that they 
were infected through sexual relations and many, without prompting, pre-
emptively mentioned the fact that they are faithful to their partners and/or have 
only ever been with one (sometimes uninfected) partner, revealing that they are 
quite aware that they are, indeed, being judged by both clinicians and society as 
sexually deviant (promiscuous and/or unfaithful) because they are infected with 
HIV. 
 
 If, indeed, we are to take full advantage of the preventative externalities of 
ART as HIV prevention, we cannot underestimate the importance of pro-active 
treatment-seeking behaviors.  Early treatment is crucial (as discussed in Chapter 
2) and adherence must be optimal.  In light of this, the many stories of patients 
who delayed being tested for HIV due to the very real fear of social and personal 
consequences (such as being thrown out of their home by a husband who would 
assume they were unfaithful) or delay enrollment in treatment to avoid voluntary 
or involuntary disclosure, can no longer be ignored.  We must take a critical look 
at how the social construction of HIV in Mozambique and globally affects ‘the 
positives’ so that we may understand how we, as a global society, can bring these 
HIV-infected persons into the prevention fold, empowering them and utilizing 
their potential to curb the HIV epidemic in the most efficacious and promising 
way available to us: through the explicit use of ART as HIV prevention. 
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Appendix 1, Table 1. Reasons for condom usage, Mozambique 2009 
 
 
 15-19 20-24 25-29 30-34 
Total # of respondents who have ev-
er had sexual intercourse 
1225 1616 1539 1295 
Number who used condom at last 
intercourse 
399 383 226 134 
% who used condom at last intercourse 32.6 23.7 14.7 10.3 
Number who used condom to prevent 
STI 
350 288 159 92 
% to prevent STI 87.7 75.2 70.4 68.7 
Number who used condom because 
‘Don’t trust partner’ 
19 23 16 14 
% because ‘don't trust partner’ 4.8 6.0 7.1 10.4 
Number who used condom due to mes-
sages advising use 
8 13 6 1 
% due to messages 2.0 3.4 2.7 0.7 
Number who used condom to prevent 
pregnancy 
265 257 132 77 
% to prevent pregnancy 66.4 67.1 58.4 57.5 
Number who used condom for ‘Other’ 
reasons 
10 14 20 8 
% for ‘other’ reasons 2.5 3.7 8.8 6.0 
Number who used condom to prevent 
STI AND to prevent pregnancy 
232 188 94 49 
% Overlap- STI/Pregnancy 58.1 49.1 41.6 36.6 
Number who used condom to prevent 
STI and due to messages 
2 5 3 0 
% Overlap- prevent STI/messages 0.5 1.3 1.3 0.0 
Source: Demographic and Health Surveys, Mozambique 2009 
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Appendix 1, Table 2. Reasons for not using condoms, Mozambique 2009 
 
 15-19 20-24 25-29 30-34 
Total # of respondents who have ev-
er had sexual intercourse 
1225 1616 1539 1295 
Number who did not use condom at 
last intercourse 
826 1233 1312 1161 
% who did not use condom at last intercourse 67.4 76.3 85.3 89.7 
Number who did not use condom be-
cause no condom available 
246 196 175 146 
% because no condom available 29.8 15.9 13.3 12.6 
Number who did not use condom be-
cause partner refused 
110 114 116 90 
% because partner refused 13.3 9.2 8.8 7.8 
Number who did not use condom be-
cause they use other contraceptive 
13 10 17 11 
% because use other contraceptive 1.6 0.8 1.3 0.9 
Number who did not use condom be-
cause condom reduces sexual pleasure 
90 93 79 55 
% because reduces pleasure 10.9 7.5 6.0 4.7 
Number who did not use condom be-
cause they ‘trust partner’ 
183 372 368 386 
% because ‘trust partner’ 22.2 30.2 28.0 33.2 
Number who did not use condom be-
cause "I'm married" 
230 530 689 626 
% because 'I’m married' 27.8 43.0 52.5 53.9 
Number who did not use condom be-
cause "I'm faithful" 
67 148 153 161 
% because "I’m faithful" 8.1 12.0 11.7 13.9 
Number who did not use condom for 
other reasons 
62 88 79 62 
% for other reasons 7.5 7.1 6.0 5.3 
Number who did not use condom be-
cause 'trust partner'/married 
35 115 133 154 
% Overlap 'trust partner'/married 4.2 9.3 10.1 13.3 
Source: Demographic and Health Surveys, Mozambique 2009 
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